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Bacteria are under constant threat by their viral parasites, the bacteriophages (phages) 
and have evolved a range of anti-phage systems to defend themselves. One of these 
systems is termed abortive infection (Abi) where, upon phage infection, an Abi system 
may be activated which initiates a bacteriostatic or bactericidal response. While the 
infected bacteria do not obviously benefit from the activation of these systems, the 
cessation of bacterial growth or premature cellular suicide prevents the release of 
phage progeny. Thus Abi can be viewed as an altruistic process as only the remaining 
clonal bacterial population benefits. The Type III toxin-antitoxin systems have 
previously been shown to be involved in Abi, however the mechanisms through which 
these systems are activated are still poorly understood. A common approach to reveal 
the phage product involved in triggering these systems is to first determine the 
mutations that a previously sensitive phage evolves to escape after exposure to an Abi 
system. Analysis of viral “escape” mutants has been used in this study to try to 
elucidate the activation mechanism(s) of two Type III systems (ToxINPa and TenpINPl) 
of several environmental phages. Several new phage products were identified in 
escape mutants as candidate factors involved in circumventing Abi – and possible 
roles in phage metabolism predicted. Furthermore, the genomes of several phages 
that could not evolve escapes, or were insensitive to Abi, are sequenced and these 
data exposed interesting curiosities regarding Abi (as well as the discovery of several 
novel and rare phages). Previously, no coliphage was identified that was capable of 
escape of the ToxINPa or TenpINPl systems. However, this study defined and 
characterised the first ToxINPa and TenpINPl coliphage escapes as well as a new 
method for isolating host-dependent coliphage escapes. Finally, multiple phages that 
infect the insect pathogen Photorhabdus luminescens TT01 (the bacterial strain from 
which the TenpINPl system originated) were isolated, genomically sequenced and 
characterised in terms of host range. The results revealed a large superfamily of 
flagellum-dependent phages that exhibit remarkable host promiscuity, possibly 
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Chapter 1 Introduction 
1.1 Bacteriophages 
1.1.1 History and significance 
Bacteriophages (phages) “bacteria eaters” are the viral parasites of bacteria 
(D’Herelle, 2007). The discovery of phages is somewhat controversial and credited to 
two different researchers who may have discovered them independently (Duckworth, 
1976). The first description of phages has been attributed to Frederick Twort, a British 
physician who carried out experiments while he was superintendent at the Brown 
Institution at London University. While working with the vaccinia virus he used an 
unfiltered fluid that was used in small pox vaccinations to try and replicate the virus. 
The vaccinia virus could not replicate but he noted that micrococci grew on the agar 
plate instead. He noticed that a number of the micrococci colonies showed a physical 
manifestation of a “disease” and described these colonies as glassy and transparent. 
Furthermore, he noted that by touching a non-diseased i.e. non glassy colony with a 
little of a glassy colony, the glassy phenotype spread throughout the colony as it grew. 
The agent that lead to the glassy phenotype still retained activity after filtration and so 
could be replicated. These observations suggested that he was in fact working with a 
bacterial virus, however, Twort never explicitly stated that. He cautiously suggested 
that his observations had not disproven the agent to be a virus and could be caused 
by other alternatives such as a self-replicating enzyme. Unfortunately, he was not able 
to carry this research further as he states at the end of the paper, “I regret that financial 
considerations have prevented my carrying these researches to a definite conclusion, 
but I have indicated the lines along which others more fortunately situated can 
proceed” (Twort, 1915). 
 
The “more fortunately situated” turned out to be Felix d’Herelle, a French-Canadian 
microbiologist who, while working at the Pasteur institute in France, characterised 
“clear spots” he would occasionally find on lawns of bacteria after mixing filtered faecal 
samples from patients with dysentery with cultures of dysentery bacilli. In these 
experiments he suggested that the causation of these “clear spots” was from an 
invisible microbe as he could not see the microbe through light microscopy (D’Herelle, 
2007). He called these microbes “bacteriophages” i.e. bacteria eater where the word 
phage comes from the Greek work “phagein” meaning to eat. It became apparent to 
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him that this bacterial parasite might be used to treat bacterial infections in humans 
paving the way for phage therapy (Fruciano and Bourne, 2007; Summers, 2001). It 
was initially heralded as an Erlich’s “magic bullet” due to its specificity in killing bacterial 
hosts. However, these early phage trials are often criticised for the lack of scientific 
rigor and mixed results (Fruciano and Bourne, 2007). Furthermore, with the discovery 
of antibiotics and the association of phage therapy with the Soviet Union at the time 
(phage therapy was often referred to as Stalin’s cure) the interest in phage research 
for therapy declined, at least in the West (Stone, 2002; Wittebole et al., 2014). 
 
At this point in time, interest in bacteriophage research was diminishing however this 
was all about to change. In 1937, Max Delbrück a German physicist turned biologist, 
moved to Caltech to work on Drosophila with T. H Morgan (Keen, 2015). As a trained 
physicist he was looking to find the simplest model organism with which to study the 
basic principles of biology. Drosophila proved to be too complex, however during his 
time at Caltech, he met with Emory Ellis a postdoctoral researcher, who was working 
with phages at the time. Delbruck soon became fascinated by phages and choose to 
use them as his model organism instead of flies. He began to collaborate with other 
scientists including, Salvador Luria and Alfred Hershey and others. This marked the 
birth of the Phage Group, which was a group of researchers using phages as a model 
“organism” to study the fundamental principles of biology. The research performed by 
members of the Phage Group defined some of the most important in the field of biology 
(Table 1). 
 
Phages have had a tremendous impact on our understanding of the fundamental 
principles of biology (Keen, 2015). A list of several of the most significant experiments 
involving phages is shown in Table 1. Furthermore, studies of phages have also led to 
the development of many molecular tools such as phage display, phage typing, 
restriction enzymes and more recently the CRISPR-Cas systems. Advances in 
sequencing has led to a boom in new phage sequences published which has revealed 
just how diverse these entities are and just how little of the phage world is understood. 
The majority of published phage genomes encode many proteins of unknown function 
potentially providing a rich source of novel biology. 
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Table 1. Key phage experiments from the 1940-70 
* signifies a Nobel laureate. Members of the phage group are in bold. This table was taken 
from (Keen, 2015). 
Year Researcher(s) Finding(s) 
1943 S. Luria*, M. Delbrück* Mutation is spontaneous and random (pre-adaptive), not directed (post-adaptive) 
1945 S. Luria* 
Viruses can mutate so as to be able to 
successfully infect previously resistant 
bacteria 
1946 A. Hershey*, M. Delbrück* Two viruses can genetically recombine when co-infecting the same cell 
1950 A. Lwoff*, L. Siminovitch, N. Kjeldgaard 
Ultraviolet radiation can induce the excision 
of a viral genome from that of its host 
1951 V. Freeman Viruses can contribute to bacterial virulence (e.g., by encoding diphtheria toxin) 
1952 A. Hershey*, M. Chase DNA, not protein, is unambiguously the hereditary material of life 
1952 N. Zinder, J. Lederberg* Viruses can transfer DNA between cells (transduction) 
1952 S. Luria*, M. Human 
Once adapted to a particular host, viruses’ 
ability to infect other hosts is greatly 
diminished (this “restriction” was later shown 
to result from restriction enzymes) 
1955 S. Benzer 
The sequence of a gene is linear; 
recombination can occur between adjacent 
nucleotides 
1961 B. Hall, S. Spiegelman Complementary DNA and RNA can hybridize 
1961 F. Crick*, L. Barnett, S. Brenner*, R. Watts-Tobin 
Nucleotides are read three units at a time (as 
codons) to form proteins 
1961 S. Brenner*, F. Jacob*, M. Meselson 
mRNA is the intermediate between DNA and 
protein; mRNA is translated into protein by 
ribosomes 
1962 D. Nathans*, G. Notani, J. Schwartz, N. Zinder 
Purified RNA can direct the synthesis of its 
encoded protein in a cell-free environment 
1967 M. Gellert (and other laboratories) DNA ligase joins together DNA fragments 
1967 M. Goulian, A. Kornberg*, R. Sinsheimer 
DNA can be synthesized from its 
precursors in vitro 
1969 
R. Okazaki, T. Okazaki, K. 
Sakabe, K. Sugimoto, A. 
Sugino 
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1.1.2 Bacteriophage taxonomy 
Phage taxonomy has not been as straight-forward partly due to the fact that there is 
no single protein present in all phages and so phage taxonomy is constantly changing. 
Originally, d’Herelle suggested that all phages were a single species with multiple 
races which he called Bacteriophagum intestinale (D’Herelle, 1918). Then with the 
invention of the electron microscope, phages could finally be observed and were 
classified based on their morphology (Luria et al., 1943). A greater understanding of 
the nature of nucleic acids also showed that the genetic material of phages differed 
and could be spilt into either single stranded DNA, double stranded DNA, single 
stranded RNA and double stranded RNA (Ackermann, 2009). In 1966, the International 
committee for the taxonomy of viruses (ICTV) was formed which aimed to classify all 
viruses, including phages. The ICTV created a taxonomy tree based on the nature of 
the nucleic acid of phages and their morphology. For example, the order Caudovirales 
contains all tailed phages which was originally spilt into three different families, 
Myoviridae, Siphoviridae and Podoviridae, based on the tail morphology. Phages 
belonging to Myoviridae, Siphoviridae, Podoviridae have long contractile tails, long non 
contractile tails, and short non contractile tails, respectively. These phage families are 
then broken down further into subfamilies and genera based on other factors such as 
the hosts they were isolated from, sizes of genomes and whether the genome was 
linear, circular or supercoiled (Nelson, 2004). 
 
There are obvious short-comings to the methods chosen for classfication by the ICTV 
as it does not take into account the genetic or proteomic information of each phage. 
This gives the false impression that phages within a family are more evolutionary 
related to each other than those outside. This is not always the case, for example, the 
podovirus P22 has a short non contractile tail and does not share homology with many 
other Podoviridae but shares homology with the Siphoviridae member λ. Both P22 and 
λ phages share such high genetic homology that recombination experiments between 
the genomes of both phages were able to produce some functional hybrids (Botstein 
and Herskowitz, 1974). However, P22 and λ are still classified as being in different 
families instead of being grouped together. Many alternative approaches to improving 
phage taxonomy have been proposed based on using genetic and/or proteomic data 
(Nelson, 2004). The ICTV is trying to acknowledge these problems and is constantly 
updating taxonomy. Recently, Caudovirales, the tailed phages that make up 96% of all 
sequenced phages have been spilt into four families. The new family called 
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Ackermannviridae was originally part of the Myoviridae family as members contained 
long contractible tails but, as they showed little genetic homology to other Myoviridae, 
the new family was proposed (Kuhn et al., 2017). It is likely that in coming years the 
original three Caudovirales familes, Myoviridae, Podoviridae and Siphoviridae will be 
subdivided even further (Aiewsakun et al., 2018).  
 
 
1.1.3 Bacteriophage lifecycles 
Phages are obligate intracellular parasites and so require a bacterial host in order to 
replicate. They have been shown to have at least four different replication life cycles 
(Figure 1.1). These are the lytic, lysogenic, pseudolysogenic and chronic cycles 
(Weinbauer, 2004). 
  
Chapter 1 Introduction 
6 
   
 
Figure 1.1 Phage replication life cycles 
Simplified phage replication life cycles showing the four different replication cycles. 
Figure adapted from (Weinbauer, 2004).  
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1.1.3.1 Lytic cycle 
The lytic cycle leads to the death of the host cell that the phage invades and is most 
commonly observed in the Caudoviridae order. The first step of a lytic cycle is called 
adsorption where the phage makes contact with a specific receptor located on the 
surface of the bacterial cell. Common bacterial receptors include lipopolysaccharide 
(LPS), flagella and a range of outer membrane proteins (Bertozzi Silva et al., 2016). 
The recognition of these receptors by the phage can be through tail fibres or tail spike 
proteins. After adsorption the next step involves injection, when the genomic material 
is injected through the tail of the phage into the bacterial host. Phage genetic material 
is then replicated using the host transcription machinery. For the Tevenvirinae, 
including T4, phage genes are under the control of three different promoters depending 
on when they need to be transcribed. The genes are labelled as early, middle and late 
and are sequentially transcribed (Miller et al., 2003). The early genes code for proteins 
involved in the metabolism of the phage and includes RNA and DNA polymerases, 
nucleases etc. During the early phase, the phage genomic material is replicated and 
the conditions are set to favour middle gene transcription. The middle genes code for 
proteins involved in the structural aspect of the phage such as the major capsid protein, 
tail tube protein and tail fibre. The phage particles are assembled at this stage and 
finally late gene products are made. Late genes encode phage products involved in 
the lysis of the host, such as holins and endolysins. Production of these phage 
products leads to the lysis of the host cell, releasing many newly formed phage 
progeny into the surrounding environment to start the cycle anew. 
 
1.1.3.2 Lysogeny 
The lytic lifecycle causes the death of the host which means that the phage progeny 
now have to find a new host in which to replicate. This can be disadvantageous if 
potential hosts are scarce and the environment is not favourable. Lysogeny is a life 
cycle that has evolved in some phages and does not always lead to the lysis of the 
host cell. Phages that undergo lysogeny are called temperate phages and upon 
injecting their genomic material into their host can incorporate it via recombination into 
the chromosomes of their hosts where they reside as prophages. For a few phages, 
such as P1, the prophage exists as a plasmid (Łobocka et al., 2004). While their hosts 
replicate, the genomic material of the temperate phages is also replicated. In this way 
all further bacterial progeny will carry phages without causing lysis of the host. Bacteria 
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carrying these temperate phages are known as lysogens. Temperate phages no longer 
need to constantly locate a new host in which to replicate and are protected from the 
environment. Lysogens can also benefit by carrying prophages as they are immune to 
further later infection of the same type of phage, via superinfection systems (discussed 
in detail later). The prophages themselves carry many new genes that can be 
beneficial to lysogens in a symbiotic relationship. However, prophages can also enter 
a lytic cycle. This can happen spontaneously in a small number of cells, for example 
in phage λ lysogens this occurs at 10-8 to 10-5 per cell (Czyz et al., 2001). There are 
various factors that can induce the release of prophages. One of the common causes 
is DNA damage, in fact, phage λ was discovered accidently by Esther Lederberg by 
exposing a λ lysogen to UV light (Gottesman and Weisberg, 2004; Lederberg and 
Lederberg, 1953). Other effectors include antibiotics, hydrogen peroxide, mitomycin C, 
changes in nutrients and uptake of foreign DNA (Banks et al., 2003; Choi et al., 2010; 
Czyz et al., 2001; Schuster et al., 1973; Setlow et al., 1973). Prophages can also cause 
the induction of other prophages carried by the host. An example of this is the 
exploitation of phage P2 by phage P4 in a process described as molecular piracy. P2 
encodes an anti-repressor called Cox which causes the induction of P4 allowing it 
effectively “steal” the structural proteins encoded by P2, forming empty P2 virions and 
packaging its own DNA in these virions (Christie and Dokland, 2012). On the other 
hand Enterococcus prophages namely, pp1, pp3 and pp5 have also been shown to 
prevent the induction of prophages pp4 and pp6 (Matos et al., 2013). 
 
Lysogeny can offer advantages for both phages and their hosts. For instance, 
temperate phages often carry useful genes including those involved in antibiotic 
resistance and virulence (Fortier and Sekulovic, 2013; Larrañaga et al., 2018). Many 
temperate phages are also transducers i.e. they can accidently package host genetic 
material into their virions and after lysis of the host, inject it into a new host, thus acting 
as a means for horizontal gene transfer (Schicklmaier et al., 1998). As lysogens are 
immune to further infection by the same phage other susceptible bacteria can be lysed 
by the spontaneous release of phage, thus reducing the competition as well as 
providing nutrients from the lysed cells (Harrison and Brockhurst, 2017). Prophages 
are also known to code for bacteriocins which can be produced by the lysogen to kill 
competitors (Gebhart et al., 2012). While carrying prophages can seem like a double 
edge sword for many lysogens, prophages can also be domesticated by losing genes 
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necessary for the formation of viral particles making them unable to enter the lytic cycle 
(Strathern and Herskowitz, 1975). 
1.1.3.3 Pseudolysogeny 
Pseudolysogeny is an intermediate between lytic and lysogeny cycles and is a 
phenomenon that is still not well understood. There are many definitions of 
pseudolysogeny because it may be a broad term used to describe a range of different 
life cycles exhibited by phages. Generally speaking, pseudolysogeny is when a phage 
infects a bacterial cell but stops replicating, likely due to host conditions being 
unfavourable. The genetic material of the phage does not stably recombine with the 
host genome as in many temperate phages and does not replicate. Instead it can 
remain unchanged until favourable growth conditions allow the resident phage DNA to 
either undergo a lytic or lysogenic cycle (Clokie et al., 2011). Nutrient starvation has 
been linked to pseudolysogeny hence, once host cells are no longer starved, phages 
may be able to then be capable of continuing either a lytic or lysogenic lifecycle (Ripp 
and Miller, 1998). 
 
1.1.3.4 Chronic 
The release of phage particles from infected bacterial cells does not always cause the 
lysis of the host cell. Filamentous phages can undergo a chronic lifecycle whereby, 
instead of lysing the bacterial cell, the viral particles are constantly shed by the cell 
without causing death to the bacterial host (Mai-Prochnow et al., 2015). This lifecycle 
has been exploited technically since bacterial hosts are not killed and filamentous 
phages (such as M13 or fd) can be engineered for phage display applications (Sidhu, 
2001). 
 
1.2 Anti-phage mechanisms 
Bacteria might be the most abundant organisms on Earth, however, phages represent 
the most abundant biological entities outnumbering their bacterial hosts 10:1 (Brüssow 
and Hendrix, 2002). There is an estimated 1031 phages in the world (Brüssow and 
Hendrix, 2002). This number is likely an underestimate as the methodologies used to 
determine the number of phages have various limitations. The original group that 
predicted that there was 2.5x108 viral particles per ml of natural water (which is likely 
where the 1031 figure was extrapolated from) counted plaque forming units using 
various host bacteria (Bergh et al., 1989). The limitations of these experiments are 
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obvious as a vast majority of phages would remain unaccounted for. Other techniques 
that have been employed are epifluorescence microscopy using either DAPI or SYBR 
green, both dyes mainly used for dsDNA quantification (Noble and Fuhrman, 1998; 
Suttle et al., 1990). Pulsed field gel electrophoresis has also been used to measure 
viral populations in the sea, however, this again only takes account of dsDNA viruses 
(Steward et al., 2000). To address this issue flow cytometry has been used which is 
able to count RNA viruses as well but flow cytometry counts still underestimate the 
number of viral particles present (Tomaru and Nagasaki, 2007). Many ssDNA and RNA 
viruses are still thought to be missed by these techniques and may be more abundant 
than previously thought (Breitbart, 2011; Steward et al., 2013). Nonetheless, the 
number of predicted phage infections is still predicted to be 1025 per second leading to 
a huge global turnover in bacterial populations (Lima-Mendez et al., 2007). Phages 
and bacteria have existed for millions of years so it is hardly surprising that, to survive 
constant phage onslaught, bacteria have developed multiple anti-phage mechanisms. 
At every stage of the phage infection cycle, bacteria have evolved mechanisms to 
control infection (Figure 1.2). These mechanisms are described in further detail in the 









































































































1.2.1 Receptor modification 
The first step of phage infection is called adsorption whereby the phage recognises a 
specific receptor on the bacterial surface, and phages tend to be very selective with 
their receptors. Consequently, should the bacteria alter this receptor in some way it 
may prevent the phage from recognising it and so prevent an infection. One problem 
that bacteria have is that many of the common phage receptors are important 
components of the bacteria such as LPS, flagella or outer membrane proteins. 
Alteration of such receptors may lead to phage resistance however, it can lead to a 
fitness cost for the bacteria which may be unfavourable in the long term, particularly if 
the phage population is relatively low. However, specific mutations can occur in some 
outer membrane protein genes that prevent phage adsorption but still retain outer 
membrane protein biological function (Morona et al., 1984). Another method to prevent 
phages recognising the receptor is for bacteria to reduce expression of genes that 
upregulate the receptor or alternatively to completely prevent access to the receptor 
by masking it in extracellular matrix (Hammad, 1998; Kim et al., 2015; Tan et al., 2015). 
Phages have been shown to circumvent this by either evolving to recognise an 
alternate receptor or by destroying the extracellular matrix masking the receptor by 
integrating depolymerising enzymes in their capsids (Kim et al., 2015). E. coli mutants 
have been shown to down regulate the LamB protein, the receptor for λ. 
Correspondingly, phage λ can evolve to circumvent this by recognising an alternate 
receptor, the OmpF protein (Meyer et al., 2012). 
 
1.2.2 Superinfection 
Once adsorbed onto a suitable receptor the phage has to inject its genomic material 
into its host. The injection step can be prevented by a mechanism called a 
superinfection system. These systems originated from temperate phages to prevent 
competition from other phages within an already infected host. As these systems are 
encoded on many prophages, some bacterial strains can already be immune to a 
range of phages. Many superinfection systems are known but the mechanisms 
involved are still not well understood, although they are all membrane associated. 
Examples of superinfection systems include Streptococcus thermophilus phage TP-
J34 where the superinfection control system is a membrane associated lipoprotein that 
prevents the injection of Siphoviridae phages by interaction with their tape measure 
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proteins (Bebeacua et al., 2013). The tape measure protein of Siphoviridae phages 
acts as a channel in which DNA can bypass the membrane and so is required for 
injection. The most well-known superinfection control systems are two in the phage 
T4. The Imm system prevents the injection of DNA by modification of the injection site 
while the Sp system inactivates phage lysozyme (Lu and Henning, 1989, 1994).  
 
1.2.3 Restriction and modification systems 
If a phage manages to inject its nucleic acid into the bacterial host it can be targeted 
by restriction and modification (RM) systems. These are by far the most studied of anti-
phage systems due to their exploitation in molecular biology (Roberts, 2005). The 
phenomena of RM systems were first observed in 1952 by Luria and Human and in 
1953 by Bertani and Weigle (Bertani and Weigle, 1953; Luria and Human, 1952). It 
was noted that the efficiency with which phages infected certain hosts was dependent 
on the host on which they were previously propagated. It appeared that phages 
remembered what host they had been propagating on so that while they replicated 
efficiency in the previous host, infection of a new host would be less efficient. The 
phages would then replicate efficiently in this new host but poorly in the previous host 
however, efficiency to the original host could be restored by propagating the phage 
back on it. Werner Arber proved that this phenomenon was the result of restriction 
modification systems which consisted of two different enzymes (Arber, 1965). The 
restriction enzyme acted as a pair of molecular scissors cleaving specific DNA 
sequences. The modification enzyme prevents the restriction enzyme from cleaving 
the bacterial DNA by modifying it by methylation.  RM systems have been 
characterised in four types based on their mechanism and genetic organisation 
(Loenen et al., 2014). 
 
Phages have evolved a range of strategies to cope with RM systems. Occasionally the 
phage DNA is also methylated by the methylase enzyme leading to all future phage 
progeny DNA being methylated and insensitive to the RM system. However, should a 
phage infect a host with a different methylase enzyme the progeny DNA follows this 
new modification and as the phage DNA no longer carries the same modification as 
the original host it reverts back to a sensitive state (Labrie et al., 2010). Phages can 
also modify their own DNA to prevent restriction. Phage T4 contains 
hydroxymethylcytosine in place of cytosine which makes it insensitive to all RM 
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systems that recognise any sequences with cytosine (Miller et al., 2003). As phages 
modify their DNA, bacteria have also developed systems to specifically recognise 
these modifications. Modification-dependent systems specifically recognise modified 
DNA, examples include the Streptococcus pneumoniae DpnI system as well as the 
McrA, McrBC and Mrr systems of E. coli (Raleigh and Wilson, 1986; Vovis and Lacks, 
1977). Phage T4 is resistant to modification dependent systems as its hydromethlated 
cytosines are also glucosylated. However, strain CT596 of E. coli contains a prophage 
which carries the GmrS-GmrD system that can recognise and cut glucosylated DNA 
(Bair and Black, 2007). Furthermore, T4 has responded in the form of a small nuclease 
inhibitor, IPI. During the injection stage of T4, hundreds of IPI proteins are injected 
alongside the genome which are able to directly inhibit the GmrS-GmrD system (Rifat 
et al., 2008). This “molecular arms race” does not end here as certain strains of E. coli 
have a GmrS-GmrD system that is encoded on a single protein and are immune to IPI. 
This is evidence of the Red Queen hypothesis which theorises that every organism 
has to constantly evolve and adapt lest they are outcompeted by other organisms that 
are also perpetually evolving and thus face extinction. It shows how both phages and 
their bacterial hosts are continuously evolving complex solutions to combat each other 
(Stern and Sorek, 2011).  
 
1.2.4 CRISPR-Cas 
The CRISPR-Cas systems are the most specific antiphage defence identified thus far 
and are often described as an adaptive immune system in bacteria (Barrangou et al., 
2007). CRISPR-Cas is short for clustered regularly interspaced short palindromic 
repeats and CRISPR associated proteins. The CRISPR array is a genetic locus made 
out of short repeating sequences that are separated by non-identical DNA sequences 
called spacers (Jansen et al., 2002). These spacers contain DNA originating from 
plasmids or phage genomes (Bolotin et al., 2005; Mojica et al., 2005; Pourcel et al., 
2005). Spacers are acquired during a phage infection, at the adaptation stage of the 
CRISPR-Cas system. Once the spacer has been acquired the next stage, expression, 
begins with the transcription of the entire CRISPR locus into a single RNA, pre-crRNA. 
This pre-crRNA is then cut and processed by Cas protein into mature crRNA. Finally, 
interference occurs during the next phage infection when identical phage sequence is 
recognised by the mature crRNA and targeted for degradation (Rath et al., 2015). 
There are three established CRISPR-Cas types defined by the composition of the Cas 
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proteins and the differences in the mechanism of acquisition and priming of spacers 
(S. Makarova et al., 2011). There are also CRISPR-Cas systems that do not fit in any 
of the three types which will likely mean the number of different types of CRISPR-Cas 
systems will increase as more is understood about them (S. Makarova et al., 2011). 
Due their ability to be exploited as precise genome editing tools, CRISPR-Cas systems 
have become a heavily researched topic, again highlighting how bacteriophage 
research has led to revolutionary molecular biological tools (Sander and Joung, 2014). 
 
The CRISPR Cas systems have been found in the genomes of 40% of bacteria and 
90% of archaea (Sorek et al., 2008). Although these figures may be lower if considering 
uncultivable microorganisms (Burstein et al., 2016). Nonetheless, there are examples 
of phages evolving counter measures to these systems. Phage T4 is likely already 
partially resistant to CRISPR-Cas as its glucosylated hydroxymethlated genome may 
interfere with the CRISPR-Cas system cutting its genome (Tao et al., 2018). Perhaps 
the simplest solution to escaping the CRISPR-Cas system are through point mutations 
of the phage genome in the spacer sequence as it would prevent recognition of the 
phage genome, and have the least impact on the phage (Deveau et al., 2008). More 
complex solutions have also been observed as phages have evolved a variety of anti-
CRISPR proteins (Hynes et al., 2018; Zhu et al., 2018). Phages have also turned the 
CRISPR-Cas system against their bacteria host. A group of Vibrio cholerae phages 
encode their own CRISPR-Cas system that targets another anti-phage system in their 
V. cholerae hosts (Seed et al., 2013). 
 
1.2.5 Abortive infection 
Abortive infection, the focus of this thesis is used to describe a wide range of anti-
phage systems acting after the injection of phage nucleic acid. The first reported 
description of abortive infection was in 1952 when phage T2r a mutant of phage T2 
(selected as it produces larger plaques) showed a reduced replication efficiency i.e 
lower multiplies of infection on starved E. coli strain B (Benzer, 1952). The scientist 
who performed the study, Seymour Benzer, called this phenomenon abortive 
adsorption. As a side note, Benzer, a member of the “phage group” eventually worked 
on the rIIA and rIIB genes and, using crosses of rII mutants produced the first fine 
genomic structure map (Benzer, 1959; Jayaraman, 2008). His most famous rII mutant, 
r1589, was used by Crick et al to show that DNA was in codons consisting of three 
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nucleotides (Crick et al., 1961). The work on abortive adsorption was characterised 
further by Samson Gross who once again observed that phage T2rI, another T2 phage 
variant, replicated less efficiently in starved E. coli K12 (Gross, 1954). Gross was 
unsure of the phage replication stage when this inhibition occurred and renamed it as 
abortive infection. 
 
One of the key hallmarks of an abortive infection is that the phage infected cell does 
not directly benefit from it. When an abortive infection system is activated by a sensitive 
phage it can have a bacteriostatic or bactericidal effect on the host. While halting 
growth, or initiating the premature death, of the cell does not benefit the bacterium, this 
leads to a reduced number, or no, phage progeny being released into the surrounding 
environment. The result is that the surrounding clonal bacteria are protected from 
further infection and so abortive infection is often viewed as a last resort “altruistic” 
response (Dy et al., 2014a; Shub, 1994). 
 
Abortive infection (Abi) is a post-infection control system and it encompasses a wide 
range of different anti-phage systems, all with very different mechanisms. Abi has been 
observed in a wide range of bacteria including E. coli, Lactococcus lactis, Vibrio 
cholerae, Shigella, Bacillus and Pectobacterium atrosepticum (Chopin et al., 2005; 
Chowdhury et al., 1989; Fineran et al., 2009; Smith et al.; Snyder and McWilliams, 
1989; Tran et al., 1999). One of the first Abi systems identified was the RexAB system 
found in phage λ (Snyder and McWilliams, 1989). Wild type E. coli K12 is a lysogen 
carrying phage λ as a prophage, which allows it to be resistant to other coliphages. 
Phage T4, however, is unaffected by the RexAB system if it contains a functional rII 
locus i.e. a functional RIIA and RIIB protein. Thus T4 rII mutants are unable to plaque 
on E. coli K12 (Landsmann et al., 1982). This was first seen by Benzer and investigated 
further by him and others (Benzer, 1959; Crick et al., 1961). The RexAB system 
consists of two proteins; RexA and RexB. Activation of the system in phage T4 is 
triggered by RexA acting as a sensor which detects a phage protein-bacterial DNA 
complex (Parma et al., 1992). Once detected, two RexA proteins cause the activation 
of RexB, a membrane protein that acts as an ion channel causing membrane 
depolarisation and, as membrane potential is lost, the death of the cell (Parma et al., 
1992). However, whether this leads to an altruistic suicide protecting the bacterial 
population remains controversial as there is also evidence suggesting that protection 
conferred by the RexAB system may be through creation of an unsuitable environment 
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for phage replication (Slavcev and Hayes, 2002). Thus the enhanced survival of 
infected cells, rather than death, may protect the bacterial population.  
 
While T4 is immune to wild type K12 lysogen abortive infection, overexpression of 
rexAB can still abort T4 suggesting that levels of rexAB are important for activity 
(Shinedling et al., 1987). However, mutations in the motA gene expression are able to 
make T4 insensitive again; the mechanism of which is not understood (Shinedling et 
al., 1987). Furthermore, overexpression of rexA halts cellular growth and causes a 
decrease in intracellular ATP levels similar to abortive infection phages (Snyder and 
McWilliams, 1989). This may suggest that perturbation of the stoichiometry of RexA 
and RexB may be a factor causing abortive infection. In order for λ to enter the lytic 
cycle it must avoid the effects of the RexAB system. It is thought that λ is able to 
upregulate RexB levels thus preventing abortive infection by RexA (Parma et al., 
1992). 
 
Certain E. coli K12 strains carry the defective lambdoid prophage e14 that carries 
another abortive infection system (Brody and Hill, 1988; Hill et al., 1989). This Abi 
system Lit (late inhibitor of T4) is a metallopeptidase that is constitutively expressed in 
an inactivated form. It is activated by a short peptide sequence called Gol that is 
located within the N terminal region of the major head protein (gp23) of phage T4 
(Bergsland et al., 1990; Copeland and Kleanthous, 2005). When activated, Lit cleaves 
a conserved motif in the translation elongation factor, Tu, that leads to the inhibition of 
translation and phage exclusion (Yu and Snyder, 1994). 
 
The Lit system is not the only example of a specific peptide sequence activating an 
abortive infection system. The clinical E. coli strain CT196, carries the prr locus which 
contains the prrC gene (Depew and Cozzarelli, 1974). During T4 infection, the phage 
produces an endonuclease inhibitor, Stp, which inhibits an RM system by binding to 
EcoprrI. However, EcoprrI forms a complex with PrrC which is released due to the 
interaction with Stp (Penner et al., 1995). PrrC is a ribonuclease that cleaves the host 
tRNALys leading to the inhibition of translation and subsequent phage exclusion. Wild 
type T4 however, is not aborted by PrrC as it is able to repair the damage caused by 
it. This locus was discovered in T4 mutants that were defective in RNA repair i.e. 
polynucleotide kinase and RNA ligase mutants (Depew and Cozzarelli, 1974). The Stp 
protein is not the only activator of PrrC. Several pyrimidine nucleotides, in particular 
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dTTP is able to directly activate PrrC, and they suggests that there may be functions 
of PrrC other than acting as an abortive infection system (Amitsur et al., 2003). 
 
Abortive infection systems are not limited to Gram negative bacteria; in fact, the 
majority of known abortive infection systems have been found in the Gram positive, 
Lactococcus lactis. This is partly due to the fact that L. lactis is an important bacterium 
in the dairy industry. Fermentation cultures of L. lactis represent the largest man made 
bacterial cultures and they are highly susceptible to phage infection (Chopin et al., 
2005; Garneau and Moineau, 2011). There are at least 23 identified L. lactis Abi 
systems identified, the abundance of which is in part due to the artificial selection of 
phage resistance phenotypes during selection of strains for the fermentation process 
(Chopin et al., 2005; Dy et al., 2014a). L. lactis Abi systems (are labelled as Abi 
followed by a letter) have a wide range of activities from preventing DNA replication of 
phages, causing the premature lysis of infected cells or interfering with phage 
packaging of DNA. A list of identified L. lactis Abi systems and their modes of actions 
(if known) is reviewed in (Ainsworth et al., 2014). 
 
The best characterised L. lactis Abi system is the AbiD1 system which, like the Lit and 
PrrC systems of E. coli, is also activated by a single phage-encoded protein. Prior to 
phage infection abiD1 mRNA is constitutively produced. This mRNA is highly unstable 
and due to a stem loop structure, the translation of it is also highly inefficient. The stem 
loop structure is located in the translation initiation region which is able to act as a 
binding site for phage bIL66 protein ORF1. Binding of ORF1 during phage infection 
stabilises the mRNA leading to the translation of the transcript (Bidnenko et al., 2002, 
2009). The AbiD1 protein then interferes with the function of another phage protein, 
ORF3, which is a RuvC-like endonuclease (Bidnenko et al., 1998). The role of ORF3 
is to resolve branched DNA structures and thus inhibition of ORF3 disrupts phage DNA 
replication and packaging (Bidnenko et al., 1998). The AbiD1 system can also be 
activated by a decrease in temperature, implying again that it too is more than “just” 
an Abi system and could have alternative functions (Bidnenko et al., 2009). 
 
Prior work in this lab identified a cryptic plasmid in the phytopathogen, P. atrosepticum 
SCRI1039 that encodes a protein, ToxNPa that shared homology with the AbiQ protein 
of L. lactis (Fineran et al., 2009). Subsequent work on ToxNPa revealed that it belonged 
to a new Type of toxin-antitoxin family and, like AbiQ, is also capable of aborting 
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infection by certain phages (Fineran et al., 2009). Further details on toxin-antitoxin 




Toxin-antitoxin (TA) systems are genetic loci that classically contain two components; 
a toxin protein and an antitoxin the neutralises the effect of the toxin. These loci were 
initially discovered as a plasmid maintenance system that worked by post 
segregationally killing (Gerdes et al., 1986a). A classical toxin-antitoxin system 
consists of two genes, an antitoxin gene and a toxin gene located downstream under 
the control of a single promoter. However, this is not always the case as three 
component toxin-antitoxin systems have been reported (Hallez et al., 2010). There are 
also examples of TA systems where the toxin gene is located upstream of the antitoxin 
(Jurenaite et al., 2013). The encoded toxin is always proteinaceous in nature and has 
a detrimental effect on the cell. The antitoxin component on the other hand can either 
be a protein or RNA and may or may not directly interact with the toxin. The nature and 
mechanism of action of the antitoxin forms the basis for the classification of TA systems 
into their different Types. To date there have been up to six reported Types of TA 
systems (Harms et al., 2018; Page and Peti, 2016). TA systems are widespread and 
although originally discovered as a plasmid maintenance system, have been found on 
bacterial chromosomes as well as phage genomes (Bast et al., 2008; Lehnherr et al., 
1993). They are also often found in multiple copies, for example E. coli MG1655 
contains 19 Type I, 13 Type II and three Type IV TA systems (Harms et al., 2018). 
Another example, Mycobacterium tuberculosis is predicted to contain 88 TA systems 
(Ramage et al., 2009). It has also been reported that pathogens have a high number 
of TA systems compared to commensals suggesting a possible role in virulence 
(Georgiades and Raoult, 2011). 
 
There have been three well established functions of TA systems, namely plasmid 
maintenance, persister formation and abortive infection (Harms et al., 2018). Plasmid 
maintenance, the original assigned function of toxin-antitoxin systems relies on the 
differential stability of the toxin and antitoxin. In general, the antitoxin is less stable than 
the toxin component. Thus, when a bacterial cell carrying a plasmid with a TA system 
divides into two, if a daughter cell does not inherit the plasmid it eventually dies due to 
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the activity of the cytoplasmic toxin. This is because the plasmid is no longer able to 
provide the antitoxin, thus once any remaining antitoxin is degraded, the more stable 
toxin would no longer be neutralised. In this way the cells become “addicted” to the 
plasmid as they are not able to survive without it (Yarmolinsky, 1995). It is thought that 
chromosomal TA systems may help prevent this addiction by providing their own 
antitoxins (Bast et al., 2008). 
 
Persister formation is one of the key reasons why TA systems has gathered interest 
(Lewis, 2010). The phenomenon of persisters was discovered by Joseph Bigger, who 
found that, after treating S. aureus with penicillin, a small percentage of cells survived. 
However after growing and exposing the survivors to penicillin again, the percentage 
of survivors was similar in both cases (Bigger, 1944). He concluded that these 
survivors were not antibiotic resistant mutants but rather antibiotic tolerant. As this 
phenotype was transient it was not due to a mutation but rather a mechanism that 
causes a small fraction of the bacterial population to enter a dormant non-replicating 
state, called persistence. After the removal of the antibiotic, persisters are able to 
return to a normal replicative state and become sensitive to antibiotics again. The role 
of TA systems and persister formation has become a controversial one recently. It is 
clear that TA systems are linked to the generation of persisters (Dörr et al., 2010; 
Tripathi et al., 2014). However, there have been many misconceptions in the field that 
have confused any definition of the exact role of TA systems with regards to persister 
formation (Kim and Wood, 2016). Furthermore, several high profile papers from one 
research group have been retracted recently, apparently due to data being affected by 
phage contamination (Harms et al., 2017). Originally that group found that 10 TA 
systems in E. coli were involved in persister formation, but it seems that this result is 
not repeatable (Harms et al., 2017; Maisonneuve et al., 2013, 2018). Although 
controversial, it had been commonly thought that the stochastic production of ppGpp, 
and subsequently the lon protease, are able to generate persisters by degradation of 
the antitoxin (Maisonneuve et al., 2013). It has been shown that persistence is 
unaffected in cells are unable to produce ppGpp or the lon protease (Chowdhury et al., 
2016; Shan et al., 2015). With the recent retraction of the Gerdes group papers this is 
now no longer thought to be the case and so the mechanism by which TA systems are 
activated to generate persisters is now unclear. 
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Several TA systems from various Types confer phage resistance (Harms et al., 2018). 
Whether this is a result of “altruistic suicide” or halting of bacterial growth caused by 
TA systems is still to be determined (Song and Wood, 2018). Abortive infection due to 
TA systems is a main focus of this thesis and this will be discussed in further detail 
later. 
 
Other than the three well established roles of TA systems, other functions of TA 
systems have been reported. The MqsR/MqsA system appears to have several 
functions. MqsR, the toxin, acts as a specific RNase targeting the sequence GCU 
independently of ribosomes, leading to changes in cellular metabolism affecting 
quorum sensing and biofilm formation (Yamaguchi et al., 2009). Furthermore, MqsR is 
able to activate another TA system, GhoT/GhoS by cleaving the mRNA of the antitoxin, 
GhoS leading to increased persistence (Cheng et al., 2014; Wang et al., 2013). The 
antitoxin component, MqsA, also plays a role other than neutralising MqsR activity. 
MqsA is able to repress RpoS, the master regulator of stress, through binding to the 
RpoS promoter. The repression of rpoS leads to the reduction of cyclic diguanylic acid 
and subsequently a decrease of biofilm formation and an increase in cell motility (Wang 
et al., 2011). MqsA can also reduce biofilm formation by binding to the promoter of the 
biofilm regulator, CsgD (Soo and Wood, 2013). The MqsR/MqsA system is not the only 
TA system involved in regulating RpoS. The YafQ/DinJ system’s antitoxin (DinJ) can 
indirectly repress RpoS by inhibiting CspE a positive regulator of RpoS (Hu et al., 
2012). The roles of TA systems also extend to virulence as the S. aureus virulence 
genes, hla and efb can be repressed by the antitoxin SavR and in complex with its 
toxin, SavRS, by binding to the promoter regions of both hla and efb (Wen et al., 2018). 
TA systems have been assigned to different Types based on the nature and mode of 
neutralisation of their antitoxins (Figure 1.3). The details of each type and their 
involvement in phage resistance are discussed in the ensuing sections. 
 
  





Figure 1.3 The six Types of TA systems 
Toxins are shown in orange with antitoxins in blue. Only Type I and III antitoxins are 
RNA; all other antitoxins are proteins. A Type VII TA system has been described (not 
shown here), with further details provided on its subheading. This figure has been 
taken from (Page and Peti, 2016). 
  




1.3.1 Type I 
The original TA system and the founding member of the Type I TA systems is the Hok-
Sok system. It was discovered on plasmid R1 where it was shown to be involved in the 
maintenance of the plasmid (Gerdes et al., 1986b). Type I TA systems have been 
found in many bacterial species (Fozo et al., 2010). They are defined as having an 
antitoxin that is the antisense RNA sequence of the toxin mRNA counterpart. The 
antitoxin of Type I TA systems form a duplex with the mRNA of their toxins that is 
targeted by RNAse III, hence neutralisation is achieved by preventing the translation 
into the toxic protein (Gerdes et al., 1986b; Thisted et al., 1994). The toxin component 
of Type I TA systems are mostly small membrane-associated proteins which function 
as phage holins by forming pores in the bacterial membrane disrupting the proton 
motive force (Brantl and Jahn, 2015). Type I toxins such as SymE and RalR can also 
function as RNases or DNases, respectively (Guo et al., 2014; Kawano et al., 2007). 
 
With regards to phage resistance, the Hok-Sok system has been shown to exclude 
phage T4, albeit only very modestly. There was only a 42% reduction in efficiency of 
plating in the presence of the hok/sok locus within a medium copy (pBR322) plasmid 
vector (Pecota and Wood, 1996). The activation mechanism of the Hok-Sok system 
still remains unknown, however, it has been suggested that the decrease of host 
translation caused by the phage and subsequent decrease of the antitoxin, Sok is the 
cause (Pecota and Wood, 1996). This may explain why phage lambda is not excluded 
by the system as host transcriptional machinery is not shut down during its infection. 
However, it still does not explain why other phages are not excluded. The authors 
suggest that there may be other unknown mechanisms developed by these phages to 
prevent the activation of the toxin (Pecota and Wood, 1996). No other Type I TA system 
has been reported to confer phage resistance, thus far. 
 
1.3.2 Type II 
The Type II TA systems are the best characterised TA systems, reflecting a wide 
research interest in the formation of persisters, although their role in persister formation 
might not be as important as previously thought (Goormaghtigh et al., 2018). Like Type 
I TA systems, these are found in almost all bacterial genomes and are also present in 
phage genomes (Leplae et al., 2011; Pandey and Gerdes, 2005). The Type II TA 
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system is defined as having a protein antitoxin that directly interacts with the toxic 
protein. The formation of the toxin-antitoxin protein complex causes the neutralisation 
of the toxin. The antitoxin and toxin are under the control of a single promoter. The 
antitoxin is also less stable than its toxin counterpart, which is partly due to it being 
partial folded, thus making it more susceptible to degradation by proteases (Cherny et 
al., 2005). The Type II TA toxins are released upon the degradation of their antitoxins 
when the stringent response activates the Clp or Lon protease (Brzozowska and 
Zielenkiewicz, 2013). 
 
The regulation of Type II TA systems is more complex than just the binding of an 
antitoxin to a toxin. The antitoxin protein consists of two domains, a C-terminal domain 
that is used for the protein-protein interaction with the toxin protein and an N-terminal 
domain containing a DNA-binding domain. There are three different DNA-binding 
domains an antitoxin may have depending on how they fold (Chan et al., 2016). The 
role of these DNA-binding domains is to provide a further level of regulation as they 
allow the antitoxin to bind to the operator region of their own operons. Without the 
binding of the toxin the antitoxin binds weakly to the operator, however the toxin, when 
in complex with the antitoxin, changes conformation allowing it to bind more strongly 
and repress transcription (Magnuson et al., 1996; Overgaard et al., 2009). The toxins 
and antitoxins can also form different complexes with each other, with different 
affinities for the operator to ensure an optimal ratio of toxin-to-antitoxin in a process 
called conditional cooperativity (Cataudella et al., 2012). For example in the RelBE 
system, an abundance of antitoxin, RelB, leads to the formation of a RelB2RelE 
heterotrimer consisting of 2 RelB antitoxins and a single RelE toxin (Overgaard et al., 
2009). This complex binds strongly to stop transcription of the TA operon. However, 
should the antitoxin levels decrease, possibly in response to cellular stress, the 
RelB2RelE complexes are disrupted by free toxin and there is a higher formation of 
RelB2RelE2 complexes which are unable to bind the promoter (Overgaard et al., 2009). 
This prevents the RelB2RelE complex from repressing the operon, thus more antitoxin 
is translated. 
 
The toxins and antitoxins of Type II TA systems are grouped into families based on 
amino acid similarity (Pandey and Gerdes, 2005; Van Melderen and Saavedra De 
Bast, 2009). There are currently 12 families of toxins and 13 families of antitoxins 
(Makarova et al., 2009). The Type II TA systems appear to be able to use different 
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families of antitoxins to neutralise the same family of toxins and vice versa for the toxins 
(Guglielmini and Van Melderen, 2011). The toxins of Type II TA systems have a wide 
range of activities. This includes inhibition of DNA gyrase, acting as an 
endoribonuclease and inactivating elongation factors (Bernard et al., 1993; 
Christensen-Dalsgaard et al., 2010; Cruz et al., 2014; Zhang et al., 2003).  
 
Type II TA systems have been linked to phage resistance. For instance, the deletion 
of the chromosomally-located mazEF locus results in a more efficient P1 infection 
(Hazan and Engelberg-Kulka, 2004). This highlights that chromosomal TA systems 
may function as effective anti-phage systems. Two homologous Type II TA systems, 
RnlAB and LsoAB, have also been shown to abort T4 mutants defective in the Dmd 
protein (Otsuka and Yonesaki, 2012). It has been shown that, during a T4 infection, 
the levels of the antitoxins from these two systems drop dramatically (Koga et al., 2011; 
Otsuka and Yonesaki, 2012). In wild type T4 the Dmd protein prevents abortive 
infection by acting as an antitoxin to both toxins (Otsuka and Yonesaki, 2012). These 
examples highlight again that phages are capable of evolving specific solutions to 
prevent abortive infection, but also show that the levels of antitoxin play a key role in 
TA activation, further emphasised in Type II TA systems by the complexity of their 
regulation. 
 
1.3.3 Type IV 
Like Type II, the Type IV TA system also has a proteinaceous antitoxin, however it 
does not directly interact with the toxin protein, a hallmark of a Type IV TA system. 
Instead the antitoxin neutralises the effects of the toxin by promoting the opposite effect 
caused by the toxin. For instance, in the CbeA-CbtA system the toxin CbtA (originally 
called YeeV) binds and inhibits MreB and FtsZ which are required for cell division (Tan 
et al., 2011). The antitoxin, CbeA, acts as an antagonist and instead promotes the 
polymerisation of both MreB and FtsZ (Masuda et al., 2012). CbeA can also prevent 
the toxicity of other MreB and FtsZ inhibitors, thus it is likely that it has a much wider 
role than just neutralising CbtA (Masuda et al., 2012). 
 
AbiE is a Type IV TA system firstly identified on a plasmid originating from L. lactis for 
its anti-phage activity (Garvey et al., 1995). The AbiE system consists of the AbiEi 
antitoxin and the AbiEii toxin which do not interact with each other (Dy et al., 2014b). 
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The exact mechanism by which AbiEii causes toxicity is unknown but is linked to its 
ability to bind GTP and its predicted nucleotidyltransferase activity (Dy et al., 2014b). 
The antitoxin, AbiEii, which is under control of the same promoter, contains a DNA 
binding domain. Similar to Type II TA systems, the antitoxin negatively autoregulates 
the transcription of the operon by repressing the AbiE promoter (Hampton et al., 2018). 
However, in contrast to the Type II TA systems, the AbiEi and AbiEii, protein were 
shown not to interact with each other, based on the results of coimmunoprecipitation 
experiments (Dy et al., 2014b). The AbiE system has been shown to abort L. lactis 
phage 712, by an unknown mechanism. However as 712 DNA replication is unaffected 
during infection of a host carrying the AbiE system, it is thought to affect phage 
packaging or release (Garvey et al., 1995). The toxin AbiEii is toxic even in the absence 
of phage so it is likely that the toxic effect on the bacterial cell itself causes abortive 
infection (Dy et al., 2014b). It is not known what component of the phage activates the 
AbiE system. 
 
1.3.4 Type V 
The GhoST system is the only Type V TA system to date and is defined as a protein 
antitoxin that neutralises the effects of the toxin by directly degrading the toxin mRNA. 
The antitoxin of the GhoST system, GhoS, acts as an RNAse that is able to cleave the 
mRNA of GhoT, the toxin (Wang et al., 2012). This TA system was named after the 
effects that the toxin causes, as GhoT is a small hydrophobic membrane associated 
peptide that disrupts the cell membrane causing the formation of ghost cells (Wang et 
al., 2012). 
 
Phage resistance has not yet been examined in the GhoST system. However, the 
GhoST is regulated by the Type II system, MqsR/MqsA. Although MqsR/MqsA has not 
been associated with phage resistance, other Type II systems have been (Cheng et 








1.3.5 Type VI 
Like the Type V system, there is also only one currentle example of a Type VI system. 
It is defined as having an antitoxin that interacts with its toxin component. 
Neutralisation however, does not occur by this interaction but by the promotion of 
degradation caused by this binding (Aakre et al., 2013). The only Type VI TA system, 
SocAB, consists of the SocA antitoxin and the SocB toxin. While both proteins are 
constitutively expressed, the antitoxin, SocA, acts as a proteolytic adaptor, that binds 
to SocB and targets it for degradation by the ClpXP protease (Aakre et al., 2013). 
Toxicity of SocB is caused by its binding to the β sliding clamp DnaN, inhibiting 
replication elongation (Aakre et al., 2013). SocB is predicted to bind to a hydrophobic 
cleft that is also the binding site of several other proteins important for DNA repair and 
replication, such as Pol IV, Pol V, MutS, MutL and Hda (Robinson et al., 2010). The 
interaction of the SocAB system has not yet been investigated with regards to phage 
infection. 
 
1.3.6 Type VII 
A seventh Type of TA system has been described where the neutralisation of the toxin 
is due to the antitoxin acting as an enzyme, causing the oxidation of a cysteine residue 
on the toxin (Marimon et al., 2016). The Hha/TomB TA system is an example of a Type 
VII TA system where the toxic Hha protein can be neutralised upon oxidation by the 
antitoxin, TomB. Like other TA systems the Hha/TomB TA system genes are 
contiguous and operonic. It was originally discovered as a regulator of biofilm and 
motility (Barrios et al., 2006). The Hha toxin affects multiple functions of the cell. It can 
interact with the H-NS protein involved in bacterial motility control (Nieto et al., 2002). 
Hha can also bind to tRNA codons and induce the activation of prophage lytic genes, 
leading to cell death (García-Contreras et al., 2008). The overexpression of Hha can 
also induce expression of ClpP, ClpX and the lon protease, all of which are involved in 
Type II TA activation, which may contribute to cell lysis (García-Contreras et al., 2008). 
 
Phage resistance via abortive infection has not be reported in the Hha/TomB TA 
system. However, Hha has been shown to upregulate OmpA (Balsalobre et al., 1999). 
OmpA is an important receptor for multiple phages and so it is possible that the 
Hha/TomB TA system may affect phage replication by other means (Morona et al., 
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1984). Furthermore, the protein product of gene 5.5 of phage T7 binds and inhibits H-
NS, showing another example of phage interaction with this system, although indirect 
(Liu and C Richardson, 1993). 
 
1.3.7 Type III 
1.3.7.1 Definition and genetic organisation 
The Type III TA systems are defined as having a non-coding RNA antitoxin that 
physically interacts with the toxic protein forming a complex to neutralise it (Fineran et 
al., 2009). Similar to other TA systems, Type III TA systems are bicistronic containing 
an antitoxin gene preceding a toxin gene under the control of a single promoter 
(Fineran et al., 2009) (Figure 1.4). The antitoxin carries a series of short repeating 
sequences that, as RNA, are cleaved into single subunits by the toxin protein (Bélanger 
and Moineau, 2015; Fineran et al., 2009). Additionally, the antitoxin and toxin 
components are separated by a Rho-independent terminator which can reduce 
transcription of the full transcript by up to 90% (Fineran et al., 2009). The multiple 
antitoxin copies and the terminator in a Type III TA locus ensure that more antitoxin is 
produced than toxin. Like the other classical TA systems i.e. Type I and Type II, the 
Type III TA systems are widespread with over 600 putative systems identified 
bioinformatically, encompassing 8 phyla (Goeders et al., 2016). 
 
The Type III TA systems can be divided into three families based on sequence 
homology of their toxin components. The three families, ToxIN, TenpIN, CptIN, follow 
a naming system where the I and N letters refer to the antitoxin and toxin component 
respectively (Blower et al., 2012b) (Figure 1.4). For instance, ToxIN refers to the entire 
system whereas ToxI refers specifically to the antitoxin, likewise ToxN for the toxin. 
For the ToxIN system of Pectobacterium atrosepticum, the first identified Type III TA 
system, the letters Pa in lower case after ToxIN is used i.e. ToxINPa (Blower et al., 
2012b). The TenpIN family is named after the Photorhabdus Type III TA system, and 
is abbreviated from Type III Endogenous to Photorhabdus Inhibitor/toxin (Blower et 
al., 2012b). Again, the TenpIN system from Photorhabdus luminescens is specifically 
referred to as TenpINPl. The final family, CptIN, is abbreviated from Coprococcus Type 
III Inhibitor/toxin, after the GD/7 system of Coprococcus catus (Blower et al., 2012b). 
  




Figure 1.4 The genetic organisation of the three families of Type III TA systems 
The TA locus is under control of a single promoter that is immediately followed by a 
sequence of repeats, that is the antitoxin, which is separated from the toxin by a rho 
independent terminator. A-C shows three TA systems belonging to the ToxIN family 
(toxin genes highlighted in blue) For the AbiQ system, the toxin gene is called abiQ 
and the antitoxin gene called antiQ. D shows the locus of the TenpINPl system with the 
toxin gene, TenpNPl in an orange box. E shows an example of the CptIN family, 
CptINEr, with the gene for the toxin component CptNEr as a green box. This figure was 
taken from (Goeders et al., 2016) and made by the author of this study.  
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While the Type III TA systems are split into their three families based on their toxins, 
their antitoxin sequence appears to be less conserved. Three characterised ToxIN 
family members, ToxINPa, ToxINBt and the AbiQ system do not share any antitoxin 
sequence homology, although the lengths of their antitoxins are somewhat conserved. 
Interestingly the number of repeats of each antitoxin between Type III TA systems also 
differ. The number of repeats have been shown to be important in neutralising the toxin 
component. For the ToxINPa system, which naturally has 5.5 repeats, only 2.5 repeats 
were crucial for toxin inhibition (Blower et al., 2009). This is different for the AbiQ 
system where only 1.8 antiQ repeats were necessary (Bélanger and Moineau, 2015). 
Additionally, it has been shown that the anti-phage capability of AbiQ is affected by the 
number of repeats (Bélanger and Moineau, 2015).  
 
1.3.7.2 Structures of Type III TA systems 
The Type III TA systems form complexes held together by RNA-protein interactions. 
The structures of three of these complexes have been solved (Blower et al., 2012a; 
Rao et al., 2015; Short et al., 2013). The two ToxIN family members, ToxINPa and 
ToxINBt form trimeric heterohexamers where three toxin proteins are located at the 
apices of the triangles which are held together by three antitoxin subunits (Figure 1.5). 
All characterised Type III TA system toxins have been identified as endoribonucleases 
and recognise a short specific sequence that is found throughout the bacterial genome 
but also within the antitoxin repeat sequence. The specific sequence recognised is 
different between different Type III toxins. The toxin cleaves the antitoxin at this 
location into their single subunits and forms the complexes. In vitro the ToxNPa toxin 
has been shown to be able to self-assembly into the complexes using either the non-
cleaved ToxIPa or cleaved ToxIPa suggesting that complex formation is spontaneous 
and does not require any other cellular factors (Short et al., 2013). However, the 
preferred substrate of ToxNPa is non cleaved ToxIPa suggesting that cleavage of 
antitoxin itself is part of the neutralisation process (Short et al., 2013). Recently, it has 
also been shown that this complex is perhaps not as stable as previously thought and 
the constant cleavage of newly transcribed antitoxin by the toxin is the main 
mechanism of neutralisation (Short et al., 2018). 
  





Figure 1.5 The Type III TA systems form RNA-protein complexes 
A. The trimeric heterohexamer of ToxINPa consists of three toxin proteins and three 
RNA pseudoknots. B. The ToxINBt system forms a similar complex to the ToxINPa 
system. C. The CptINEr complex is a heterotetramer consisting of two toxic proteins 
held together by two RNA antitoxins. This figure was taken from (Goeders et al., 2016) 
and made by the author of this study. 
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The ToxIN family members whose antitoxins have been solved, ToxIPa and ToxIBt, 
have been shown to fold into a classic H-type pseudoknot containing two single 
stranded tails at either end of the structure (Blower et al., 2011; Short et al., 2013). 
These are common RNA structures characterised by three different sections of the 
RNA strand, looped around each other and held together by a central core consisting 
of duplex and/or triplex hydrogen bonds deriving from base-pair interactions. For both 
ToxIPa and ToxIBt, the core consists of three triplexes in which the third triplex formed 
of GUU has an interdigitation of a guanine that acts to separate the two stems of the 
knot (Figure 1.6A-B). Given the low sequence homology between ToxIPa and ToxIBt, 
it was unexpected that such a similar pseudoknot structure would be formed. However, 
the antitoxins are unable to complement each other and specificity is achieved by the 
specific interactions each ToxN makes with its own ToxI. Each ToxN contains 
electropositive grooving in which the protein residues and RNA bases form hydrogen 
bonds. The tails at either end of the pseudoknot play a key role in this. The active site 
of ToxNPa consisting of Tyr29, Lys33, Thr52, Ser53 and Lys55 interacts and hold the 
3’ end of the ToxI tail in place (Blower et al., 2011). For the ToxINBt system, a single 
ToxNBt interacts with the 5’ tail of the pseudoknot. The same ToxNBt also interacts via 
Lys148 with C19 and G20 from triplex one (Short et al., 2013). A different ToxNBt then 
interacts with the 3’ tail as well the U10 which binds to a hydrophobic pocket located 
on the same ToxNBt (Short et al., 2013). The difference in the ToxN-ToxI interactions 
between the two TA systems is a result of the differences in sequence specificity. 
ToxNPa specifically cleaves RNA at AAAU/G whereas ToxNBt cleaves AAAAA 
(Short et al., 2013). 
 
  





Figure 1.6 The pseudoknot structures of Type III antitoxins 
A. The ToxIPa antitoxin folds into a H type pseudoknot containing a triple triplex core. 
B. The ToxIBt antitoxin exhibits a similar fold to ToxIPa. C. CptIEr has a different fold 
containing a rare A-minor twist structure. The colours of the bases represent the 
corresponding base in each of the three antitoxins. Black lines represent hydrogen 
bonds between bases. This figure has been taken from (Goeders et al., 2016) and 
made by the author of this study. 
 
  




The third Type III TA structure to be solved as a complex belongs to the CptIN family. 
The CptINEr complex differs from the two ToxIN family complexes as it instead forms 
a heterotetramer consisting of two toxins and two antitoxins (Figure 1.5C). The reason 
why CptINEr forms a different complex may be the result of the difference in length of 
its antitoxin CptIEr (Figure 1.4E). The CptIEr is longer than the ToxI antitoxins and also 
has a different pseudoknot fold giving it flexibility to adopt its distinctive complex form 
(Figure 1.6C). While CptIEr also folds into an H-type pseudoknot it does not contain a 
core containing triplex bonds and forms instead a counter-clockwise A minor twist motif 
(Rao et al., 2015). There hasn’t yet been a structure solved for a Type III TA system 
belonging to the TenpIN family but for TenpINPl, given that it has a long antitoxin, it is 
predicted to form a similar complex to what is seen for CptINEr (Figure 1.4D). 
 
While the ToxI antitoxins exhibit a similar overall fold to each other that differs from 
that of the CptI example, the toxin proteins also follow a similar pattern. The ToxNPa 
and ToxNBt have very similar folding that includes a six anti-parallel β-sheet and five 
variable loop core (Blower et al., 2011; Short et al., 2013). The loops play a role in the 
interaction with the antitoxin, with one of the loops forming part of the active site 
(Blower et al., 2011; Short et al., 2013). One of the distinctive features of ToxNPa and 
ToxNBt is a kink in helix three (Figure 1.7A-B). The AbiQ toxin, which also has a similar 
fold to both ToxNPa and ToxNBt also has this kink (Figure 1.7C). The regions 
corresponding to the active sites are also similar, for instance, the RNAse activity of 
AbiQ can be abolished by a Ser51Leu mutation. However, substitution of Ser51 with a 
threonine, the corresponding residue in the active ToxN maintains its activity. In 
contrast, while the CptNEr toxin also contains a similar structure consisting of anti-
parallel B-sheets it does not contain the distinctive kink in helix three (Figure 1.7E). 
Instead the corresponding helix, helix 4, is considerably shorter. It is also known that 
the Type II toxins belonging to the MazF, Kid and CcdB families also share similar 
folding (Goeders et al., 2016). While MazF and Kid are endoRNAses, similar to the 
Type III toxins, CcdB family toxins are DNA gyrase inhibitors and yet have similar β 
core folds. However, the active sites are non-conserved, even if they do share the 
same activity, e.g. ToxN and Kid (Goeders et al., 2016). Interestingly, the absence of 
the kink in the Kid structure, means it more closely resembles the CptNEr toxin (Figure 
1.7D-E). 
 








Figure 1.7 Solved structures of Type III toxins and the Type II toxin, Kid 
A. ToxNPa, B. ToxNBt, C. AbiQ, D. Kid and E. CptNEr. All toxins shown are endoRNases 
and exhibit similar folds. A, B and C contain an obvious kink which is notably absent 
in D and E (labelled). This figure has been taken from (Goeders et al., 2016) and made 








1.3.7.3 Functions of Type III TA systems 
To date, Type III TA systems have been shown to have at least two roles, plasmid 
maintenance and phage resistance through abortive infection.  
 
1.3.7.3.1 Plasmid maintenance 
As described previously, TA systems were originally identified through their role in 
plasmid maintenance through post segregationally killing. This relies on an unstable 
antitoxin and a more stable toxin where loss of the plasmid quickly results in cellular 
death because the antitoxin is degraded quicker, leading to cell death through the 
release of the toxin. Thus only cells that have maintained the plasmid are able to 
survive. The toxins of Type III TA systems have been shown to be bacteriostatic, where 
a period exists when production of the antitoxin can rescue the cells and allow 
replication again (Fineran et al., 2009). It is predicted that a point of no return exists, 
where production of the antitoxin no longer rescues the cell and cellular death soon 
follows. This point has not been defined precisely but is thought to occur after eight 
hours for the ToxINPa system which suggests that its plasmid maintenance capability 
is not through post segregationally killing but rather the cessation of growth in TA-
plasmid free cells (Fineran et al., 2009). 
 
The ToxINPa and the CptINEr systems have been shown to retain up to 100% of 
plasmids in an E. coli W3110 background compared to just 50% in the controls with no 
Type III TA system (Rao et al., 2015; Short et al., 2013). While the ToxINPa system 
was originally identified on a plasmid, the CptINEr system is located on the 
chromosome of Eubacterium rectale. Thus it is curious that it can function as a plasmid 
maintenance system in E. coli (Blower et al., 2012b). In contrast the ToxINBt system, 
which is naturally found on a plasmid had no effect on plasmid retention in E.coli 
compared to the control (Short et al., 2013). The likely reason for this is that ToxNBt is 
less toxic in E. coli compared to ToxNPa, suggesting that its diminished toxicity on E. 
coli is not strong enough to allow plasmid retention. In contrast the ToxINBt system has 
been able to act as a plasmid maintenance system in its natural host, Bacillus subtilis. 
A part of the B. subtilis lifecycle is sporulation, in which the bacteria enter a dormant 
form, known as a spore. As a spore the bacterium, is highly resistant to hostile 
environmental conditions, showing similar traits to the persistence phenotype 
Chapter 1 Introduction 
37 
 
previously described. Likewise, sporulation is reversible, and the bacteria are able to 
revert back to an active state when conditions are favourable. During sporulation the 
rate of plasmid loss can be as high as 95% (Turgeon et al., 2008). The ToxINBt system 
has been shown to reduce plasmid loss during sporulation by a factor of 10 (Short et 
al., 2015). It was shown that the total number of mature spores decreased as a result 
of toxin activation in forespores that have lost the plasmid (Short et al., 2015). 
 
1.3.7.3.2 Abortive infection 
The first Type III TA system to be identified was ToxINPa from a cryptic plasmid 
originating from P. atrosepticum SCRI1039 (Fineran et al., 2009). The ToxNPa protein 
showed homology with the abortive infection system AbiQ, of L. lactis and likewise was 
able to abort several P. atrosepticum phages (Fineran et al., 2009). The first P. 
atrosepticum phage to be characterised in detail is ΦTE, a transducing Myoviridae 
member (Blower et al., 2012a). ΦTE was strongly aborted by the ToxINPa system 
however, rare escapes could be isolated at a frequency of 10-8 (Blower et al., 2012a). 
Characterisation of these insensitive escape phages revealed that they had an 
expanded region in a non-coding region of their genome that could produce an 
antitoxin mimic. One ΦTE escape appeared to have undergone recombination with the 
ToxIPa region and so was capable of escape by producing the natural ToxIPa (Blower 
et al., 2012a). The production of these antitoxin mimics resulted in total insensitivity of 
these ΦTE escapes to the ToxINPa system. No other types of ΦTE escape were 
identified in this system, and thus the activation mechanism of ToxINPa could not be 
determined.  
 
In the search to identity novel phage escape mutants, the ToxINPa system was cloned 
onto a plasmid and shown to abort phages in heterologous hosts such as E. coli and 
Serratia ATCC 39006 (S39006) (Fineran et al., 2009). Prior to that study, a large 
number of coliphages were found to be sensitive to the ToxINPa system, but none were 
able to evolve escapes (unpublished, 2009-2017, Salmond lab). In S39006, a group of 
three highly similar Tevenvirinae members, ΦCHI14, ΦX20 and ΦCBH8 were isolated 
that were aborted by ToxINPa but capable of evolving escapes at frequencies ranging 
from 10-6 to 10-8 (Chen et al., 2017). Three different escape loci were identified in these 
phages. The most common was a large deletion in a region capable of coding for 
numerous hypothetical proteins, or by mutations in the asiA gene or a single escape 
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that had a mutation in an ORF of unknown function, ORF84 (Chen et al., 2017). As the 
large deletion region and ORF84 had no obvious predicted functions, their roles in 
ToxINPa activation could not be determined. The asiA gene function is a well-known 
activator of middle gene transcription in phage T4 (Colland et al., 1998a). As a middle 
gene activator, AsiA is capable of affecting numerous middle genes thus it role in 
abortive infection is not clear. 
 
The other well studied Type III TA system with regards to abortive infection is the AbiQ 
system. AbiQ was able to abort a wide range of phages and like the ToxINPa system, 
functions as an anti-phage system when transferred into a heterologous host (Samson 
et al., 2013). Three different lactococcal phages, P008, bIL170 and Phage c2 were 
aborted by AbiQ and were able to evolve escapes. Analysis of these escapes revealed 
mutations in a single protein in all three phages (Samson et al., 2013). These were 
three different proteins in all three phages but all proteins had unknown functions. 
Finally, the coliphage, Phage 2, was found to be aborted by E. coli carrying the AbiQ 
system. Escapes of phage 2 were in a putative DNA polymerase. Again, the role that 
this putative DNA polymerase plays in activating AbiQ is unknown (Samson et al., 
2013). While the exact mechanism is not known of AbiQ, there are several key 
observations that have been made. Firstly, the levels of AbiQ do not increase during 
phage infection. This has also been observed in the case of the ToxNPa protein. 
Secondly, the replication of phage DNA is not prevented during infection in the 
presence of AbiQ, evident by viral DNA build up. Lastly, while the levels of the AbiQ 
protein do not decrease, the transcript levels of AbiQ do decrease which may play a 
role in AbiQ activation (Emond et al., 1998). 
 
One other Type III TA system has been shown to function as an abortive infection 
system. The TenpINPl system, originating from the chromosome of Photorhabdus 
luminescens, when cloned onto a plasmid and transferred to E. coli is capable of 
aborting several coliphages (Blower et al., 2012b). Interestingly, when transferred to 
S39006, the three Tevenvirinae family phages that were aborted by ToxINPa, were also 
aborted by TenpINPl. However, no escapes were detected (Chen et al., 2017). This 
suggests that the activation of ToxINPa and TenpINPl is different. Type III TA activation 
specificity has also been observed between ToxINPa and AbiQ. For example, phage 
T4 is not aborted by the ToxINPa system but is strongly aborted by AbiQ and unable to 
evolve escapes (Fineran et al., 2009; Samson et al., 2013). 






1.4 Summary and aims of this research 
The purpose of this study was to further understand the mechanisms of Type III TA 
system activation during phage infection. As so few phage escape mutants were 
previously characterised it was decided that, novel phages should be isolated and 
tested for sensitivity to the Type III TA systems, namely the ToxINPa and TenpINPl 
systems. The same rationale was employed from previous studies in which escapes 
of phages sensitive to Type III TA systems would be sequenced to identify the nature 
of their mutation and the role they play in the activation of the TA system. Initially work 
begun solely on P. atrosepticum phages as this was the natural host of the ToxINPa 
system and the most “natural” way that phages might interact with this TA system. 
Serendipitously, various other coliphages and a single Serratia phage were added to 
the study leading to further interesting novel escape loci being identified. Finally, the 
TenpINPl system which has been shown to be an effective abortive infection system 
has never been shown to abort any phages infecting the host that it derived from, P. 
luminescens, TT01 (Rao, 2014). Furthermore, a TT01 phage has never been 
characterised in depth, thus the final chapter investigates the nature of these TT01 








Chapter 2 Material and methods 
2.1 Media, reagents and solutions 
A list of all the media used in this study is shown in Table 2.1. Antibiotics and other 
supplements used are listed on Table 2.2. All other solutions are shown in Table 2.3. 
All media and solutions were sterilised either by autoclaving at 121ºC for 20 mins or, if 
not appropriate, filtered sterilised using a 0.22 µM filter (Millipore). 
 
Table 2.1 Media used in this study 
Medium Ingredients per litre 
Lysogeny broth (LB) 10 g Tryptone 
 5 g Yeast extract 
 5 g NaCl 
2x LB 20 g Tryptone 
 5 g Yeast extract 
 10 g NaCl 
LB-agar (LBA) LB 
 15 g Agar 
Top agar LB 
 3.5 g Agar 
Top agarose LB 
 3.5 g Agarose 
Marine broth (MB) [Difco 2216] 5 g Peptone 
 1 g Yeast extract 
 0.1 g Ferric citrate 
 19.45 g Sodium chloride 
 5.9 g Magnesium chloride 
 3.24 g Magnesium sulfate 
 1.8 g Calcium chloride 
 0.55 g Potassium chloride 
 0.16 g Sodium bicarbonate 
 0.08 g Potassium bromide 
 34 mg Strontium chloride 
 22 mg Boric acid 
 4 mg Sodium silicate 
 2.4 mg Sodium fluoride 
 1.6 mg Ammonium nitrate 
 8 mg Disodium phosphate 
Marine broth agar (MBA) MB 









Table 2.2 Antibiotics and supplements 
Chemical/supplement Stock solution Working concentration 
Antibiotics   
Ampicillin (Ap) 1 g.ml-1 in dH20, stored at 
-20ºC 
100 µg.ml-1 
Chloramphenicol (Cm) 500 mg.ml-1 in EtOH, 
stored at -20ºC 
50 µg.ml-1 
Kanamycin (Km) 500 mg.ml-1 in dH20, 
stored at -20ºC 
50 µg.ml-1 






Table 2.3 Solutions used in this study 
Solution Components 
Phage buffer 10 mM Tris-HCl at pH 7.4 
 10 mM MgSO4 
 0.01% gelatin 
DNA work  
50x Tris-acetate EDTA (TAE) buffer (L) 242 g Tris base 
 100 ml EDTA 
 57.1 ml glacial acetic acid 
 pH 8.0 
Agarose gel 1.5% agarose in 1x TAE 
 500 ng.ml-1 ethidium bromide 
6x Loading dye, purple NEB – B7024S 
Solution A 10 mM MES 
 50 mM CaCl2 
 10 mM MnCl2 
Solution A with glycerol 10 mM MES 
 50 mM CaCl2 
 10 mM MnCl2 
 15% (w/v) Glycerol 
Photorhabdus wash buffer 1 mM HEPES 
 5% (w/v) sucrose 
 pH 7.0 
5x HF buffer NEB – F518L 
  




2.2 Bacterial strains 
A summary of all bacterial strains is shown in Table 2.4. All bacterial strains were 
grown in LB apart from two strains. Photorhabdus luminescens, TT01 were grown in 
LB supplemented with 0.1% (w/v) sodium pyruvate and Vibrio harveyi were grown in 
MB. Liquid cultures were grown overnight on a rotary wheel at 30ºC for Pectobacteria, 
Serratia and Bacillus strains. All Rhizosphere isolates were also grown at 30ºC. 
Staphylococcus aureus, Pseudomonas and E. coli strains were grown at 37ºC. For 
long term storage of strains; 1 ml of overnight was added to 1 ml 50% glycerol and 






Table 2.4 Bacterial strains used in this study 




SCRI1043 Wild type (Bell et al., 2004) 
SCC34 Uncharacterised LPS 
mutant of SCRI1043 
(Blower et al., 2012a) 
TER2 flgN::Tn, ΦTE-resistant, 
KmR, derivative of Pba 
1043 
 
(Blower et al., 2012a) 
SCRI1 Wild type *SCRI, Ian Toth 
SCRI124 Wildtype *SCRI, Ian Toth 
SCRI139 Wild type *SCRI, Ian Toth 
SCRI41 Wild type *SCRI, Ian Toth 
SCRI13 Wild type *SCRI, Ian Toth 
SCRI1001 Wild type *SCRI, Ian Toth 
SCRI1034 Wild type *SCRI, Ian Toth 
SCRI1039 Wild type *SCRI, Ian Toth 
SCRI1044 Wild type *SCRI, Ian Toth 
SCRI1055 Wild type *SCRI, Ian Toth 
SCRI1056 Wild type *SCRI, Ian Toth 
SCRI1058 Wild type *SCRI, Ian Toth 
SCRI1064 Wild type *SCRI, Ian Toth 
Table continued overleaf 
*SCRI – Now called the James Hutton Institute 
  




Table 2.4 continued Bacterial strains used in this study 




SCRI101 Wild type *SCRI, Ian Toth 
SCRI112 Wild type *SCRI, Ian Toth 
SCRI114 Wild type *SCRI, Ian Toth 
SCRI122 Wild type *SCRI, Ian Toth 
SCRI132 Wild type *SCRI, Ian Toth 
SCRI198 Wild type *SCRI, Ian Toth 
SCRI103 Wild type *SCRI, Ian Toth 
SCRI106 Wild type *SCRI, Ian Toth 
SCRI115 Wild type *SCRI, Ian Toth 
SCRI116 Wild type *SCRI, Ian Toth 
SCRI124 Wild type *SCRI, Ian Toth 
SCRI127 Wild type *SCRI, Ian Toth 
SCRI130 Wild type *SCRI, Ian Toth 
SCRI166 Wild type *SCRI, Ian Toth 
SCRI192 Wild type *SCRI, Ian Toth 
39048 Wild type (Monson et al., 2018) 
   
E. coli   
DH5α  Invitrogen 
EPI300  Epicentre 
MG1655  (Blattner et al., 1997) 
   
Vibrio harveyi Wild type (Bassler et al., 1994) 
   
Staphylococcus aureus   
H Wild type  (Mayr-Harting, 1955) 




PA01 Wild type, ATCC 15692 Laboratory collection 




5383 Wild type Laboratory collection 




CV026 Tn5 mutant of ATCC 
31532 
(McClean et al., 2018) 
 Table continued overleaf  
 
*SCRI – Now called the James Hutton Institute 
  





Table 2.4 continued. Bacterial strains used in this study 
Strains Relevant characteristics Reference or source 
Citrobacter rodentium   
ICC169 Spontaneous NalR 
derivative of ICC168 
Laboratory collection 
   
Bacillus   
Bacillus thuringiensis 
subsp. kurstaki 
Wild type  Laboratory collection 
HD-1   
HD-73 Wild type  Laboratory collection 
Bacillus subtilis subsp. 
subtilis 
  
JH642 Wild type (Smith et al., 2014) 
   
Dickeya   
D. solani MK10 Wild type Isolated from potato in 
Israel (Pritchard et al., 
2013a) 
D. zeae NCPPB 3532 Wild type Isolated from potato in 
Australia (Pritchard et al., 
2013b) 
D. chrysanthemi NCPPB 
402 
Wild type Isolated from 
chrysanthemum in United 
States (Pritchard et al., 
2013b) 
D. dieffenbachiae NCPPB 
2976 
Wild type Isolated from 
dieffenbachia in United 
States (Pritchard et al., 
2013b) 
D. dianthicola NCPPB 
453 
Wild type Type strain from Dianthus 
(Pritchard et al., 2013a) 
D. paradisiaca NCPPB 
2511 
Wild type Isolated from plantain in 
Colombia (Pritchard et al., 
2013b) 
Photorhabdus   
Ph. luminescens 
laumondii TT01 




tenpIN::KmR (Rao, 2014) 
ΔflgG mutant TT01 ΔflgG mutant (Easom and Clarke, 
2008) 
ΔmotAB mutant TT01 ΔmotAB mutant (Easom and Clarke, 
2008) 
Ph. luminescens akhurstii 
LN2 
Wild type Gift from David Clarke 
(Qiu et al., 2014) 
 Table continued overleaf  
  




Table 2.4 continued. Bacterial strains used in this study 
Strains Relevant characteristics Reference or source 
Photorhabdus   
Ph. luminescens 
laumondii HP88 
Wild type Gift from David Clarke 
(Ghazal et al., 2016) 
Ph. luminescens akhurstii 
P2H 
Wild type Gift from David Clarke 
Ph. luminescens akhurstii 
K4D 
Wild type Gift from David Clarke 
Ph. asymbiotica ATCC 
43950T 
Wild type Gift from David Clarek 
(Fischer-Le Saux et al., 
1999) 
Ph. asymbiotica Kingcliffe Wild type Gift from David Clarke 
Ph. spp Mexico Wild type Gift from David Clarke 
Ph. spp Epypt Wild type Gift from David Clarke 
   
Xenorhabdus strains   
X. feltiae Wild type Gift from David Clarke 
X. nematophila Wild type Gift from David Clarke 
   
Serratia marcescens   
DB10 Wild type (Flyg et al., 1980) 
1695 Clinical isolate (Aucken and Pitt, 1998) 
0006 Environmental isolate (Aucken and Pitt, 1998) 
1047 Clinical isolate (Aucken and Pitt, 1998) 
0026 Environmental isolate (Aucken and Pitt, 1998) 
4028 Clinical isolate (Aucken and Pitt, 1998) 
3078 Clinical isolate (Aucken and Pitt, 1998) 
0038 Environmental isolate (Aucken and Pitt, 1998) 
1024 Clinical isolate (Aucken and Pitt, 1998) 
3127V Clinical isolate (Aucken and Pitt, 1998) 
0035 Environmental isolate (Aucken and Pitt, 1998) 
3888 Clinical isolate (Aucken and Pitt, 1998) 
0028 Environmental isolate (Aucken and Pitt, 1998) 
3255 Clinical isolate (Aucken and Pitt, 1998) 
0040 Environmental isolate (Aucken and Pitt, 1998) 
2529 Clinical isolate (Aucken and Pitt, 1998) 
0030 Environmental isolate (Aucken and Pitt, 1998) 
3127 Clinical isolate (Aucken and Pitt, 1998) 
3078V Clinical isolate (Aucken and Pitt, 1998) 
ATCC 274 Clinical isolate (Regué et al., 1991) 
S6 Clinical isolate (Yang et al., 1990) 
SM365 Laboratory strain (Sapriel et al., 2003) 
   
Rhizosphere isolates FAME prediction  
10Ep11 Proteus vulgaris (Berg et al., 2002) 
9Ez25 Serratia grimesii (Berg et al., 2002) 
 Table continued overleaf  
  




Table 2.4 continued. Bacterial strains used in this study 
Strains Relevant characteristics Reference or source 
Rhizosphere isolates FAME prediction  
9Ez29 Serratia grimesii/Pantoea 
agglomerans 
(Berg et al., 2002) 
9Ec15 Xenorhabdus 
nematophila 
(Berg et al., 2002) 





(Berg et al., 2002) 
4Rz1 Enterobacter intermedius (Berg et al., 2002) 















(Berg et al., 2002) 
4Rr2 Proteus vulgaris (Berg et al., 2002) 
3Rc3 Serratia fonticola (Berg et al., 2002) 
4Rz6 Serratia grimesii/Pantoea 
agglomerans 
(Berg et al., 2002) 
9Rz10 Serratia grimesii (Berg et al., 2002) 
3Rp10 Serratia grimesii/Pantoea 
agglomerans 





(Berg et al., 2002) 
3Rr8 Serratia plymuthica (Berg et al., 2002) 
4Rc6 Serratia plymuthica (Berg et al., 2002) 
4Rx5 Serratia plymuthica (Berg et al., 2002) 
3Rr9 Serratia proteomaculans (Berg et al., 2002) 
3Rc15 Serratia proteomaculans (Berg et al., 2002) 
8Rx9 Weeksella zoohelcum (Berg et al., 2002) 
5Rr4 Weeksella zoohelcum (Berg et al., 2002) 
3Rp5 Xenorhabdus 
luminescens 
(Berg et al., 2002) 
3Rp5 Xenorhabdus 
luminescens 
(Berg et al., 2002) 
4Rx4 Xenorhabdus 
nematophila 
(Berg et al., 2002) 
10Bp14 Pantoea agglomerans (Berg et al., 2002) 
3Bz10 Serratia grimesii (Berg et al., 2002) 
  





A list of all bacteriophages used in this study is shown in Table 2.5. All chloroform used 
in the sterilisation of phage lysates was saturated with sodium hydrogen carbonate. 
 
2.3.1 Isolation and purification of novel environmental phages 
Several phages used in this study were newly isolated from the environment. All 
phages bar one were isolated from water samples from either the Milton sewage works 
or the river Cam. ΦRC62 was isolated from a rotting potato bought from a supermarket. 
Briefly the water samples were filtered using a 0.22 µm filter or for ΦRC62 the rot 
scraped from the potato and suspended in sterile dH20 and filtered. 5 ml of the filtered 
water samples were mixed in a flask containing 5 ml 2x LB and 500 µl of the host 
bacterium and enriched overnight at the growth temperature of the host. The following 
day, 1 ml of this solution was added to a 1.5 ml Eppendorf tube containing 500 µl of 
chloroform and vortexed for two minutes. It was then centrifuged at 10,000 RPM for 2 
minutes. Next, 10 µl of the resulting supernatant was added to 200 µl of an overnight 
culture of the appropriate host and mixed with 4 ml of molten top agar and poured as 
a top lawn onto LBA plates. The plates were left to set and incubated overnight at the 
growth temperature of the host bacteria. A single plaque from plates showing plaques, 
was picked with a sterile cocktail stick and added to a 1.5 ml Eppendorf tube containing 
200 µl of phage buffer. 20 µl of chloroform was added to this and then vortexed quickly. 
This was spun down and the supernatant serially diluted and the phage plated out to 
single plaques. Another single plaque was picked and the process repeated three 
times to ensure phage purity and this phage was then made used to make phage 
lysates of high titre.  
  




Table 2.5 Phages used in this study 
Phage Host isolated on Relevant 
characteristics 
Reference or source 
ΦA1 SCRI1043 Wild type Finham sewage works, 
Conventry (Toth, 1991) 
ΦA2 SCRI1043 Wild type Finham sewage works, 
Conventry (Toth, 1991) 
ΦA2 SCRI1043 Wild type Finham sewage works, 
Conventry (Toth, 1991) 
ΦA4S SCRI1043 Wild type Finham sewage works, 
Conventry (Toth, 1991) 
ΦA4L SCRI1043 Wild type Finham sewage works, 
Conventry (Toth, 1991) 
ΦA5 SCRI1043 Wild type Finham sewage works, 
Conventry (Toth, 1991) 
ΦA6 SCRI1043 Wild type Finham sewage works, 
Conventry (Toth, 1991) 
ΦM2 SCRI1043 Wild type Finham sewage works, 
Conventry (Toth, 1991) 
ΦM4 SCRI1043 Wild type Finham sewage works, 
Conventry (Toth, 1991) 
ΦM5 SCRI1043 Wild type Finham sewage works, 
Conventry (Toth, 1991) 
ΦS21 SCRI1043 Wild type Finham sewage works, 
Conventry (Toth, 1991) 
ΦS22 SCRI1043 Wild type Finham sewage works, 
Conventry (Toth, 1991) 
ΦS32 SCRI1043 Wild type Finham sewage works, 
Conventry (Toth, 1991) 
ΦS33 SCRI1043 Wild type Finham sewage works, 
Conventry (Toth, 1991) 
ΦS34 SCRI1043 Wild type Finham sewage works, 
Conventry (Toth, 1991) 
ΦS41 SCRI1043 Wild type Finham sewage works, 
Conventry (Toth, 1991) 
ΦS42 SCRI1043 Wild type Finham sewage works, 
Conventry (Toth, 1991) 
ΦS61 SCRI1043 Wild type Finham sewage works, 
Conventry (Toth, 1991) 
ΦS64 SCRI1043 Wild type Finham sewage works, 
Conventry (Toth, 1991) 
ΦS71 SCRI1043 Wild type Finham sewage works, 
Conventry (Toth, 1991) 
Table continued overleaf 
 
  




Table 2.5 continued. Phages used in this study 
Phage Host isolated on Relevant 
characteristics 
Reference or source 
ΦS72 SCRI1043 Wild type Finham sewage works, 
Conventry (Toth, 1991) 
ΦB1 SCRI1043 Wild type Gift from Arild Sletten 
(Bioforsk, Aas, Norway) 
(Blower et al., 2009) 
ΦB24 SCRI1043 Wild type Gift from Arild Sletten 
(Bioforsk, Aas, Norway) 
(Blower et al., 2009) 
ΦR1 SCC34 Wild type River Cam, Cambridge 
(This study) 
ΦRC6 SCRI1043 Wild type Willow pond, botanical 
garden, Cambridge (This 
study) 
ΦRC9 SCRI1043 Wild type Milton sewage works, 
Cambridge (This study) 
ΦRC18 SCRI1043 Wild type Milton sewage works, 
Cambridge (This study) 
ΦRC30 SCRI1043 Wild type River Cam, Cambridge 
(This study) 
ΦRC33 SCRI1043 Wild type River Cam, Cambridge 
(This study) 
ΦRC36 SCRI1043 Wild type River Cam, Cambridge 
(This study) 
ΦRC41 SCRI1043 Wild type Milton sewage works, 
Cambridge (This study) 
ΦRC50 SCRI1043 Wild type River Cam, Cambridge 
(This study) 
ΦRC58 SCRI1043 Wild type River Cam, Cambridge 
(This study) 
ΦRC62 SCRI1043 Wild type Rotting potato, “Gift” from 
George, Cambridge 
ΦRC63 SCRI1043 Wild type River Cam, Cambridge 
(This study) 
ΦRC64 SCRI1043 Wild type River Cam, Cambridge 
(This study) 
ΦR11 SCC34 Wild type River Cam, Cambridge 
(This study) 
ΦTE SCC34 Wild type (Blower et al., 2012a) 
ΦM1 SCRI1043 Wild type (Toth et al., 1997) 
ΦM1-E1 SCRI1043 (pTA46) ToxINPa escape (Blower et al., 2017) 
ΦM1-E2 SCRI1043 (pTA46) ToxINPa escape (Blower et al., 2017) 
ΦM1-E3 SCRI1043 (pTA46) ToxINPa escape (Blower et al., 2017) 
ΦM1-E4 SCRI1043 (pTA46) ToxINPa escape (Blower et al., 2017) 
ΦM1-E5 SCRI1043 (pTA46) ToxINPa escape (Blower et al., 2017) 
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Table 2.5 continued. Phages used in this study 
Phage Host isolated on Relevant 
characteristics 
Reference or source 
ΦM1-E6 SCRI1043 (pTA46) ToxINPa escape (Blower et al., 2017) 
ΦM1-E7 SCRI1043 (pTA46) ToxINPa escape (Blower et al., 2017) 
ΦM1-E8 SCRI1043 (pTA46) ToxINPa escape (Blower et al., 2017) 
ΦM1-E9 SCRI1043 (pTA46) ToxINPa escape (Blower et al., 2017) 
ΦM1-E10 SCRI1043 (pTA46) ToxINPa escape (Blower et al., 2017) 
ΦM1-E11 SCRI1043 (pTA46) ToxINPa escape (Blower et al., 2017) 
ΦM1-E12 SCRI1043 (pTA46) ToxINPa escape (Blower et al., 2017) 
ΦM1-E13 SCRI1043 (pTA46) ToxINPa escape (Blower et al., 2017) 
ΦM1-E14 SCRI1043 (pTA46) ToxINPa escape (Blower et al., 2017) 
ΦM1-E15 SCRI1043 (pTA46) ToxINPa escape (Blower et al., 2017) 
ΦM1-E16 SCRI1043 (pTA46) ToxINPa escape (Blower et al., 2017) 
ΦM1-E17 SCRI1043 (pTA46) ToxINPa escape (Blower et al., 2017) 
ΦM1-E18 SCRI1043 (pTA46) ToxINPa escape (Blower et al., 2017) 
ΦM1-E19 SCRI1043 (pTA46) ToxINPa escape (Blower et al., 2017) 
ΦM1-E20 SCRI1043 (pTA46) ToxINPa escape (Blower et al., 2017) 
ΦM1-E21 SCRI1043 (pTA46) ToxINPa escape (Blower et al., 2017) 
ΦM1-E22 SCRI1043 (pTA46) ToxINPa escape (Blower et al., 2017) 
ΦM1-E23 SCRI1043 (pTA46) ToxINPa escape (Blower et al., 2017) 
ΦM1-E24 SCRI1043 (pTA46) ToxINPa escape (Blower et al., 2017) 
ΦM1-E25 SCRI1043 (pTA46) ToxINPa escape (Blower et al., 2017) 
ΦM1-E26 SCRI1043 (pTA46) ToxINPa escape (Blower et al., 2017) 
ΦM1-E27 SCRI1043 (pTA46) ToxINPa escape (Blower et al., 2017) 
ΦM1-E28 SCRI1043 (pTA46) ToxINPa escape (Blower et al., 2017) 
ΦM1-E29 SCRI1043 (pTA46) ToxINPa escape (Blower et al., 2017) 
ΦM1-E30 SCRI1043 (pTA46) ToxINPa escape (Blower et al., 2017) 
ΦM1-E31 SCRI1043 (pTA46) ToxINPa escape (Blower et al., 2017) 
ΦM1-E32 SCRI1043 (pTA46) ToxINPa escape (Blower et al., 2017) 
ΦM1-E33 SCRI1043 (pTA46) ToxINPa escape (Blower et al., 2017) 
ΦM1-E34 SCRI1043 (pTA46) ToxINPa escape (Blower et al., 2017) 
ΦM1-E35 SCRI1043 (pTA46) ToxINPa escape (Blower et al., 2017) 
ΦM1-E36 SCRI1043 (pTA46) ToxINPa escape (Blower et al., 2017) 
ΦM1-E37 SCRI1043 (pTA46) ToxINPa escape (Blower et al., 2017) 
ΦM1-E38 SCRI1043 (pTA46) ToxINPa escape (Blower et al., 2017) 
ΦM1-E39 SCRI1043 (pTA46) ToxINPa escape (Blower et al., 2017) 
ΦM1-E40 SCRI1043 (pTA46) ToxINPa escape (Blower et al., 2017) 
ΦM1-E41 SCRI1043 (pTA46) ToxINPa escape (Blower et al., 2017) 
ΦM1-E42 SCRI1043 (pTA46) ToxINPa escape (Blower et al., 2017) 
ΦM1-E43 SCRI1043 (pTA46) ToxINPa escape (Blower et al., 2017) 
ΦM1-E44 SCRI1043 (pTA46) ToxINPa escape (Blower et al., 2017) 
ΦM1-E45 SCRI1043 (pTA46) ToxINPa escape (Blower et al., 2017) 
ΦM1-E46 SCRI1043 (pTA46) ToxINPa escape (Blower et al., 2017) 
Table continued overleaf 




Table 2.5 continued. Phages used in this study 
Phage Host isolated on Relevant 
characteristics 
Reference or source 
ΦM1-E47 SCRI1043 (pTA46) ToxINPa escape (Blower et al., 2017) 
ΦM1-E48 SCRI1043 (pTA46) ToxINPa escape (Blower et al., 2017) 
ΦM1-E49 SCRI1043 (pTA46) ToxINPa escape (Blower et al., 2017) 
ΦRC10 SCRI1043 Wild type River Cam, Cambridge 
(This study) 
ΦRC10a SCRI1043 (pFR2) TenpINPl escape This study 
ΦRC10b SCRI1043 (pFR2) TenpINPl escape This study 
ΦRC10c SCRI1043 (pFR2) TenpINPl escape This study 
ΦRC10d SCRI1043 (pFR2) TenpINPl escape This study 
ΦRC10e SCRI1043 (pFR2) TenpINPl escape This study 
ΦRC10f SCRI1043 (pFR2) TenpINPl escape This study 
ΦRC10g SCRI1043 (pFR2) TenpINPl escape This study 
ΦRC10h SCRI1043 (pFR2) TenpINPl escape This study 
ΦRC10i SCRI1043 (pFR2) TenpINPl escape This study 
ΦRC10j SCRI1043 (pFR2) TenpINPl escape This study 
ΦRC10k SCRI1043 (pFR2) TenpINPl escape This study 
ΦRC10l SCRI1043 (pFR2) TenpINPl escape This study 
ΦRC10m SCRI1043 (pFR2) TenpINPl escape This study 
ΦRC10n SCRI1043 (pFR2) TenpINPl escape This study 
ΦRC10o SCRI1043 (pFR2) TenpINPl escape This study 
ΦRC10p SCRI1043 (pFR2) TenpINPl escape This study 
ΦCHAI1 DH5α Wild type River Cam, Cambridge 
(This study) 
ΦCHAI2 DH5α Wild type River Cam, Cambridge 
(This study) 
ΦCHAI3 DH5α Wild type River Cam, Cambridge 
(This study) 
ΦCHAI4 DH5α Wild type River Cam, Cambridge 
(This study) 
ΦCHAI5 DH5α Wild type River Cam, Cambridge 
(This study) 
ΦCHAI6 DH5α Wild type River Cam, Cambridge 
(This study) 
ΦCHAI7 DH5α Wild type River Cam, Cambridge 
(This study) 
ΦCHAI8 DH5α Wild type River Cam, Cambridge 
(This study) 
ΦCHAI8a DH5α (pTA46) ToxINPa escape This study 
ΦCHAI8b DH5α (pTA46) ToxINPa escape This study 
ΦCHAI8c DH5α (pTA46) ToxINPa escape This study 
ΦCHAI8d DH5α (pTA46) ToxINPa escape This study 
ΦCHAI8e DH5α (pTA46) ToxINPa escape This study 
ΦCHAI9 DH5α Wild type River Cam, Cambridge 
(This study) 
Table continued overleaf 
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Table 2.5 continued. Phages used in this study 
Phage Host isolated on Relevant 
characteristics 
Reference or source 
ΦCHAI9-E1 EPI300 (pFR2) TenpINPl escape This study 
ΦTRB18 DH5α Wild type (Blower, 2009) 
ΦTRB19 DH5α Wild type (Blower, 2009) 
ΦF1 DH5α Wild type (Rao, 2014) 
ΦF2 DH5α Wild type (Rao, 2014) 
ΦF4 DH5α Wild type (Rao, 2014) 
ΦF4-E1 EPI300 (pTA46) ToxINPa escape This study 
ΦF4-E2 EPI300 (pFR2) TenpINPl escape This study 
ΦF5 DH5α Wild type (Rao, 2014) 
ΦF6 DH5α Wild type (Rao, 2014) 
ΦF7 DH5α Wild type (Rao, 2014) 
T4 E. coli Wild type Laboratory collection 
T6 E. coli Wild type Laboratory collection 
T6-E1 EPI300 (pFR2) TenpINPl escape This study 
T6-E2 EPI300 (pFR2) TenpINPl escape This study 
T6-E3 EPI300 (pFR2) TenpINPl escape This study 
T6-E4 EPI300 (pFR2) TenpINPl escape This study 
T6-E5 EPI300 (pFR2) TenpINPl escape This study 
T6-E6 EPI300 (pFR2) TenpINPl escape This study 
ΦOT8s S 39006 
(pMUT13) 
Wild type (Blower, 2009) 
ΦOT8s-E1 S 39006 
(pMUT13, pTA46) 
ToxINPa escape This study 
ΦOT8s-E2 S 39006 
(pMUT13, pTA46) 
ToxINPa escape This study 
ΦOT8s-E3 S 39006 
(pMUT13, pTA46) 
ToxINPa escape This study 
ΦOT8s-E4 S 39006 
(pMUT13, pTA46) 
ToxINPa escape This study 
ΦOT8s-E5 S 39006 
(pMUT13, pTA46) 
ToxINPa escape This study 
ΦOT8s-E6 S 39006 
(pMUT13, pTA46) 
ToxINPa escape This study 
ΦOT8s-E7 S 39006 
(pMUT13, pTA46) 
ToxINPa escape This study 
ΦOT8s-E8 S 39006 
(pMUT13, pTA46) 
ToxINPa escape This study 
ΦOT8s-E9 DH5α (pTA46) ToxINPa escape This study 
ΦOT8s-E10 DH5α (pTA46) ToxINPa escape This study 
ΦOT8s-E11 DH5α (pTA46) ToxINPa escape This study 
ΦOT8s-E12 DH5α (pTA46) ToxINPa escape This study 
ΦOT8s-E13 DH5α (pTA46) ToxINPa escape This study 
ΦOT8s-E14 DH5α (pTA46) ToxINPa escape This study 
Table continued overleaf 
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Table 2.5 continued. Phages used in this study 
Phage Host isolated on Relevant 
characteristics 
Reference or source 
ΦOT8s-E15 DH5α (pTA46) ToxINPa escape This study 
ΦOT8s-E16 DH5α (pTA46) ToxINPa escape This study 
ΦLT TT01 Wild type Feng Rao (unpublished) 
ΦJB2 TT01 Wild type Jessica Bergman 
(unpublished) 
ΦJB15 TT01 Wild type Jessica Bergman 
(unpublished) 
ΦRAY0 TT01 Wild type This study 
ΦRAY1 TT01 Wild type This study 
ΦRAY19 TT01 Wild type This study 
ΦRAY26 TT01 Wild type This study 
ΦRAY27 TT01 Wild type This study 
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2.3.2 Isolation of TA escape phages 
The wild type Abi-sensitive phages were plated out on the appropriate lawn of bacteria 
containing the Type III TA plasmid of choice. Briefly, this involved 10 µl of serially 
diluted plaque pure phage onto 100 µl of overnight bacteria mixed with 4 ml molten top 
agar, poured as an overlay onto LBA plates. Plates were left to cool and incubated at 
the growth temperature of the host. A single plaque was picked from the resulting 
plaques using a sterile cocktail stick and added to a 1.5 ml Eppendorf tube containing 
200 µl of phage buffer. 20 µl of chloroform was then added, the sample vortexed and 
spun down. 10 µl of the supernatant was then used to make a serial dilution and a 
phage lysate was made as previously described using the same Type III TA containing 
host as before. Escapes were confirmed by efficiency of plating assays using a 
functioning and non-functioning frameshift Type III TA system containing strains. 
 
2.3.3 Determining phage titres and production of phage lysates 
Phage titres were calculated by plaque forming units per ml of phage lysate. To 
determine the titre, the lysate was serially diluted in phage buffer. Next 10 µl of each 
dilution was added to 200 µl of the appropriate overnight culture of bacteria and mixed 
with 4 ml of molten top agar. This mixture was poured evenly onto LBA plates and left 
to set. Plates were then incubated overnight at the growth temperature of the host 
bacteria. The next day plaques were counted to determine the titre. 
 
To make phage lysates, plates with plaques that were semi-confluent i.e. overlapping 
plaques with small areas of bacterial lawn still remaining were used to generate the 
lysates. The top lawn was scraped off into a glass universal containing 2 ml of phage 
buffer and 500 µl of chloroform. This was then vortexed for 2 mins and then centrifuged 
at 4500 RPM for 20 mins at 4ºC. The resulting supernatant was then pipetted into a 
glass bijou bottle with 100 µl of chloroform added to maintain sterility. These phage 
lysates were stored at 4ºC.  
 
2.3.4 Determining efficiency of plating 
The efficiency of plating (EOP) is used as a measure of how well a phage replicates in 
one host compared to another (Ellis and Delbrück, 1939). EOPs were used for 
determining the strength of abortive infection by the Type III TA systems, as well as in 
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host range testing. For the Type III TA testing, the phage titre on a host containing a 
functional Type III TA system was divided by the phage titre on the same host 
containing a non-functioning frameshift version. With regards to the host range testing, 
the EOP is the titre of the phage on the new bacterial host divided by the titre of the 
phage on the host that the phage lysate was made with. Thus an EOP of 1 means that 
there is no difference in replication on the test host compared to the control host. EOPs 
greater than 1 mean that replication is more productive in the test host and EOPs less 
than 1 signifies weaker replication in the test host. 
 
2.3.5 Adsorption assays 
Adsorption assays were performed using the Photorhabdus luminescens TT01 phage, 
ΦRAY26. For these assays, an overnight of bacterial culture was added to a 25 ml 
flask up to a volume of 10 ml and adjusted to an O.D.600 reading of 1. The phage, 
ΦRAY26 was added at a multiplicity of infection (MOI) of 0.01. The MOI is calculated 
as the titre of phage in pfu.ml-1 divided by number of bacterial cells as cells per ml. The 
flasks were added to a water bath with shaking at 300 RPM and at 30ºC. As soon as 
phage was added a 100 µl sample was taken from the flask as a time zero sample. 
This was added to a 1.5 ml Eppendorf tube containing 900 µl of phage buffer and 50 
µl chloroform, and vortexed briefly then put on ice for the duration of the assay. The 
assay was run for 30 mins with samples taken at 2.5 min intervals for the first 15 mins, 
then a sample at 20 mins and a final sample at 30 mins. All samples taken were 
immediately vortexed in the same conditions as the time zero sample. After the assay, 
samples were centrifuged for 5 mins at 12,000 RPM. 10 µl of the resulting supernatant 
was used to determine the titre of the phage. Results were recorded as the ratio of free 
phage for each time point compared to time zero. 
 
2.3.6 Transmission electron microscopy of phages 
Phages to be imaged by transmission electron microscopy were first grown to a high 
titre lysate using top agarose. 10 µl of this phage lysate was added to a charged copper 
grid for 5 mins. The grids were then washed twice in filtered dH20 by placing the grids 
on a drop of water and drying on filter paper immediately. Grids were then negatively 
stained for 2 mins using 2% uranyl acetate. The electron microscope used for taking 
phages images was a Tecnai G2 series transmission electron microscope. 
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2.4 Recombinant DNA techniques 
2.4.1 Bacterial plasmid extraction 
Extraction of plasmids were performed using the Thermo scientific miniprep kit. 
Protocol used as stated by the manufacturers. After extraction, plasmids were either 
used immediately or stored at -20ºC. A list of all plasmids used is shown in Table 2.6. 
 
Table 2.6 Plasmids used in this study 
Plasmid Description Reference or source 
pTA46 toxIPa, toxNPa with native promoter in 
pBR322, ApR 
(Fineran et al., 2009) 
pTA47 toxIPa, toxNPa-FS with native 
promoter in pBR322, ApR 
(Fineran et al., 2009) 
pFR2 tenpIPl, tenpNPl with native promoter 
in pBR322, ApR 
(Blower et al., 2012b) 
 
pFR8 tenpIPl, tenpNPl-FS with native 
promoter in pBR322, ApR 
(Blower et al., 2012b) 
 
pTA114 toxIBt, toxNBt with native promoter in 
pBR322, ApR 
(Short et al., 2013) 
pFLS63 toxIBt, toxNBt-FS with native promoter 
in pBR322, ApR 
(Short et al., 2013) 
pFLS116 cptIEr, cptNEr with native promoter in 
pBR322, ApR 
(Blower et al., 2012b) 
 
pTW03 cptIEr, cptNEr-FS with native promoter 
in pBR322, ApR 
Tom Whittaker, 
unpublished 
pMUT13 lamB, KmR (McGowan et al., 2005) 
pTRC99a ApR Gift from, David Clarke’s 
lab 
pBMM800 TT01 flgG in pTRC99a, ApR (Easom and Clarke, 2008) 
pBMM802 TT01 motAB in pTRC99a, ApR (Easom and Clarke, 2008) 
 
 
2.4.2 Phage gDNA extraction 
Phage genomic DNA was extracted by a phenol/chloroform DNA extraction method 
with the use of vacuum grease to separate the organic and aqueous phases. Phages 
selected for genomic extraction were made as high titre lysates using top agarose to 
prevent impurities from agar. For each extraction, three 1.5 ml Eppendorf tubes were 
filled with a pea size amount of sterile vacuum grease (Dow Corning). These tubes 
were centrifuged at 4500 RPM for 1 min to pellet the grease. In one of these tubes, 
450 µl of phage lysate, 4.5 µl of 1mg/ml DNase I and 2.5 µl of 10 mg/ml RNase were 
added. This tube was then incubated for 30 mins at 37ºC. Next 11.5 µl 20% SDS and 
4.5 µl of 10mg/ml proteinase K were added to the tube and incubated for a further 30 
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mins at 37ºC. After incubation, 500 µl of a phenol:chloroform:isoamyl alcohol (25:24:1) 
mixture was added. The tube was inverted three times and centrifuged for 5 mins at 
4500 RPM. The resulting tube should have a top aqueous phase that is separated from 
the organic phase by a thin layer of vacuum grease. The supernatant (aqueous phase) 
was removed and added to a new 1.5 ml Eppendorf tube containing vacuum grease. 
500 µl of the phenol:chloroform:isoamyl mixture was added, mixed and centrifuged as 
before. The resulting top supernatant was transferred again to the final 1.5 ml 
Eppendorf tube containing vacuum grease and 500 µl of a chloroform:isoamyl alcohol 
(24:1) mixture was added. This was inverted three times to mix and then centrifuged 
for 5 mins at 4500 RPM. The supernatant was then transferred to a new 1.5 ml 
Eppendorf tube with no vacuum grease. 4.5 µl of 3M sodium acetate adjusted to pH 
5.2 and 500 µl 100% isopropanol was added. The tube was then incubated for at least 
15 mins at room temperature. Next the tubes were centrifuged at 12000 RPM for 20 
mins at 4ºC to pellet the precipitated DNA. The supernatant was discarded and the 
pellet was washed twice with 400 µl 70% ethanol by centrifugation at 12000 RPM for 
5 mins and discarding the supernatant. After the final wash the pellet was dried on the 
bench to remove residual ethanol and then suspended in 100 µl dH20. DNA was stored 
at 4ºC for short term use or frozen at -20ºC for long term storage. 
 
 
2.4.3 Gel electrophoresis  
Gel electrophoresis was used to check the quality of genomic DNA, plasmids and PCR 
amplified products. The agarose gels were made by adding agarose in TAE buffer and 
dissolved using a microwave. After ensuring the agarose was completely dissolved, 
the solution was left to cool for 5 mins after which ethidium bromide was added. Gels 
were run in TAE buffer at 80 volts for 40 mins. For greater resolution a lower voltage 
and longer time was used. Gels were visualised using the Gel view UV transilluminator 
connected to the Gene Genious Bio-Imaging system from Syngene synoptics. 
 
2.4.4 DNA extraction from gels 
DNA bands from gels that required further manipulation were cut from gels using a 
scalpel. The DNA was then extracted from the band using the GeneJET gel extraction 
kit (ThermoFisher Scientific) according to the protocol from the manufacturer.  
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2.4.5 Picogreen assay 
To determine the purity and concentration of dsDNA from phage genomic DNA 
extractions, a picogreen assay was used. The kit used was the Quanti-iT™ PicoGreen 
™ dsDNA assay kit (ThermoFisher Scientific). The protocol used was according to the 
manufacturer’s instructions. 
 
2.4.6 Polymerase chain reaction 
All PCR reactions were performed using the Phusion polymerase (NEB). The 
components required for the PCR reaction are shown in Table 2.7. PCR reactions 
were run using the Veriti 96 well thermal cycler (Applied Biosystems) with the 





Table 2.7 PCR components 
Component Volume (µl) 
Forward primer 2.5 
Reverse primer 2.5 
5x HF buffer 10 
DNA 1 
Phusion polymerase 0.5 
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Table 2.8 PCR conditions 
Condition Temperature (ºC) Time 
Initial denaturation 98 2 mins 
Cycle 29 times 
Denaturation 98 2 sec 
Annealing 55-60 (varies depending 
on primers) 
15 sec 
Extension 72 15 sec per kb 
   
Final extension 72 2 mins 





Table 2.9 Primers used in this study 
Primer Sequence (5’-3’) Description 
TRB35 AAAGTGCCACCTGACGTC Forward sequencing primer for 
pBR322 
TRB36 ATGACGATGAGCGCATTG Reverse sequencing primer for 
pBR322 
oRC19 ACCTACAATGCCCCAGATGC Forward sequencing primer for 
phim1-23 and rc10-26 
oRC20 CGGTCGTACTTGGCTTCGGG Reverse sequencing primer for 
phim1-23 and rc10-26 
oRC34 GAAGTCTACTGATGTTGTGA Forward sequencing primer for 
ΦOT8s motA 
oRC35 GAATAACCGGTTGTGACTGC Reverse sequencing primer for 
ΦOT8s motA 
oRC52 GAGTCATAATCTTCAGAACG Forward sequencing primer for 
ΦOT8s asiA 
oRC53 AACTGTGACGATGTATTGGT Reverse sequencing primer for 
ΦOT8s asiA 
oRC54 GTACGCTGACGATGAATATT Forward sequencing primer for 
T6 alc 
oRC55 TCTTCTGCGAACTTGTTGAA Reverse sequencing primer for 
T6 alc 
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2.4.7 DNA sequencing 
2.4.7.1 Sequencing of plasmids and PCR amplicons 
All sequencing of plasmids and PCR amplified products were performed at the GATC 
now part of Eurofins Genomics in Germany. 7.5 µl of the DNA sample was sent with 
2.5 µl of the primer in a 1.5 ml Eppendorf tube. 
 
2.4.7.2 Whole genome sequencing 
Prior to sequencing all extracted phage genomes were run on agarose gels and a 
picogreen assay performed to confirm concentration and quality. All phages, apart from 
five TT01 phages, were sent for whole genome sequencing at MicrobesNG based in 
Birmingham. The platform used for sequencing at MicrobesNG is Illumina using 2x250 
bp paired-end reads and contigs were assembled using SPAdes. Due to the small size 
of phage genomes the majority of genomes were returned as a single contig. The 
quality of genomes varied but generally coverage was several times that of the genome 
with certain genome coverages reaching as high as 1000x. The data for all phage 
genomes including FASTA sequences, annotations and coverage is available in the 
appendices. 
 
As mentioned above, five TT01 phage genomes were not sequenced by MicrobesNG 
and were sent for sequencing at the Sanger Institute, located at the genome campus 
in Hinxton. These genomes were sequenced by Pacbio sequencing twice and 
genomes were assembled using contigs returned from both sequencing runs. As 
before, all information for these genomes is available in the appendices. 
 
2.4.7.3 Genome annotations and analysis 
Phage genomes were annotated using the Artemis genome browser that is freely 
available from the Wellcome Sanger Institute website. For the prediction and 
annotation of open reading frames, two gene prediction tools, Glimmer and GeneMark 
were used. Protein function and homologous proteins were identified by performing a 
protein BLAST on all predicted proteins. For the identification of tRNA genes, 
tRNAScan and ARAGORN was used. Nucleotide comparisons were performed using 
EMBOSS stretcher with Artemis comparison tool used for protein alignments. For the 
construction of phylogenetic trees MEGA7 was used and proteins were aligned using 
muscle. 
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2.4.8 Bacterial transformation 
2.4.8.1 Chemical transformation 
Chemical or heat shock transformation of plasmid DNA was used for E. coli cells. To 
prepare the competent cells, 500 µl of the bacterial overnight was grown in 25 ml LB 
supplemented with 375 µl of 1 M MgCl2. The culture was grown in a 250 ml flask with 
shaking at 250 RPM at 37ºC until the O.D.600 was between 0.4 to 0.6. The culture was 
then added to a pre-chilled universal tube and left for 1 hour at 4ºC. This was then 
centrifuged at 4500 RPM for 10 mins at 4ºC. The supernatant was discarded and the 
resulting pellet suspended in 10 ml of solution A that had been chilled on ice. This was 
then left on ice for 20 mins then centrifuged under the same conditions as before. The 
supernatant was discarded again and the pellet suspended in 1 ml of solution A 15% 
glycerol to make the competent cell mixture. This mixture was then used immediately 
or stored at -80ºC for later use. 
 
For transformation 50 µl of the competent cell mixture was added to a 1.5 ml Eppendorf 
tube with 0.5 µl of miniprepped plasmid DNA and left on ice for 1 hour. This was then 
moved to a water bath at 42ºC for 2 mins after which 1 ml of LB was added and the 
cells were left to recover on a rotating wheel for 1 hour at 37ºC. The cells were then 
spread onto LBA plates containing the appropriate selection and incubated at 37ºC 
overnight. 
 
2.4.8.2 Electroporation transformation 
For non E. coli cells, electroporation was used. The standard electroporation protocol 
is shown below, for Ph. luminescens an adapted protocol was used. To prepare 
electroporation competent cells, a 250 ml flask containing 25 ml of LB was inoculated 
with 500 µl of an overnight culture of the bacteria. This was grown in a water bath at 
the growth temperature of the bacteria, with shaking at 250 RPM. The bacterial culture 
was grown to an O.D.600 of 0.6 then decanted into a pre-chilled universal tube and left 
on ice for 30 mins. The cells were then pelleted by centrifugation at 4500 RPM for 10 
mins at 4ºC. The resulting supernatant was discarded and the pellet suspended in 10 
ml ice cold dH20. It was immediately pelleted again as before and suspended in 10 ml 
ice cold 10% glycerol. This was also pelleted and the pellet finally suspended in 1 ml 
10% glycerol. These electrocompetent cells were either used immediately or stored at 
-80ºC for later use. 
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For the electroporation, 50 µl of electrocompetent cells and 1 µl of plasmid was added 
to a precooled electroporation cuvette. Conditions for electroporation were 200Ω, 25 
µFd and 2.5 kV. Cells were left to recover for 1 hr in 1 ml of LB at 30ºC and then spread 
on LBA plates containing the appropriate antibiotic. The DNA from resulting colonies 
was sequenced to confirm the successful uptake of the plasmid and to confirm that no 
mutations had occurred. 
 
2.4.8.3 Ph. luminescens electroporation 
2 ml of an overnight culture of Ph. luminescens were added to 200 ml LB containing 
0.1% sodium pyruvate. The culture was grown in a 2 litre flask with shaking at 250 
RPM at 30ºC until reaching an O.D.600 reading of 0.3. It was then chilled on ice for 90 
mins after which the culture was pelleted by centrifugation at 4500 RPM for 20 mins at 
4ºC. The supernatant was discarded and the pellet suspended in 200ml of 
Photorhabdus wash buffer. This wash was repeated twice but suspended in 100 ml 
then 10 ml wash buffer. Finally, after the last spin, the cells were suspended in 200 µl 
wash buffer and were used immediately. In a prechilled electroporation cuvette, 50 µl 
of competent Ph. luminescens and 1.5 µl of plasmid DNA were added. The cells were 
electroporated at 2.5 kV, 200 Ω and 25 µF with a time constant of 5 ms. Cells were 
recovered immediately by the addition of 1 ml LB and transferred to a 1.5 ml Eppendorf 
tube to recover for 3 hours at 30ºC. Selection of transformant cells was performed by 
plating the recovered cells onto LBA plates containing 0.1% sodium pyruvate and the 
appropriate antibiotic. Plates were incubated for 3 days at 30ºC and the DNA from any 
resulting colonies was sequenced to confirm the uptake of the plasmid. 








To date there are only five phages isolated on P. atrosepticum, including ΦTE and 
ΦM1 that have had their genomes entirely sequenced. Based on sequence homology 
they can be split into two groups, either ΦTE-like or ΦM1-like. The ΦTE-like group 
contains two members, ΦTE and vB_PatM_CB7 (direct submission, CB7 for short, 
accession no. KY514263). The ΦM1-like group contains three members, ΦM1, Peat1 
(Kalischuk et al., 2015)(accession no. KR604693) and PP90 (direct submission, 
accession no. NC_031096). P. atrosepticum causes black leg in potatoes and as such 
the use of phages have been studied as a potential solution to prevent the disease 
(Buttimer et al., 2017a). In fact, it has been reported that Tesco has been using the 
bacteriophage cocktail, Biolyse, developed by APS biocontrol to reduce soft rot and 
enhance the shelf life of their potatoes, prior to packaging (Branston, 2012). This 
bacteriophage cocktail will undoubtedly include several uncharacterised P. 
atrosepticum phages and as they will still be viable on potatoes bought in 
supermarkets, it would be useful to characterise these phages further. At least two of 
the five fully sequenced P. atrosepticum phages, ΦTE and ΦM1 have been shown to 
be transducers. While this makes these phages useful molecular tools, it makes them 
undesirable to be used as part of a phage cocktail since they may cause the unwanted 
horizontal gene transfer of genes involved in antibiotic resistance and virulence. The 
limited number of P. atrosepticum phage genomes published, the current use of these 
phages in commericial phage cocktails and the fact that these phages could be 
transducers necessitates further characterisation. Furthermore, genomic data on new 
P. atrosepticum phages isolated in this laboratory will assist with defining the natures 
of the phages that are aborted and or not aborted by the Type III TA systems. 
 
3.2 Whole genome sequencing of 36 novel environmental P. atrosepticum 
phages 
 
To address the paucity of information that there is on P. atrosepticum phages, 36 
phages isolated on P. atrosepticum SCRI1043 or SCC34 were sent for whole genome 
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sequencing. These phages were isolated over a period ranging from June 1987 to 
October 2017, derived from water samples obtained from Coventry, Cambridge or 
Norway. One phage, ΦRC62, was isolated during this period from a rotting potato 
originating from a supermarket in Cambridge. 14 of these phages sequenced were 
from a library of phages isolated during this study. These are phages with the prefix, 
ΦRC or ΦR followed by a number. The remaining phages were isolated by past 
members of the lab or collaborators. Genomic data returned for these 36 phages 
showed that they can be split into six groups based on sequence homologies. The 
groups are as follows, ΦTE-like, ΦM1-like (based on the previously published ΦTE 
and ΦM1 phages) and four new groups named after the first phage isolated in each 
group called ΦR1-like, ΦRC6-like, ΦRC63-like and ΦR11-like.  
 
3.2.1 ΦTE-like phages 
3.2.1.1 Genomic analysis of ΦTE-like phages 
 
Of the 36 P. atrosepticum phages sequenced, 12 showed high similarity to ΦTE. As 
such, these phages belong to the genus Cr3virus derived from the Vequintavirinae 
subfamily.  These 12 phages can be further spilt into three sub groups based on 
percentage identity of aligned sequences (Table 3.1). Within each subgroup, phages 
are highly similar to each other, sharing more than 99% identity. Subgroup one 
comprises two members, ΦS34 and ΦS61, and shares the highest identity with ΦTE. 
Subgroup two which consists of three members, (ΦA2, ΦA5 and ΦS22) also shares a 
high sequence identity with ΦTE and with members of subgroup one, but to a lesser 
degree. Subgroup three is the largest group, consisting of the remaining seven phages 
and is the least similar to ΦTE of the subgroups. Phage CB7 was also added to the 
analysis and is the least related to all other ΦTE-like phages. Representatives from 
each subfamily, ΦS34, ΦA2 and ΦA4S were annotated. Analysis of these phages 
showed that ΦTE-like phages have genome lengths of 142,349 to 145,315 base pairs 
with 242 to 266 predicted open reading frames (ORFs) (Table 3.2). The ΦTE-like 
phages also carry at least 2 tRNAs, apart from CB7 which only has a single tRNA. All 
the phages carry tRNA-Tyr while the second tRNA, if present, is either tRNA-Cys or 
tRNA Leu. A genomic map of ΦS34 is shown in Figure 3.1. ACT alignments made 
using a tblastx comparison show that very small differences exist within subgroups but 
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outside of subgroups there are less conserved proteins spread throughout the 
genomes (Figure 3.2).  
 
   









































































































































































































































































































































































































































































































































































































































































































































































































































Table 3.2 Genomic characterisation of ΦTE-like phages 
Phage Subgroup Genome size (bp) Predicted 
ORFs 
tRNAs 
ΦTE - 142,349 242 tRNA-Cys, 
tRNA-Tyr 
ΦS34 1 145,315 261 tRNA-Cys, 
tRNA-Tyr 
ΦS61 1 145,315 NA NA 
ΦA2 2 144,475 266 tRNA-Leu, 
tRNA-Tyr 
ΦA5 2 144,476 NA NA 
ΦS22 2 144,481 NA NA 
ΦA4S 3 142,686 259 tRNA-Leu, 
tRNA-Tyr 
ΦA4L 3 143,656 NA NA 
ΦA6 3 142,681 NA NA 
ΦS21 3 142,685 NA NA 
ΦS41 3 143,587 NA NA 
ΦS72 3 142,686 NA NA 
ΦB1 3 142,686 NA NA 

















Figure legend on next page 
Figure 3.1 Genomic map of ΦTE-like phage, ΦS34. 
 Forward reading frames are labelled F1-3 with reverse reading frames labelled as R1-
3. Genes involved in metabolism, virion structure or lysis are in green, blue or red, 
respectively. Genes that have no predicted function but are homologous to 
hypothetical proteins in previously published phage genomes are shown in grey. 
Hypothetical protein that have no significant matches to published proteins are shown 












Figure 3.2 continued overleaf 
  







Figure 3.2 continued overleaf 
  










Figure 3.2 ACT comparison diagrams of ΦTE-like phages. 
 Genome comparisons of the subgroups one (A), two (B) and three (C) show little 
differences compared to each other. However outside of the subgroups (D) there are 
more pronounced differences. The comparisons were done using a tblastx comparison 
file. Red bars show areas of high amino acid similarity. 
  






3.2.1.2 TEM imaging of ΦTE-like phages 
 
All ΦTE-like phages were imaged by transmission electron microscopy. They were all 
shown to belong to the Myoviridae family as characterised by long contractile tails 
(Figure 3.3, 3.4). This is in agreement with the genomic data obtained and images of 
the phages closely resemble previous TEM images of ΦTE. All the ΦTE-like phages 
have isometric icosahedral heads measuring roughly 100 nm across from either side 
of the icosahedral face with extended tails of about 120 nm. No contracted phages 















Figure 3.3 TEM images of individual ΦTE-like phages. 












Figure 3.4. TEM image of several ΦTE-like phage, ΦA5. 
 Phages shown in the image all have extended tails. No phages with contracted tails 










3.2.2 ΦM1-like phages 
3.2.2.1 Genomic analysis of ΦM1-like phages 
 
12 of the newly sequenced P. atrosepticum phages and two previously submitted 
phages (Peat1 and PP90) shared high homology with ΦM1. Collectively these phages 
shared more than 76.3% identity with each other. ΦM1 was classified as a Phikmvvirus 
which belongs to the subfamily Autographivirinae (Blower et al., 2017). This subfamily 
of viruses have linear genomes that are usually flanked by repeating sequences of 
DNA termed direct terminal repeats (DTRs) (Lavigne et al., 2003). ΦM1’s DTR could 
not be established by primer walking and thus was estimated by analysis of restriction 
enzyme digestion patterns of its genome (Blower et al., 2017). All ΦM1-like phages 
were sequenced by Illumina sequencing, thus the short reads often cause the direct 
repeats to overlap with each other and thus are not present in the final assembled 
contig. The predicted DTR of ΦM1 was used as a reference to try to predict the DTR 
regions of the ΦM1-like phages. However, for four of the phages, ΦS33, ΦS42, ΦS71 
and ΦB24, DTRs were present in the final assembled contig and thus these could be 
correctly assigned. 
 
The 12 newly sequenced phages can be split into five further subgroups based on their 
relatedness. Subgroups in this case shared more than 97.9% identity (Table 3.3). 
ΦRC10 was annotated as a representative of the ΦM1-like phages as sequence 
comparisons showed that it was the least similar to ΦM1 but it also had an interesting 
Abi phenotype, discussed in the next chapter. Similar to ΦM1, all ΦRC10 open reading 
frames are coded on the forward reading frame (Figure 3.5). ΦM1-like phages have 
genome lengths of 43,661 - 45,633 base pairs with 52 to 61 ORFs. Only ΦM1 has a 
single tRNA, tRNA-Ile, no other ΦM1-like phage annotated contains any tRNAs.  
 
Other non P. atrosepticum phages similar to the ΦM1-like phages include two P. 
carotovorum phages, PPWS1 (LC063634, (Hirata et al., 2016)) and PP16 
(NC_031068, unpublished) which share 78% and 59% nucleotide identity respectively 
with ΦRC10. There is also a phage isolated on a Dickeya species called BF25/12 
(KT240186, unpublished) which shares 48.3% nucleotide identity with ΦRC10. ACT 






comparison images generated using tblastx comparison between ΦRC10 and closely 
related phage genomes shows that their genomes are syntenic (Figure 3.6). 
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Table 3.4 Genomic data of ΦM1-like phages 
Phage Subgroup Genome size (bp) Predicted 
ORFs 
tRNAs 
M1 1 43,827 52 tRNA-Ile 
B24 1 43,661 NA NA 
M5 2 43,984 NA NA 
A1 3 43,726 NA NA 
M4 3 44,418 NA NA 
M2 4 44,487 NA NA 
S32 4 44,235 NA NA 
S33 4 44,024 NA NA 
S42 4 43,898 NA NA 
S64 4 44,132 NA NA 
S71 4 43,960 NA NA 
RC9 5 44,125 NA NA 
RC10 5 44,129 55 None 
Peat1 - 45,633 61 None 
PP90 - 44,570 56 None 
 
NA – Not annotated 
 
  








Figure 3.6 continued overleaf 
  








Figure 3.6 Genome wide protein comparison of ΦRC10 and related phages. 
A. ΦRC10 compared with ΦM1 and Peat1. B. ΦRC10 compared with P. carotovorum 
phages, PP90 and PPWS1. C. ΦRC10 compared to P. carotovorum phage ΦPP16 
and Dickeya phage ΦBF25/12. D. ΦRC10 compared to ΦT7 and ΦKMV. Comparisons 
files were made using tblastx analysis with a cut off value of 1x10-4. Red bars signify 
areas of high amino acid sequence homology. 






3.2.2.2 TEM analysis of ΦM1-like phages 
 
As expected from the genomic data, all ΦM1-like phages were proven to be members 
of the Podoviridae family (Figure 3.7). This family is defined as double stranded DNA 
phages with a short non contracting tail. Heads measure from 57 nm to 69 nm which 
is slightly larger than the ΦM1 original measurements of 55 nm (Toth et al., 1997). 
 
 
Figure 3.7 TEM images of ΦM1-like phages. 
All phages belong to the Podoviridae family. Black bars represent 100 nm.  






3.2.3 ΦR1-like phages 
3.2.3.1 Genomic analysis of ΦR1-like phages 
 
ΦR1-like phages are a group of eight phages from the library with genomes that 
displayed more than 93% identity to each other (Table 3.5). As there were no P. 
atrosepticum phages sequenced that resemble this type of phage as of yet, they were 
named after the first phage isolated of the group called ΦR1. Blastn analysis of the 
genomes revealed that they have homology with podoviruses from the T7virus genus. 
This genus is in the subfamily Autographivirinae, the same as the ΦM1-like phages. 
Similar to ΦM1-like phages the ΦR1-like phages were predicted to have linear 
genomes flanked by DTRs. The location of the DTRs of the ΦR1-like phages are based 
on two similar T7viruses that have their DTRs annotated in the NCBI database, 
Yersinia phage vB YenP AP10 (direct submission, AP10 for short, KT852574.1) and 
Citrobacter phage SH2 (direct submission, KU687348.1). Addition of the DTRs show 
that the lengths of the ΦR1-like phages range from 40,255 to 41,375 (Table 3.6). 
 
As ΦR1 was the establishing member of this group it was chosen for annotation. This 
revealed that, similar to the ΦM1-like phages, all 50 predicted open reading frames of 
ΦR1 are coded on the forward reading frame (Figure 3.8). There were no tRNA genes 
detected in the genome. Nucleotide comparisons of ΦR1 showed that it shared 59.7%, 
58.8%, 62.1% and 60.5% nucleotide identity with T3 (KC960671.1), T7 (GU071091.1), 
AP10 and SH2 respectively. ΦR1 has very high nucleotide sequence identity, (96%), 
with a previously submitted P. carotovorum phage, Jarilo (direct submission, 
MH059637.1). This percentage identity is even higher than certain ΦR1-like phages 
when compared to each other (Table 3.5). Compared to ΦM1 and KMV, ΦR1 shows 
much less homology sharing sequence identities of 48% with both phages. ACT 
generated images of ΦR1 and other T7viruses show that there are no large 
rearrangements between the phage genomes of this genus. (Figure 3.9, A-C). 
Compared to ΦM1 and ΦKMV, however, there is much less amino acid homology seen 























































































































































































































































































































































Table 3.6 Genomic data of ΦR1-like phages 
Phage Genome size (bp) Predicted ORFs 
ΦR1 40,728 50 
ΦRC58 40,307 NA 
ΦRC64 40,255 NA 
ΦRC41 40,686 NA 
ΦRC30 41,375 NA 
ΦRC36 41,233 NA 
ΦRC33* 39,494 NA 
ΦRC18 40,553 NA 
 
*ΦRC33’s raw sequence data returned in three contigs and so is not a complete 
genome and will need to be resolved by resequencing the gaps. 














































































































































































































































































Figure 3.9 continued overleaf 
  







Figure 3.9 Genome wide predicted protein comparisons of ΦR1 and related phages. 
 A. ΦR1 compared with closely related P. carotovorum phage Jarilo and another ΦR1-
like phage, ΦRC18. B. ΦR1 compared with T-series phages, T3 and T7. C. ΦR1 





compared to Yersinia phage AP10 and Citrobacter phage SH2. D. ΦR1 compared to 
ΦM1 and KMV. 





3.2.3.2 TEM analysis of ΦR1-like phages 
 
As expected all ΦR1-like phages when viewed under TEM resemble podoviruses. 




Figure 3.9 TEM images of ΦR1-like phages. 









3.2.4 ΦRC6-like phages 
3.2.4.1 Genomic analysis of ΦRC6-like phages 
 
The ΦRC6-like phages are a set of three phages that share more than 94.5% 
sequence identity to each other (Table 3.7). Blastn results of the ΦRC6-like phages 
show very poor homology with phages belonging to the Ounavirinae subfamily. This 
subfamily is currently comprised of four genera which are the Ea214virus, Felix01virus, 
Mooglevirus and Suspvirus named after the first phages isolated for each group. 
Comparisons of the genomes of the founding phages of each genus show that the 
ΦRC6-like viruses do not closely match any of the genera and taxonomically should 
define a new genus (Table 3.7). 
 
As the founding member of the ΦRC6-like phages, ΦRC6 was annotated. A genomic 
map of ΦRC6 is shown in Figure 3.9. The ΦRC6-like phages have genomes that range 
from 93,058 to 93,203 base pairs. Annotation of ΦRC6 has revealed that it has 151 
open reading frames with 24 tRNAs (Table 3.8). The large number of tRNAs is a 
common feature of the Ounavirinae with the founding members of each genus carrying 
19 to 26 tRNAs (Table 3.8). Another interesting feature of ΦRC6 is that it contains a 
possible CRISPR repeat within its genome (Figure 3.10). This putative CRISPR repeat 
contains three repeats of 33 base pairs with spacer lengths of 56 and 61 base pairs. 
CRISPR repeats also are preceded by a 100 to 500 base pair long AT rich leader 
containing a promoter (Wei et al., 2015). The putative leader is shown in Figure 3.10B 
beginning at the predicted -35 promoter region and has an AT content of 66.1%. 
However, it appears that the -10 promoter region within the leader is not essential for 






































































































































































































































































































Figure legend shown overleaf 






Figure 3.9 Genomic map of ΦRC6. 
 F1-3 indicates ORFs on the forward reading strand with R1-3 for the reverse. Arrows 
in green, blue and red are ORFs involved in metabolism, virion structure and lysis, 
repectively. ORFs encoding proteins of unknown functions that have homologs in other 
phages are in grey. Yellow arrows represent ORFs that have no significant matches in 
NCBI. Pink bars represent the location of tRNAs with the putative CRISPR repeat 
displayed as an orange bar. 
  








Table 3.8 Genomic data of ΦRC6-like phages 
Phage Genome length 
(bp) 
ORFs tRNAs 
ΦRC6 93,203 151 24 
ΦRC50 93,185 NA NA 
ΦRC62 93,058 NA NA 
Ea214 84,576 118 26 
Felix01 86,155 247 22 
Moogle 87,999 126 21 
SUSP1 90,743 138 19 
 
NA – not annotated 
 
  















Spacer 1 TAGGTAGTTATGCATAAAATTTCCTGTGCA 
GTTTACTTCACATTGGCTCACAAATA 
 




Figure 3.10 ΦRC6 contains a putative CRISPR repeat. 
A Organisation of the putative CRISPR. The putative CRISPR repeat in ΦRC6 
contains an AT rich leader sequence followed by three 36 bp direct repeats, 
interspersed by two different spacer regions. The sequences of the different 
components of the putative CRISPR repeat is shown in B. Sequences of the different 
regions. Letters in bold in the leader sequence are the predicted -35 (TTTAGA) and -









3.2.4.2 TEM analysis of ΦRC6-like phages 
 
Phages of the Ounavirinae subfamily are part of the Myoviridae family. The ΦRC6-like 
phages were confirmed to be Myoviruses through TEM analysis (Figure 3.11). The 
heads of ΦRC6-like phages measure 57 to 68 nm across with an extended tail of 115 





Figure 3.11 TEM images of ΦRC6-like phages. 









3.2.5 ΦRC63-like phages 
3.2.5.1 Genomic analysis of ΦRC63-like phages 
 
The ΦRC63-like phage “group” currently contains only a single phage, ΦRC63. 
Analysis of the genome shows that it can be classed as a jumbo phage with a genome 
size of 240, 968 base pairs long. Jumbo phages have genomes over 200, 000 base 
pairs long and are considered relatively rare phages (Yuan and Gao, 2017). Annotation 
of the ΦRC63 genome revealed that it is circular with 271 predicted ORFs (Figure 
3.12). Blastn results of the ΦRC63 genome leads to no phages hits. However, during 
annotation of the genome several proteins showed homology to other submitted jumbo 
phage genomes. The most common significant hit came from proteins originating from 
an Erwinia amylovora phage called Risingsun (MF_49646). Other related phages 
include Pseudomonas aeruginosa phage El (NC_007623), E. amylovora phage Caitlin 
(NC_031120) and Salmonella phage SPN3U5 (NC_027402). All these phages are 
jumbo phages but share very low nucleotide sequence homology with each other 
(Table 3.9). ACT comparison images using blastn and tblastx comparisons show that 
amino acid homology is much more conserved than nucleotide homology suggesting 
convergent evolution (Figure 3.13). Like many of the other jumbo phages, many of the 
predicted open reading frames have no known function. For ΦRC63, 193 of the ORFs 
are unknown which accounts for 71.2% of the open reading frames. Another interesting 
feature to note is that while both the forward and reverse strands encode predicted 
ORFs, there are only 34 predicted ORFs on the reverse strand with the majority of 
ORFs coded on the forward reading strand. The location of the ORFs on the reverse 
strand are also dotted around the genome rather than in localised areas (Figure 3.12). 
 
  









Figure 3.12 Genomic map of ΦRC63. 
 Coloured boxes on the outer ring represent ORFs on the forward reading frame with 
boxes on the inner ring representing ORFs on the reverse reading frame. Green, blue 
and red boxes represent ORFs encoding proteins involved in metabolism, virion 
structure and lysis, repectively. Grey boxes represent ORFs encoding proteins of an 
unknown function that have homologs in other phages. Yellow boxes represent ORFs 
encoding proteins that have no homologous proteins in NCBI.  









Table 3.9 Nucleotide comparisons of ΦRC63 and related phages 
 ΦRC63	 Rising	sun	 El	 Caitlin	 SPN3U5	
ΦRC63	 100	 47.4	 46.9	 46.2	 47	
Rising	sun	 47.4	 100	 48.1	 47.7	 47.8	
El	 46.9	 48.1	 100	 47.1	 46.9	
Caitlin	 46.2	 47.7	 47.1	 100	 56.9	
SPN3U5	 47	 47.8	 46.9	 56.9	 100	
 











Figure 3.13 continued overleaf 
  







Figure 3.13 Genome comparisons of ΦRC63 and related phages.  
A. Blastn and tblastx comparisons of ΦRC63 with E. amylovora phage Risingsun and 
P. aeruginosa phage El. B. Blastn and tblastx comparisons of ΦRC63 with E. 
amylovora phage Caitlin and Salmonella phage SPN3U5. 
  





3.2.5.2 TEM analysis of ΦRC63-like phage 
 
High titre purified lysates of ΦRC63 were prepared for TEM. Images obtained 
confirmed that it was a member of the Myoviridae. The size of a ΦRC63 particle is 
larger than previous Myoviridae phages of P. atrosepticum. The head measures 118 
nm across with an extended tail of 143 nm. This is approximately 1.5 times larger than 
the head of ΦTE. The larger size of the particle is presumably a result of harbouring a 




Figure 3.14 TEM image of ΦRC63.  
Black bar represents 100 nm.  





3.2.6 ΦR11-like phages 
3.2.6.1 Genomic analysis of ΦR11-like phages 
 
The final “group” of P. atrosepticum phages is the ΦR11-like group that currently 
comprises of only one member, ΦR11. Like ΦRC63, ΦR11 is also a jumbo phage 
possessing an even larger genome of 269,692 base pairs (Figure 3.15). It encodes 
354 ORFs which share homology with multiple ORFs from two E. amylovora jumbo 
phages, Y3 (KY984068) and Yoloswag (KY448244). Of the 354 predicted ORFs, 293 
have no known function, and 161 of the 293 ORFs do not encode products exhibiting 
homology with any proteins. As with Y3 and Yoloswag, ΦR11 does not encode any 
tRNAs. Other related phages include P. aeruginosa phage, PaBG (NC022096.1), P. 
putida phage, Lu11 (NC017972.1), NTCB and Ralstonia phage RSL1 (NC010811.2). 
There is little information on the other phages as they represent a very rare class of 
jumbo phages that have been recently sequenced with very few of their proteins 
sharing homology with any other phage apart from each other. 
 
Due to its similarity to Y3 and Yoloswag, the genome of ΦR11 has been orientated to 
start at the same start site which encodes a putative helicase. Homologues of this 
helicase are also found in the other related jumbo phages mentioned above and so 
their genomes have been reoriented to begin at this helicase gene for genome 
comparisons. ACT generated tblastx images show that the genes encoding the 
products of these phages compared to ΦR11 are disordered (Figure 3.16). Genes 
encoding many of the homologous proteins begin in different areas from the expected 
positions based on ΦR11. One example of this is a terminase in ΦR11 located at 
position 2522 to 5329. For Y3 (ARW58644.1) and Yoloswag (AQT28491.1) the 
homologs are located in similar locations as well, 2538 to 5369 and 2470 to 5283, 
respectively. However, the homolog in RSL1 (YP001960095.1) is located in a 
completely different location position, 166,748 to 168,940 (location based on RSL1 
genome beginning with the same helicase as ΦR11). Many other regions of the phage 
are also inverted suggesting that these phages have plastic genomes with many genes 
















Figure 3.15 Genomic map of ΦR11.  
ΦR11 has a circular double stranded DNA genome of 269, 692 base pairs encoding 
354 predicted ORFs. Green, blue and red boxes, indicate genes involved in 
metabolism, virion structure and lysis, respectively. Grey boxes represents genes of 
unknown functions with homologs in other phages. Yellow boxes indicate genes with 
unknown functions with no significant hits on the NCBI database. Boxes on the outer 
ring are ORFs encoded in the forward reading strand with boxes on the inner ring 
representing those on the reverse strand. 
  









Figure 3.16. Genome comparison of ΦR11 and related phages suggest plastic 
genomes. 
 A Phages Y3 and yoloswag compared to ΦR11 which have the highest degree of 
amino acid homology in their products compared to other phages. B and C show 
Pseudomonas phages, PaBG and Lu11, phage NTCB and Ralstonia phage RSL1, 
respectively. Genomes of all phages are orientated to begin at the same homologous 
protein, a putative helicase. Images were generated using ACT, using a tblastx 





comparison with a cut off value of 1x10-4. Red bar signifies areas of high amino acid 
sequence homology with blue bars showing high homology of inverted amino acid 
sequences.   





3.2.6.2 TEM analysis of ΦR11-like phages 
 
TEM images of phage Y3 and Lu11 show what has been described as hair-like 
structures on their tails (Buttimer et al., 2018; V. Shaburova a et al., 2006). Only one 
other group of sequenced phages has been reported to have these hair-like structures 
which are the Rak2-like phages that are jumbo phages and includes members such 
as P. carotovorum phage CBB (Buttimer et al., 2017b) and coliphage 121Q 
(NC_025447.1, (Hua, 2016)). TEM images of ΦR11 virions show that they may contain 
such hair-like appendages around their tails as well (Figure 3.17). Image resolution 
however, is not of a high enough quality to definitely conclude that these phages are 
“hairy”. Given the high amino acid sequence identity ΦR11 shares with Y3 it is very 
likely that it is also a hairy jumbo phage. ΦR11 has a head size of roughly 120 nm with 




Figure 3.17 TEM images of jumbo phage ΦR11. 
Three intact ΦR11 virions are visible in the image. Image quality is not high enough to 
accurately determine if there are hairy appendages but there are thin fibre like strands 
visible from areas around the tail that may be hairs. The black bar represents 100 nm. 
 
  





3.2.7 Predicted receptor and host ranges of the P. atrosepticum phages 
 
To predict the putative receptor of the 36 sequenced P. atrosepticum phages, they 
were tested on two mutant strains of SCRI1043 (Table 3.10). These were a flagellar 
mutant, TER2, which was previously shown to be resistant to ΦTE, and SCC34 an 
uncharacterized LPS mutant, that is resistant to ΦM1. Phages that were unable to 
infect TER2 but are able to infect SCC34 were considered flagella-dependent. On the 
other hand, if a phage could not infect SCC34, but could infect TER2, then it was 
considered LPS dependent. Phages that could not infect either strain were either 
considered to recognise an alternative receptor, or because the LPS mutant, SCC34 
is uncharacterized, another area of the LPS. 
 
Results from the ΦTE-like phages show that they are flagella dependent since they did 
not infect the flagellar mutant but were able to infect the LPS mutant. This follows the 
same pattern as ΦTE which was previously shown to be flagella-dependent (Blower et 
al., 2012a). The ΦM1-like phages also follow the same pattern as ΦM1 i.e. they are 
able to infect the flagellar mutant, but not the LPS mutant. The ΦR1-like phages can 
infect both flagellar and LPS mutants. This suggests that their receptor is either an 
alternative exposed area of the LPS or another type of receptor, such as an outer 
membrane protein. The ΦRC6-like phages showed a mixed pattern where ΦRC6 
cannot infect either the LPS or flagellar mutants. However, the other two ΦRC6-like 
members, ΦRC50 and ΦRC62 could not infect the LPS mutant but could infect the 
flagellar mutant. ΦRC6 has two predicted tail fibres which will need to be compared 
with those of ΦRC50 and ΦRC62 to determine if the difference in infectivity could be 
due to subtle differences in the amino acid sequence. It is possible that ΦRC6 
recognises a different exposed area of the LPS, thus is capable of infecting SCC34. 
Both the jumbo phages are unable to infect TER2 but are able to infect SCC34, 
suggesting that they are both flagella dependent. 
 
The 36 P. atrosepticum phages were also tested on a library of P. atrosepticum and P. 
carotovorum strains (Table 3.10). The ΦTE-like phages tended to be highly selective, 
with all capable of infecting only one other P. atrosepticum strain, (other than 
SCRI1043) which is SCRI1044. Interestingly ΦTE-like phages that belong to either 
subgroup one or two could infect an additional P. atrosepticum strain (SCRI41). The 





ΦM1-like phages generally had a much broader host range with all members capable 
of also infecting SCRI1044 and SCRI1064. Furthermore, ΦM1-like phages belonging 
to subgroups one to four could infect three other P. atrosepticum strains, SCRI41, 
SCRI13 and SCRI1064. Members belonging to subgroup five could only infect 
SCRI1044 and SCRI1064. The ΦR1-like phages also had a broad host range, capable 
of infecting six P. atrosepticum strains. Curiously, a few of the ΦR1-like phages 
appeared to infect one or two of the P. carotovorum strains. The ΦRC6-like phages 
showed a more selective host range with all members capable of infecting only two 
other P. atrosepticum strains. ΦRC6 itself could infect an additional P. atrosepticum 
strain. Another interesting result was that all ΦRC6-like phages could infect a P. 
carotovorum strain. Jumbo phage ΦRC63 was also quite selective and was only 
capable of infecting one other P. atrosepticum strain. However, it was also shown to 
be able to infect two other P. carotovorum strains. ΦR11 had a slightly broader host 
range than ΦRC63 and is capable of infecting six P. atrosepticum and two P. 




































   













































































































































































































   
 
S34 Y X Y X X X Y X X X Y X X X X X X X X X X X X X X X X X X X
S61 Y X Y X X X Y X X X Y X X X X X X X X X X X X X X X X X X X
A2 Y X Y X X X Y X X X Y X X X X X X X X X X X X X X X X X X X
A5 Y X Y X X X Y X X X Y X X X X X X X X X X X X X X X X X X X
S22 Y X Y X X X Y X X X Y X X X X X X X X X X X X X X X X X X X
A4S Y X Y X X X X X X X Y X X X X X X X X X X X X X X X X X X X
A4L Y X Y X X X X X X X Y X X X X X X X X X X X X X X X X X X X
A6 Y X Y X X X X X X X Y X X X X X X X X X X X X X X X X X X X
S21 Y X Y X X X X X X X Y X X X X X X X X X X X X X X X X X X X
S41 Y X Y X X X X X X X Y X X X X X X X X X X X X X X X X X X X
S72 Y X Y X X X X X X X Y X X X X X X X X X X X X X X X X X X X
B1 Y X Y X X X X X X X Y X X X X X X X X X X X X X X X X X X X
1 B24 X Y Y X X X Y Y X Y Y X X X Y X X X X X X X X X X X X X X X
2 M5 X Y Y X X X Y Y X Y Y X X X Y X X X X X X X X X X X X X X X
A1 X Y Y X X X Y Y x Y Y X X X Y X X X X X X X X X X X X X X X
M4 X Y Y X X X Y Y X Y Y X X X Y X X X X X X X X X X X X X X X
M2 X Y Y X X X Y Y X Y Y X X X Y X X X X X X X X X X X X X X X
S32 X Y Y X X X Y Y X Y Y X X X Y X X X X X X X X X X X X X X X
S33 X Y Y X X X Y Y X Y Y X X X Y X X X X X X X X X X X X X X X
S42 X Y Y X X X Y Y X Y Y X X X Y X X X X X X X X X X X X X X X
S64 X Y Y X X X Y Y X Y Y X X X Y X X X X X X X X X X X X X X X
S71 X Y Y X X X Y Y X Y Y X X X Y X X X X X X X X X X X X X X X
RC9 X Y Y X X X X X X X Y X X X Y X X X X X X X X X X X X X X X
RC10 X Y Y X X X X X X X Y X X X Y X X X X X X X X X X X X X X X
R1 Y Y Y X X X Y Y X Y Y Y X X Y X X X X X X Y X X X X Y X X X
RC58 Y Y Y X X X Y Y X Y Y Y X X Y X X X X X X X X X X X X Y X X
RC64 Y Y Y X X X Y Y X Y Y Y X X Y X X X X X X X X X X X X X X X
RC41 Y Y Y x X X Y Y X Y Y Y X X Y X X X X X X X X X X X Y X X X
RC30 Y Y Y X X X Y Y x Y Y Y X X Y X X X X X X X X X X X X X X X
RC36 Y Y Y X X X Y Y X Y Y Y X X Y X X X X X X X X X X X X Y X X
RC33 Y Y Y X X X Y Y X Y Y Y X X Y X X X X X X X X X X X X X X X
RC18 Y Y Y X X X Y Y X Y Y Y X X Y X X X X X X X X X X X X X X X
RC6 X X Y X X X X X X X Y Y X X Y X X X X X X X X X X X Y X X X
RC50 X Y Y X X X X X X X Y X X X Y X X X X X X X X X X X Y X X X
RC62 X Y Y X X X X X X X Y X X X Y X X X X X X X X X X X Y X X X
RC63 Y X Y X X X X X X X Y X X X X X X X X X X X X X X X Y Y X X
R11 Y X Y Y Y X X X X Y Y Y X X Y X X X X X X X X X X X Y Y X X



























Prior to this study there were only five fully sequenced genomes of P. atrosepticum 
phages and to address the paucity of genomic information on P. atrosepticum phages, 
36 phages that were isolated on SCRI1043 were sequenced. Characterisation of this 
library of phages showed that they could be divided into six different groups. 24 of 
these phages were classed as ΦTE-like or ΦM1-like given their high similarity to the 
corresponding phages. ΦTE and ΦM1 were both shown to be transducing phages and 
are highly efficient at transferring chromosomal or plasmids markers in P. atrosepticum 
(Blower et al., 2012a; Toth et al., 1997). As the ΦTE-like and ΦM1-like phages are the 
most common group found and as they are similar to the two transducing phages, they 
should be screened for their ability to transduce. This observation may suggest that 
transducing phages of P. atrosepticum may be relatively common and this highlights 
the need to screen all phages for their ability to transduce, should they be used for 
future phage therapy cocktails. While the ΦTE-like and ΦM1-like phages are similar to 
each other there are many subtle difference in their genomes that may account for 
their different phenotypes. For instance, the host ranges of the ΦTE-like group phages 
are different within the group and similarly for the ΦM1-like group. Similar to the 
majority of sequenced phages, most predicted proteins from both groups of phages 
are hypothetical, with no known function. 
 
The remaining 12 phages from the library were spilt into four different groups. One of 
these groups, the ΦR1-like phages, showed high similarity to a previously submitted 
P. carotovorum phage, phage Jarilo (MH059637, unpublished). Sequence 
comparisons show that even though Jarilo was isolated on a different bacterial host, 
P. carotovorum DSM30170, certain ΦR1-like viruses shared higher sequence 
homology to Jarilo compared to other members within the group. Host range results of 
the ΦR1-like phages also show that certain members could also infect either one or 
two P. carotovorum strains. One explanation for this is that, as the genomes of the P. 
carotovorum strains were never sequenced and the strains described by only 
biochemical assays, it could be that they were misclassified. Alternatively, they could 
be classified correctly and then this could mean that some ΦR1-like phages can indeed 
infect P. carotovorum. This could be a logical assumption to make given the isolation 





of phage Jarilo, a very similar phage isolated on a P. carotovorum strain. Phages have 
been historically named after the host on which they have been isolated (Adriaenssens 
and Brister, 2017). This was done in the past because phages were originally 
considered to be highly specific for their host. This was a reason for their use to identify 
specific bacterial strains by phage typing (Clark and March, 2006). However, naming 
phages in this way has given the impression that phages isolated on their respective 
hosts are propagating on that host in the environment. The ΦR1-like phages are 
referred to as P. atrosepticum phages, while phage Jarilo would be referred as a P. 
carotovorum phage. However, theoretically if one of the susceptible P. carotovorum 
strains had been used to isolate ΦR1-like phages then they would also be classed as 
P. carotovorum phages. In reality, it is likely that the ΦR1-like phages are in fact 
replicating on different P. atrosepticum and P. carotovorum strains in the environment, 
and indeed other species of unknown bacteria. 
 
The ΦRC6-like group is another of the new groups of P. atrosepticum phages 
sequenced. They were shown to belong to the Ounavirinae subfamily showing 
sequence homology to the founding phages of the four genera in the subfamily. One 
of the interesting features discovered when analysing their genomes was a potential 
CRISPR repeat. In bacteria, these repeats have DNA fragments (known as spacers) 
separating them, that are homologous to phage genomes and they function as an 
adaptive anti-phage system to recognise phages with the same DNA as phages from 
previous infections. However, it has also been shown that V. cholerae phages have 
been shown to carry their own CRISPR-Cas systems (Seed et al., 2013). These 
phages encode CRISPR-Cas systems that interfere with another antiphage system in 
their host, V. cholerae called phage-inducible chromosomal islands (PICI), that 
impedes phage replication (Naser et al., 2017). Analysis of the two spacers in ΦRC6 
revealed no homologous sequences in NCBI although only about 7% of all known 
spacers have a sequence homology with published sequences in the databases, with 
the other 93% of spacers showing no sequence homology to anything (Shmakov et 
al., 2017). It is unknown whether the CRISPR repeats found in ΦRC6 are true repeats 
as there are no CRISPR-Cas homologs found in the phage. However most of the 
genomes encode hypothetical proteins with many of the proteins having no significant 
hits so it is possible that there are proteins that can interact with the predicted CRISPR 
repeats. P. atrosepticum strains have also been reported to carry a CRISPR-Cas 





system so perhaps the repeats can be used instead by a host encoded system (Staals 
et al., 2016). 
 
The final two phages, ΦRC63 and ΦR11 are two different jumbo phages which are 
both flagellum-dependent. ΦRC63 shows no nucleotide similarity to any sequenced 
phage, while ΦR11 shows a low degree of nucleotide homology to two previously 
isolated jumbo phages. However, both phages share many protein homologs with 
other jumbo phages previously submitted to the databases. As these jumbo phages 
have been sequenced very recently there is little information, apart from bioinformatic 
analyses or TEM images. There is information on the receptor for one of the jumbo 
phages, Salmonella phage SPN3US, which was found to be flagella-dependent. This 
concurs with the receptor data for ΦRC63 and ΦR11 that suggests that both the P. 
atrosepticum phages are dependent on flagella (Lee et al., 2011). Jumbo phages are 
currently thought to represent a relatively rare group of phages with very few genomes 
deposited in databases (Yuan and Gao, 2017). This makes the genomic data of 
ΦRC63 and ΦR11 particularly valuable in helping understand this rare group of large 
phages. It also suggests that we have perhaps only revealed the tip of an iceberg with 
the phage sequences analysed in this chapter and there must be considerable diversity 
of phage genomes yet to be discovered. 
 
 








The archetypal Type III toxin antitoxin system, ToxINPa, was serendipitously 
discovered on a cryptic plasmid, pECA1039, originating from the phytopathogen P. 
atrosepticum SCRI1039 (Fineran et al., 2009). It has since been shown to be an 
effective antiphage system against several P. atrosepticum phages (Fineran et al., 
2009). The first P. atrosepticum phage to be characterised in detail with regard to 
abortive infection, is the transducing flagella-dependent Myoviridae member, ΦTE. 
This phage was isolated from sewage effluent originating from the Milton sewage 
works in Cambridge on an uncharacterised LPS mutant, SCC34 of P. atrosepticum 
(Fineran et al., 2009). ΦTE is aborted by the ToxINPa system but able to evolve rare 
escape mutants that are no longer aborted. These escape phages were found to have 
an expansion of a repeat region in their genomes that was able to code for a functional 
“pseudo-antitoxin”(Blower et al., 2012a). As well as being the first P. atrosepticum 
phage studied with regards to Type III TA mediated Abi it was also the first P. 
atrosepticum phage that was genomically sequenced. The second P. atrosepticum 
phage to be studied with regards to Type III TA mediated Abi is ΦM1. This a 
transducing, LPS-dependent Podoviridae member that was isolated in 1988 from 
samples obtained at the Finham sewage works in Coventry (Toth et al., 1997). ΦM1 is 
aborted not just by ToxINPa but also by another Type III TA system, (TenpINPl) which 
originates from the chromosome of Ph. luminescens, when cloned and expressed on 
a plasmid in P. atrosepticum  (Blower et al., 2009, 2017). Escape mutants of ΦM1 from 
both TA systems were found to have mutations in a single ORF encoding a toxic 
protein of unknown function (Blower et al., 2017). 
 
Escape mutants of both ΦTE and ΦM1 provided little information on the possible 
mechanism of Type III TA system activation in P. atrosepticum phages. This chapter 
attempts to address this matter and covers the impacts of P. atrosepticum harbouring 
Type III TA systems on multiple P. atrosepticum phages. This includes the phages 
described in the previous chapter plus further characterisation of ΦTE and ΦM1, the 
original aborted P. atrosepticum phages.  




4.2 ΦTE-like phages require an antitoxin repeat to escape the ToxINPa system  
 
ΦTE was the first phage characterised that could escape the ToxINPa system. All ΦTE 
escapes that were insensitive to the ToxINPa system had an expanded region that 
could code for an RNA antitoxin mimic. Thus far there have been no other escape 
mutations identified so it is still not clear if there are any other means of escape. The 
ΦTE-like phages described in the previous chapter had been previously screened for 
sensitivity to the ToxINPa system by Tim Blower during his PhD study but at that time 
there was no knowledge of the genomic nature of the phages. He found that some 
phages that are now known to be ΦTE-like were all aborted by the ToxINPa system. 
However, none of these phages tested were able to evolve escapes. The ΦTE-like 
phages were tested again in this study with titres above 1010 pfu.ml-1 and this confirmed 
that the previous data were accurate (data not shown). However, as these phages 
were genomically similar to ΦTE this result was both curious and unexpected. The 
genome region that contains the source of antitoxin repeats in ΦTE escape mutants 
was compared to the annotated representative members from each of the subgroups, 
ΦS34, ΦA2 and ΦA4s (Figure 4.1). Closer analysis of the region revealed that in all 
three of the subgroups, the potential antitoxin mimic region was partially or completely 
deleted. 
 
ΦTE contains a short region in its genome that matches closely with approximately 1.5 
of the ToxIPa repeat. However, this region is out of phase with ToxIPa so that even when 
transcribed will not code for the complete functional antitoxin repeat necessary to 
neutralise ToxIPa (Figure 4.2A). In order to escape ΦTE has to produce a completely 
functional ToxIPa RNA subunit. It is thought that ΦTE is able to evolve escape mutants 
at a very low frequency (1x10-8), due to strand slippage during replication that causes 
the 1.5 times ToxIPa mimic region to be expanded to either 4.5 times or 5.5 times 
(Blower et al., 2012a). These phage mutants which can produce a complete “pseudo 
ToxIPa” mimic enable resistance to abortive infection by ToxINPa, presumably by 
neutralising ToxNPa. Phages ΦS34 and ΦA2, are not able to escape as they containing 
only 0.5 times of a potential antitoxin mimic and thus, even if strand slippage occurs, 
they can never produce a complete functional ToxIPa mimic (Figure 4.2). For phage 
ΦA4s this region is completely deleted and there is no genomic sequence that closely 
resembles ToxIPa (Figure 4.1).  






Figure 4.1 continued overleaf 
  






Figure 4.1 continued overleaf 
  






Figure 4.1 Figure legend overleaf 
  





Figure 4.1 ΦTE escape locus compared to the same region of phages, ΦS34, ΦA2 
and ΦA4s. 
 A. ΦTE’s escape locus compared to ΦS34. Both phages share high nucleotide 
similarity in this region, however there is an insertion of a small nucleotide sequence 
in ΦTE compared to ΦS34 and ΦA2 that allows it to code for a 1.5 times antitoxin 
mimic. B. ΦTE’s escape locus compared to ΦA2. ΦA2 shares less homology in this 
region with ΦTE encoding ORFs with products of unknown functions (grey boxes) that 
are not present in ΦA2. ΦA2 also contains an endonuclease that is not present in ΦTE. 
The antitoxin mimic region for ΦA2 is also the same as in ΦS34 with ΦTE containing 
a small nucleotide insertion. C. ΦTE’s escape locus compared to ΦA4s which show 
the least nucleotide homology for the three subgroup representatives. ΦA4s does not 
have any nucleotide sequence that shares any homology with the antitoxin mimic 
sequence found in ΦTE. Comparison files were generated using a blastn comparison 
with a 1x10-4 cut off value. Red bars show nucleotide sequences of high homology with 
blue bars representing inverted nucleotide sequences of high homology. 
  





Figure 4.2 Phages ΦS34 and ΦA2 do not contain a complete ToxIPa mimic. 
 A. The ToxIPa RNA pseudoknot subunit structure required to neutralise ToxNPa. Taken 
from (Blower et al., 2011). B The 36 nucleotide long ToxIPa sequence required to 
neutralise ToxNPa aligned with the ToxIPa mimic produced by ΦTE escapes. C. The 
nucleotide sequence of the ToxIPa mimic region of ΦTE, ΦS34 and ΦA2. Wild type 
ΦTE contains a 1.5 times ToxIPa mimic repeat that is out of phase with the ToxIPa. 
When transcribed the region produces either a ToxIPa mimic with regions 2-8 or 1-7 
and thus a completely functional ToxIPa subunit is not produced. Expansion of this 
region however, allows a complete ToxIPa mimic to be produced. ΦS34 and ΦA2 do 
not contain a complete repeat and when transcribed contains the regions 2-7. As they 
do not contain regions 1 or 8, these phages do not have the potential to encode a 
complete functional unit. The colours and numbers are coordinated in A, B and C and 








4.3 Abortive infection in ΦM1-like phages 
4.3.1 Extensive analysis of ΦM1 escapes show mutations in a single toxic ORF 
 
ΦM1 was the second characterised phage that could escape the ToxINPa system. The 
original ΦM1 escapes sequenced had mutations in a single ORF, M1-23, encoding a 
toxic protein of unknown function (Blower et al., 2017). As all 10 mutations were unique 
it was though that other mutations in the M1-23 protein must also be able to allow 
escape. To characterise this protein further, 51 newly isolated escapes were 
sequenced, 35 of which were by a rotation student, Samuel Kidman. Collectively, all 
51 newly isolated escapes, the 10 original escapes, and other escapes sequenced 
throughout this ΦM1 phage study are shown here for completeness (Table 4.1). This 
led to the discovery of 21 different mutations (Figure 4.3). The escape locus of M1 is 
also shown in Figure 4.4 with all the different mutations mapped onto the Figure which 
is drawn to scale. With the addition of the new mutations, mutations in all three bases 
in the start codon have been observed, confirming that the start site of M1-23 had been 
correctly assigned. Interesting escapes of ΦM1 include ΦM1-E11 which has a 
mutation that causes an extremely N-terminal truncation resulting in a two amino acid 
long peptide. This, and other N-terminal truncations, show that the M1-23 protein is 
not essential for the replication of ΦM1. The majority of ΦM1 escapes contained 
missense mutations leading to substitutions, mostly in the C-terminal domain amino 
acids. This implies that the C-terminal region is important for the ability of the protein 
to activate ToxINPa. Furthermore, escapes ΦM1-E48 and ΦM1-E49 (both the same 
mutation) have a mutation in the stop codon leading to a 10 amino acid extension. The 
addition of this short amino acid sequence must somehow interfere with the ability of 
M1-23 to activate ToxINPa, presumably again by disrupting the integrity of the C-
terminal region of the protein. 
 
ΦM1 was additionally shown to be aborted by another Type III TA system, TenpINPl, 
when expressed in SCRI1043. Again, as in the ToxINPa system, escapes from TenpINPl 
had the same mutations in the M1-23 protein. This was possibly a surprising result, as 
ΦTE (which is more strongly aborted by ToxINPa) is completely insensitive to TenpINPl 
(Blower et al., 2017). However, the results for ΦM1 suggests that activation of both the 
ToxINPa and TenpINPl system can also be linked. All ΦM1 experiments performed here 
were published during the period of this PhD (Blower et al., 2017).  

































ΦM1-E10 15171 G to A G3A Met to Ile Asp to Asn 1 
ΦM1-E11 15175 A to T A7T Lys to Stop Gln to Leu 1 
ΦM1-E12 15256 A to T A88T Lys to Stop Glu to Val 1 
ΦM1-X 15288 AA to A AA120A FS to Stop after 
9aa 






ΦM1-B 15292 C to T 
 






ΦM1-E21 15359 T to C T191C Leu to Pro - 1 
ΦM1-E22 15384 T to G T216G Tyr to Stop - 2 
ΦM1-E23 
ΦM1-Y 15397 G to A G229A Asp to Asn - 1 
ΦM1-W 15398 A to T A230T Asp to Val - 1 
ΦM1-E24 15398 A to C A230C Asp to Ala - 2 
ΦM1-E25 
ΦM1-U7 15398 A to G A230G Asp to Gly - 1 




ΦM1-D 15410 T to C T242C Met to Thr - 2 
ΦM1-E 
ΦM1-E28 15410 T to G T242G Met to Arg - 1 
ΦM1-V 15415 T to G T247G Tyr to Asp - 2 
ΦM1-E29 









Table 4.1 continued. M1-23 mutations 
Phages Mutation 

































ΦM1-E47 15419 T to C T251C Leu to Pro - 1 
ΦM1-E48 15424 T to C T256C Stop to Arg 
(extension of 10 aa) 
- 2 
ΦM1-E49 
Different mutations: 21 Total mutations: 70 
 
 
FS – frame shift 
aa – Amino acid 
Stop – stop codon 
  








Figure 4.3 Alignments of M1-23 and escape variants. 
 Amino acids that are identical to the wild type protein are highlighted in green. Amino 
acids that are highlighted in blue represent differences from the wild type protein. 
 
  
















Figure 4.4 The escape locus of ΦM1.  
Taken from (Blower et al., 2017). The figure is drawn to scale. Green bars represent 
stop codons. Red bars represent the locations of all identified mutations and a 
representative phage escape mutant harbouring that mutation. As phiM1-22 overlaps 
with phiM1-23, certain N-terminal mutations also affect the phiM1-22 product (Table 
4.1). The phiM1-23 product has an unknown function while phiM1-22 and phiM1-24 
encodes a predicted DNA exonuclease and endonuclease, respectively. 
  




4.3.2 ΦRC10 is highly sensitive to TenpINPl and escapes via a M1-23 
homologue 
 
ΦRC10 is an M1-like phage that was found to be highly sensitive to TenpINPl but, in 
terms of EOP, insensitive to ToxINPa (Table 4.2). The genome of ΦRC10 contains a 
M1-23 homologue called RC10-26 which differs by only a single amino acid (Figure 
4.5). Previously described phages that showed high homology to ΦM1 were analysed 
and their M1-23 homologs aligned (Figure 4.5). The M1-23 homologs are largely 
conserved including the amino acid residues found to be important in ToxINPa 
activation of ΦM1. Only one phage, PPSW1, has differing amino acids in residues 
important for ToxINPa activation. As the sequence is fairly conserved it may mean that 
M1-23 homologues confer some advantage in the environment as they are not 
necessary for replication in lab conditions. 
 
In order to assess whether RC10-26 was involved in TenpINPl activation, 16 
spontaneous escapes were isolated and their RC10-26 sequences determined (Table 
4.3). The data showed they contained similar mutations to those found in ΦM1 ToxINPa 
escapes. There were nine different mutations with six mutations already seen in ΦM1 
escape. Three of the mutations however, were novel, and this may suggest that, even 
though a large number of ΦM1 escapes had already been sequenced, it may be 
possible to generate more escape mutations. 
 
ΦRC10 did not activate ToxINPa (as determined by EOPs) but plaques picked from 
plates of ΦRC10 propagated on SCRI1043 containing ToxINPa contained mutations in 
RC10-26 (data not shown). Therefore, it is unclear why ΦRC10 is more sensitive to 
TenpINPl than ΦM1, or why it is not aborted by ToxINPa even though ΦRC10 phages 



























Table 4.2. EOP data of ΦM1 and ΦRC10 
Phage TA system EOP 
ΦM1 ToxINPa 1.3x10-5 
 TenpINPl 1.1x10-2 
ΦRC10 ToxINPa 0.64 
 TenpINPl 1.3x10-5 
 
  

















Figure 4.5 M1-23 alignment with homologous proteins. 
 Green highlighted amino acid represents conserved residues. Red highlighted bases 




M1-23 1 MTKMNNKARRTARELKHLGASIQTTSLL--GKVDATRDAEDATRLREMLDDVEAPIGLLE 58
RC10-26 1 MTKMNNKARRTARELKHLGASIQMTSLL--GKVDATRDAEDATRLREMLDDVEAPIGLLE 58
Peat1-24 1 MTKMNNKARRTARELKHLGASIQTTSLL--GKVDATRDAEDATRLREMLDDVEAPIGLLE 58
PP90-25 1 MTKMNNKARRTARELKHLGASIQMTSLL--GKVDATRDAEDATRLREMLDDVEAPIGLLE 58
PPWS1-24 1 MTKMNKTARRVARELKYCGVPVETTDVTSRGKGVASRIVQDVQDLRDMFDG-DAPIALIE 60
PP16-26 1 MTKMNKQARRVARELKYTGVAIDTTDVMPRGKGDAQQAAECATRLREMFDDFEALIGLLE 60
BF25/12 1 MTKMNKQARRVARELKYTGVAIDTTDVMSRGKGVATRDAEDATRLREMFDDYEAPIGLLE 60
M1-23 59 HELLKLRKRKPALYRELRDEFQMGYLG 85
RC10-26 59 HELLKLRKRKPALYRELRDEFQMGYLG 85
Peat1-24 59 HELLKLRKRKPALYRALRDEFQMGYLG 85
PP90-25 59 HELLKLRKRKPALYRELRDEFQMGYLG 85
PPWS1-24 61 HGLLKLRKLDVTAYLNLVAEFGMEYLG 87
PP16-26 61 HELLKLRKHNVALYRELRDEFQMGYLG 87
BF25/12 61 HELLKLRKRNVTLYRELCDEFQMGYLG 87























ΦRC10a A1T Met to Leu Tyr to Phe 1 No 




Ile to Thr and Gly to 
Arg 
- 1 No 
ΦRC10e T242G Met to Arg - 1 Yes 
ΦRC10h 
ΦRC10k 
G242GG Tyr to Val (extends 
protein by 66 aa) 
- 2 No 
ΦRC10m 
ΦRC10n 
T247G Tyr to Asp - 2 Yes 
ΦRC10d A248C Tyr to Ser - 1 Yes 
ΦRC10i A248G Tyr to Cys - 5 Yes 
ΦRC10j      
ΦRC10l      
ΦRC10o      
ΦRC10p      
ΦRC10c 
ΦRC10f 
T256C Stop to Arg 
(extension of 10 aa) 
- 2 Yes 
Different mutations: 9  Total mutations: 16 
 
*Similar to ΦM1, rc10-26 overlaps with rc10-25 which encodes a putative DNA 
exonuclease. 
Aa – amino acid 
Stop – stop codon 
 
  




4.4 Type III TA mediated Abi infection in other P. atrosepticum phages 
The other groups of P. atrosepticum phages were screened against both the ToxINPa 
or the TenpINPl system. Phage titres of around 1010 pfu.ml-1 were used in all the 
screens. Results from the screen showed that the ΦR1-like group (ΦRC63 and ΦR11) 
were not aborted by SCRI1043 carrying either ToxINPa or TenpINPl. In contrast, ΦRC6-
like group were strongly aborted by the ToxINPa system but remained unaffected by 
the TenpINPl system. Attempts were made to isolate ToxINPa escapes from the ΦRC6-
like group but no putative escape plaques could be propagated. 
 
4.5 Discussion 
This chapter looks at the interaction of Type III TA systems with the six different groups 
of P. atrosepticum phages described in the previous chapter. Three of the six groups 
were aborted by one or more Type III TA systems. The other three remaining groups 
remained insensitive to Type III TA mediated abortive infection. The three groups that 
were sensitive to Type III TA systems were the ΦTE-like, ΦM1-like and ΦRC6-like 
group. None of these phages have any genes in common so it is unclear why these 
phages activate Type III TA systems while the other insensitive phages do not. Even 
within the three sensitive groups, Type III TA system activation seems to differ. The 
ΦTE-like and ΦRC6-like groups are highly sensitive to abortive infection from the 
ToxINPa system but are insensitive to the TenpINPl system, suggesting that different 
Type III TA systems have different mechanisms of activation. However, ΦM1 is aborted 
by both systems and is able to escape both through mutations in a single protein, M1-
23, suggesting that the mode of activation of the Type III TA system may also be linked, 
in this phage. Another interesting observation is that ΦRC10 (a ΦM1-like phage) 
shows high sensitivity to the TenpINPl system but doesn’t seem to be aborted by 
ToxINPa. The M1-23 homolog in ΦRC10 only differs by a single amino acid which may 
account for the different sensitivity. ΦRC10 escapes of either the TenpINPl or ToxINPa 
system have mutations in the M1-23 homolog (RC10-26) that map to similar mutations 
previously identified in ΦM1 escapes. Thus it seems that this protein plays an important 
role in Type III TA system activation. Interestingly however, homologues of this protein 
are not found in ΦTE-like to ΦRC6-like phages confirming that there must be other 
routes to Type III mediated Abi system. 
 




Data from the ΦTE-like phages suggest that activation of ToxINPa at least for ΦTE-like 
phages occurs through an essential phage process. The ΦTE-like phages are unable 
to evolve to escape the ToxINPa system and only ΦTE itself (which may represent a 
natural rare variant) has the potential to generate an antitoxin mimic. Even then, 
escape mutants of ΦTE occurs at an extremely low frequency (1x10-8) with the majority 
of the wild type ΦTE population being aborted (Blower et al., 2012a). ΦRC6-like 
phages also exhibit a similar phenotype in that none are able to evolve escapes. This 
suggests that activation of ToxINPa may target essential genes or that the very rare 
mutations required for escape are not selectable at the titres used. It is possible that 
several mutations are required, however very high titres are used for the assays 
(around 1010) so this is unlikely. Yet as powerful as ToxINPa seems in this case these 
phages are completely insensitive to the TenpINPl system. 
 
The results of the ΦM1 and ΦRC10 experiments tell a completely different story from 
that of the ΦTE-like and ΦRC6-like phages. In ΦM1 and ΦRC10 phages both the 
ToxINPa and TenpINPl systems abort the phages, albeit to different degrees and yet 
escapes for both phages are through mutation of a single non-essential protein. This 
is in stark contrast to the ΦTE-like and ΦRC6-like data suggesting that Type III TA 
system activation is specific and may even target an essential process. A large number 
of ΦM1 and ΦRC10 escapes have been isolated and in all cases, the same protein 
(M1-23 or RC10-26) was mutant suggesting that this protein plays a key role in 
activating two Type III TA systems. Homologues of this protein are also found in other 
closely related phages that infect other bacterial species, including P. carotovorum and 
Dickeya (Figure 4.5). Many of the homologues are conserved suggesting that the 
protein is functional in these phages so it is likely that this protein plays an important 
role in viral replication under certain environmental conditions. The M1-23 protein was 
also shown to be toxic, even in the absence of ToxINPa, and when expressed in a 
different host i.e. E. coli (Blower et al., 2017). As M1-23 is toxic, this suggests that it 
must be interacting with the different bacteria although the nature of this interaction is 
still a mystery. 
 
The ΦR1 group phages are not aborted by either the ToxINPa or TenpINPl system, 
although they are in the same subfamily as the ΦM1-like phages. They do not contain 
a M1-23 homologue. However, neither does the ΦTE-like nor ΦRC6-like phages. The 




two jumbo phages, ΦRC63 and ΦR11 also do not activate the ToxINPa or TenpINPl 
systems. There is very little information on jumbo phages but it is thought that the 
advantage that these phages have through carrying the large number of genes is that 
they don’t have to rely as heavily on host encoded proteins to replicate. This may result 
in less interaction with the host which may be the reason why they are not aborted. 
  
The work in this chapter leads to the following observations. Firstly, responses to Type 
III TA systems are different among the different groups of phages, even within the 
same group (ΦM1 and ΦRC10) where the Type III systems can be activated to differing 
extents. Furthermore, the activation mechanism for Type III TA systems may differ 
between systems yet can also be linked (TE is aborted by the ToxINPa but not TenpINPl 
system while ΦM1 is aborted by both systems and escapes through mutations in a 
single gene). Finally, there is no gene or common protein product common between 
phages that activate the Type III TA system. Different proteins may be interacting with 
the Type III TA system directly or different proteins interfere with host factors that can 
cause Type III TA activation. The M1-23 protein is toxic even in the absence of ToxINPa 
suggesting that its normal function involves interaction with the host rather than a direct 
interaction with ToxINPa. 
 





Chapter 5 ToxINPa abortive infection in coliphage ΦCHAI8 
5.1 Introduction 
 
The work in the previous chapter showed that the Type III TA systems are able to 
cause abortive infection in phages from widely different genetic backgrounds. It also 
showed that a Type III TA system from another bacterium (Ph. luminescens) is able to 
abort phages in P. atrosepticum. Previous work has showed that ToxINPa, when cloned 
and expressed on a plasmid in E. coli, is also able to abort range of coliphages (Blower 
et al., 2012b). Unfortunately, while there have been numerous attempts in this 
laboratory to isolate coliphage escapes from the ToxINPa and TenpINPl systems, none 
of the phages isolated that were aborted could escape (unpublished). 
 
Although no coliphage escapes of ToxINPa and TenpINPl were isolated prior to this 
study, the Moineau laboratory that works on another Type III TA system, AbiQ, 
managed to isolate a coliphage that is aborted by AbiQ but additionally able to evolve 
escapes (Samson et al., 2013). The AbiQ system derives from Lactococcus lactis and 
is able to abort many lactococcal phages but, like ToxINPa and TenpINPl could still 
function as an antiphage system when transferred into a different host, such as E. coli. 
One of the coliphages (phage 2, a V5virus) was aborted by E. coli carrying the AbiQ 
system but could evolve escapes. When analysed these escapes had mutations in a 
single ORF that encodes a putative DNA polymerase. 
 
During the course of this study, nine coliphages were isolated from the river Cam (as 
part of an outreach demonstration to teach school children how to isolate phages from 
the environment). This constituted part of a programme called Authentic Biology which 
aims to encourage schools to collaborate with their local university on a biological 
project. The collection of coliphages isolated during the teaching of the demonstration 
were tested for their sensitivity to both the ToxINPa and TenpINPl system.  One of these 
phages, ΦCHAI8, was aborted by the ToxINPa system but proved able to evolve, 
escapes as described in this chapter. 
 
  




5.2 ΦCHAI8 is aborted by ToxINPa and is able to evolve escapes 
The coliphages were isolated on DH5α from water samples that originated from either 
the Milton sewage works or the river Cam in 2016. These phages were named with 
the prefix ΦCHAI followed by a number. They were screened for sensitivity to both 
ToxINPa and TenpINPl by spotting a serial dilution of phages on a lawn of DH5α 
containing a plasmid with either pTA46 (ToxINPa), pFR2 (TenpINPl) or their non-
functioning frame shift equivalents (Figure 5.1). Results from the screen identified one 
phage (ΦCHAI8) that was aborted by ToxINPa but could evolve escapes that were no 
longer sensitive to the ToxINPa system (Table 5.1). Isolated plaques were picked, 
purified and confirmed to breed true as escape mutants based on EOP assays. These 
escape mutants replicated as efficiently on the plasmid containing the functioning 











Figure 5.1 Spot test showing ΦCHAI8 sensitivity to the ToxINPa system 
Spot test of wild type ΦCHAI8 on a lawn of DH5α containing a plasmid with either A. 
a non-functioning ToxINPa system, pTA47 or B. a functioning ToxINPa system, pTA46. 
10 µl spots of serially diluted phages were used. 
 
  














Table 5.1 EOPs of ΦCHAI8 and escape mutants 
Phage EOP vs ToxINPa 
EOP vs 
ToxINPa FS 
ΦCHAI8 1.4x10-6 1 
ΦCHAI8a 0.028 1 
ΦCHAI8b 0.39 1 
ΦCHAI8c 0.42 1 
ΦCHAI8d 0.06 1 
ΦCHAI8e 0.26 1 
 
  




5.3 ΦCHAI8 is a V5virus 
 
Transmission electron microscopy images of ΦCHAI8 showed that it has a long 
contractile tail and thus belongs to the Myoviridae family (Figure 5.2). The genomic 
DNA of ΦCHAI8 was extracted and sequenced. The sequence revealed that ΦCHAI8 
had a circular double stranded DNA genome of 138,889 base pairs (Table 5.2). 
Annotation of the genome predicted 211 ORFs and 7 tRNAs. A genome map of 
ΦCHAI8 is shown in Figure 5.3. Blastn results of the ΦCHAI8 genome showed that it 
belongs to the V5virus genus. This genus of phages was named after coliphage V5 
which had little nucleotide sequence homology to any  sequenced phages at that time 
(Santos et al., 2011). The V5 genome has not been published and all genome analysis 
of V5 is based on a descendent of the phage called rV5 (or recovered V5). This phage, 
rV5, formed part of a phage cocktail which was used to treat cattle infected with E. coli 
O157:H7. After the phage therapy treatment, phages (including rV) were recovered 
from the animals. As rV5 may have acquired mutations during its passage through the 
cattle it is considered a different phage (Kropinski et al., 2013). Nucleotide 
comparisons of ΦCHAI8 with other V5viruses showed that they have similar lengths, 
ORFs, tRNAs and nucleotide sequence identities with each other (Table 5.2). ACT 
generated images of ΦCHAI8 vs rV5 showed only very small insertions/deletions 
between the two phages (Figure 5.4). ΦCHAI8 also shows very high sequence 
homology with the genome of phage 2, which, as mentioned previously, is aborted by 
the AbiQ system but also able to evolve escapes (Figure 5.4). 
 
  






Figure 5.2 Transmission electron microscope images of ΦCHAI8 
TEM images of A. ΦCHAI8 with a contracted tail and B. with an extended tail. Black 
bars represent 100 nm. 
 
  






Table 5.2 Genomic analysis of ΦCHAI8 and comparisons to other V5virus members 





ΦCHAI8 138, 889 215 7 100 Unpublished 
rV5 137, 947 233 6 93.1 DQ832317.1 
E. coli 0157 
typing phage 5* 137, 973 214 6 92.3 KP869103.1 
APCEc02* 135, 400 219 5 89.7 KR698074.1 
Phage 2 JES-
2013 136, 910 220 4 91.3 KC690136.1 
PDX* 138, 427 N/A N/A 91.4 MG963916.1 
Slur12* 136, 898 207 7 92.8 LN881735.1 
Slur16* 136, 896 206 7 92.8 LN881727.1 
FV3 136, 947 218 5 87.9 JQ031132.1 
Murica 135, 391 212 7 92.2 KT001917.1 
FFH2 139, 020 216 6 89.7 KJ190158.1 
V18* 129, 454 207 3 88.6 KY683736.1 
 
*Phage sequences that had to be reoriented to begin at the same location as ΦCHAI8 
and rV5 
  





Figure 5.3 Genomic map of ΦCHAI8 
The genome has been orientated to begin at RIIA and with RIIB in accordance to other 
phages encoding RIIA and RIIB homologs. F1-3 show ORFs on the forward reading 




strands split into their three different reading frames. R1-3 is the same but for the 
reverse strand. Arrows in green, blue and red, represent ORFs encoding proteins 
involved in metabolism, virion structure and lysis. Unlabelled structural proteins are 
homologs of PVP-SE1 structural proteins identified during a structural proteomics 
experiment. Grey arrows represent ORFs of unknown function with the location of 
tRNAs shown as pink boxes. 
 
  







Figure 5.4 ΦCHAI8 shows high similarity to both rV5 and Phage 2 
Comparisons were generated using Artemis comparison tool using a tblastx 








5.4 ToxINPa escapes of ΦCHAI8 have deletions in a putative RNA escape locus 
 
To determine the escape loci of ΦCHAI8, five independently isolated ToxINPa escapes, 
ΦCHAI8a-e, had their genomes sequenced. This revealed that all escapes had 
deletions of varying sizes in a common locus (Figure 5.5). The escape with the largest 
deletion (ΦCHAI8c) deleted 4,175 bases, disrupting seven proteins (Table 5.3). On 
the other hand, the escape containing the smallest deletion (ΦCHAI8d) showed only a 
single base deleted within an ORF, CHAI8-77. This ORF, CHAI8-77 was completely 
deleted in all other escapes, suggesting that it plays an important role in escaping the 
ToxINPa system. Homologs of CHAI8-77 found in other V5viruses have not been 
assigned a function, apart from containing a predicted AAA-ATPase domain. To predict 
the function of CHAI8-77, it was entered into a Phyre2 pipeline using the default 
settings. The Phyre2 program artificially models a structure using the submitted amino 
acid sequence and using the model, maps it onto similar known protein structures 
(Kelley et al., 2015). For CHAI8-77, the top hit mapped to the kinase domain of the T4 





Figure 5.5 The escape locus of ΦCHAI8 ToxINPa escapes 
 Red bars represent the nucleotide sequences deleted in escapes. The black box 
represents ORFs encoding proteins involved in the putative RNA repair system. 
 
  





Table 5.3. ORFs within the ΦCHAI8 escape locus 






(aa) E value Significant BLASTP hit 
CHAI8-75 66423 66073 351 116 1.00E-79 putative transcriptional regulator 
[Escherichia phage 2 JES-2013] 
CHAI8-76 67025 66471 555 184 4.00E-136 putative phosphoesterase 
[Escherichia phage 2 JES-2013] 
CHAI8-77 67440 67033 408 135 3.00E-91 hypothetical protein [Escherichia 
coli] contains AAA and 
polynucleotide kinase domains 
CHAI8-78 67559 68476 918 305 0.00E+00 putative RNA ligase and tail 
attachment protein [Escherichia 
phage vB_EcoM_FFH2] 
[Escherichia phage slur16] 
CHAI8-79 68473 68823 351 116 5.00e-79 
 
hypothetical protein Ec2_0077 
[Escherichia phage JES2013] 
CHAI8-80 68832 69593 762 253 0.00E+00 putative Sir2-like protein 
[Enterobacteria phage vB_EcoM-
FV3] [Escherichia phage slur16] 
















Figure 5.6 Phyre2 alignment of CHAI8-77 has a similar fold to T4 Pnk 
Phyre2 alignment of CHAI8-77 (query sequence) and the top hit, the kinase domain of 
T4 Pnk (template sequence). Conserved residues are highlighted in grey, deletions in 
ΦCHAI8 in orange and deletions in Pnk in red. Catalytic residues determined by the 








The Pnk protein (short for polynucleotide kinase) forms part of an RNA repair pathway 
in T4. It is a bifunctional protein capable of both kinase and phosphatase activities 
(Sirotkin et al., 1978). As part of an RNA repair pathway it is required to repair the 
3’PO4/5’OH ends of damaged RNA. The kinase activity cleaves the terminal 3’-PO4 
converting it to a 3’OH while the phosphate drives the phosphorylation of the 5’-OH 
end to 5’PO4. To join the break, a second protein, Rnl1, a RNA ligase is able to ligate 
the “healed” gap (Amitsur et al., 1987). The Pnk-Rnl1 proteins are an evolutionarily 
conserved RNA repair pathway with homologs found in other viruses, bacteria, 
protozoans, yeasts and plants (Englert and Beier, 2005; Wang and Shuman, 2005; 
Wang et al., 2002).  
 
Pnk is encoded by pseT and is a 301 amino acid long protein arranged in two domains. 
The N-terminal region of the protein specifically residues 1-147 contain the kinase 
domain with the C-terminal region i.e. residues 149-301 covering the phosphatase 
domain (Wang et al., 2002). CHAI8-77 is only 135 amino acids long and shows 
structural homology with the kinase domain of Pnk (Figure 5.6). A conserved amino 
acid sequence at position 9 to 16, GxxGxGKS, is present in the kinase domain of Pnk. 
This sequence is defined as a Walker A box motif which is sometimes referred to as a 
P loop. This motif (in particular the lysine residue) is essential for ATP binding (Hanson 
and Whiteheart, 2005). Two of the motifs in the Walker A box, Lys15 and Ser16, 
additionally form part of the active site. This active site is comprised of three other 
residues, Asp35, Arg38 and Arg126, involving a total of five residues (Wang and 
Shuman, 2002). CHAI8-77 may also contain a Walker A box but only three of the active 
site residues are conserved (Figure 5.6). There is a tryptophan and lysine residue in 
place of Arg38 and Arg126, respectively. Lysine, alike arginine is a positively charged 
residue, however this conservative substitution at both Arg38 and Arg126 still 
abolishes kinase activity in the T4 Pnk (Wang and Shuman, 2002). Conversely, in 
another related bifunctional kinase phosphatase protein, CPT, involved in 
chloramphenicol resistance in Streptomyces venezuelae, the Arg38 residue is 
replaced by an isoleucine suggesting that these residues need not be strictly 
conserved between the related proteins (Izard, 2001). 
 
Both the kinase and phosphatase activities of Pnk are essential for its RNA repair 
function. As CHAI8-77 only matches the kinase domain, it is missing the fundamental 




phosphatase domain. Interestingly, the upstream adjacent protein to CHAI8-77, 
CHAI8-76 is a predicted phosphoesterase which could provide the phosphatase 
activity and compensate for the lack of such in CHAI8-77. Further analysis revealed 
that CHAI8-76 is a member of the phosphoprotein phosphatase family, a type of 
serine/threonine phosphase that contains five conserved motifs (Barford et al., 1998; 
Lohse et al., 1995) (Figure 5.7). These five motifs play an important role in catalysis 
and substrate binding (Goldberg et al., 1995; Griffith et al., 1995; Zhuo et al., 1994). 
There has been a sixth motif proposed (Connelly and Leach, 2002) but generally five 
motifs are defined (Krogh et al., 2005; Williams et al., 2008). These phosphatases are 
part of a large evolutionarily conserved double stranded DNA repair pathway involving 
two proteins called the MR (Mre11-Rad50) complex. The phosphatase, Mre11 acts as 
a manganese-dependent nuclease with Rad50 associated with ATPase activity (Paull 
and Deshpande, 2014). Homologs of Mre11 and Rad50 are not only present in phages 
but also bacteria, archaea and eukaryotes (Connelly and Leach, 2002; Herdendorf et 
al., 2011; Paull and Deshpande, 2014; Reiter et al., 2002).  
 
As mentioned previously the T4 RNA repair pathway requires both the Pnk protein and 
a RNA ligase, Rnl1 (Amitsur et al., 1987). ΦCHAI8 contains a Rnl1 homolog, located 
downstream and adjacent to CHAI8-77 called CHAI8-78 that is also commonly deleted 
in escapes. The Rnl1 proteins share six conserved motifs that make up a nucleotide-
binding pocket that is also present in CHAI8-78 (Figure 5.8). Thus, together, CHAI8-
76, CHAI8-77 and CHAI8-78 may be able to provide the necessary activities required 
to function as an RNA repair pathway. 
 
  












Figure 5.7 CHAI8-76 shares five conserved motifs found in Mre11 proteins. 
 Conserved residues from all proteins are shaded in grey. The proteins that are 
included in the figure are two phages, T4 and λ, a bacterium, Ec (E. coli), an archaeon, 
Pf (Pyrococcus furiosus), a yeast, Sc (Saccharomyces cerevisiae) and human, Hs 
(Homo sapiens).   
  





Figure 5.8 Alignments of T4 Rnl1 with CHAI8-78 and another homologue from phage 
RM378. 
 The six nucleotidyl transferase motifs are shaded in dark green (I), light green (Ia), 
dark blue (III), light blue (IIIa), red (IV) and purple (V). In bold are residues that were 
shown to be essential for protein function in T4.   






This chapter focuses on one particular phage (ΦCHAI8) and mutants that escape the 
ToxINPa system. Other coliphages that had been previously isolated were either 
insensitive to ToxINPa or were aborted but couldn’t escape and so ΦCHAI8 provided 
an invaluable new insight into ToxINPa activation in coliphages. Escapes of ΦCHAI8 
insensitive to the ToxINPa system were shown to have deletions in genes encoding a 
putative RNA repair pathway. This is a novel escape locus that has not been 
associated with Type III TA system activation before. However, it is not the first time 
the Pnk and Rnl1 proteins have been implicated in abortive infection.  
 
In T4, Pnk and Rnl1 prevents abortive infection by the Prr system. The Prr system 
forms a component of a two part antiphage defence in E. coli. The other component is 
the type Ic DNA restriction endonuclease EcoprrI. T4 is able to prevent restriction by 
EcoprrI through producing an inhibitor protein called Stp (Penner et al., 1995). 
However, E. coli have evolved a second line of defence to counter Stp by complexing 
PrrC with EcoprrI. Thus, when Stp physically inhibits EcoprrI, this complex is disrupted 
leading to the release of PrrC, which is an anticodon nuclease that targets tRNA-Lys. 
Depletion of this tRNA then leads to abortive infection. T4 can prevent abortive 
infection from occurring as Pnk and Rnl1 are able to repair the damage caused by 
PrrC. Thus, only T4 Pnk/Rnl1 mutants are aborted by PrrC and hence the name Prr 
(an abbreviation of pnk, rnl restriction) (Amitsur et al., 1987; Jabbar and Snyder, 1984). 
This is the opposite from what is observed from ΦCHAI8 and ToxINPa where deletion 
of the RNA repair protein homologs instead prevents abortive infection. Additionally, 
ΦCHAI8 does not have an Stp homolog and T4 itself is not aborted by ToxINPa 
suggesting a different mechanism for abortive infection. 
 
The putative RNA repair system differs from that of T4 and other related RNA repair 
systems. In ΦCHAI8 and other V5viruses, the Pnk homolog is incomplete with only the 
kinase domain present. Instead there is a phosphatase located adjacent to it that 
accounts for the lack of the phosphatase domain. The phosphatase also doesn’t match 
the phosphatase domain of Pnk but instead has homology to another nucleotide repair 
pathway protein involving double stranded DNA breaks. Interestingly, the yeast RNA 
repair system also shows differences to T4 in that all three activities i.e. kinase, 




phosphatase and RNA ligase are all encoded on a single protein. Furthermore, the 
different domains can also be artificially expressed on three different polypeptides and 
still retain their respective activities. Homologs from T4 and mice has also been shown 
to be able to complement the different domains (Schwer et al., 2004, 2008). Thus it 
seems plausible that this RNA repair system can be found on three different proteins 
in ΦCHAI8. Whether these three proteins in ΦCHAI8 function as a RNA repair system 
is still to be determined biochemically, indeed a Pnk homolog of Xanthomonas, 
AvrRxo1-ORF1, which is both a Type III secretion effector and a Type II toxin is an 
important virulence factor (Han et al., 2015; Triplett et al., 2016). There is also an 
additional function of Rnl1 which is in attachment of tail fibres to the baseplate (Rand 
and Gait, 1984; Wood and Henninger, 1969). Thus it is still unclear whether ToxINPa 
activation is caused by the putative RNA repair function.  
 
The only other coliphage characterised with regards to Type III toxin-antitoxin mediated 
abortive infection is phage 2 active against the AbiQ system. Phage 2 escapes of the 
AbiQ system have mutations in a putative DNA polymerase. ΦCHAI8 also contains a 
homolog of this DNA polymerase, which raises some questions. It would be interesting 
to see if ΦCHAI8 is also aborted by AbiQ and, if aborted, whether it escapes through 
mutations in the DNA polymerase. Based on the amino acid sequence of the ΦCHAI8 
and phage 2 DNA polymerase, it can be classified in DNA polymerase family A. This 
family of DNA polymerases are also known to have DNA repair capabilities due to 
exonuclease activity, and are involved in DNA repair caused by UV damage (Sharma 
and Smith, 1987). This is interesting for two reasons. Firstly, a theme is beginning to 
emerge whereby putative nucleotide repair pathways are implicated in Type III toxin-
antitoxin mediated abortive infection. Secondly while there is no function yet assigned 
to the M1-23 protein of ΦM1 (Chapter 4) it has been shown to bind to UvrA, a protein 
involved in DNA damage repair caused by UV in bacteria. The ORF encoding M1-23 
is also located between genes encoding an exonuclease and an endonuclease, 
perhaps implying an involvement with nucleotide metabolism/repair.  
 
While ΦCHAI8 and phage 2 are both similar V5viruses, it is interesting to note that 
escapes of the two different Type III TA systems, ToxINPa and AbiQ have different 
mutations. This highlights again that activation of these Type III TA systems apparently 
use different mechanisms. T4 itself is strongly aborted by AbiQ but is completely 




insensitive to ToxINPa. However, it seems more than coincidental that the only 
coliphages capable of escaping ToxINPa and AbiQ are very similar so there could be a 
common factor to both phages that triggers activation of both ToxINPa and AbiQ. 
Further work will need to be done to further characterise the putative RNA repair 












The Type III TA systems, ToxINPa, TenpINPl and AbiQ, come from diverse bacterial 
backgrounds; ToxINPa from a plasmid of the potato pathogen P. atrosepticum, 
TenpINPl from the chromosome of the insect pathogen, Ph. luminescens and AbiQ 
from a plasmid originating from the dairy-associated Gram positive Lactococcus lactis 
(Blower et al., 2012b; Fineran et al., 2009; Samson et al., 2013). Even when 
transferred into a heterologous host (E. coli) they are still able to function as an abortive 
infection system against certain phages. Phages that are aborted also come from a 
wide variety of bacterial backgrounds and phages that are able to escape have widely 
different escape loci (Blower et al., 2017; Chen et al., 2017; Samson et al., 2013). This 
shows that activation of Type III TA cannot be specific to a single common protein that 
is phage derived, but rather a common process involving several different proteins 
from both the phage and the host harbouring the Type III TA system. One avenue that 
has not been investigated in detail is host specificity in response to Type III TA 
mediated abortive infection. A reason for this is that phages tend to be host specific as 
they have evolved to adsorb to specific host receptors and therefore it is difficult to 
isolate a phage that could infect widely different hosts. Furthermore, a narrow host 
range often means that the different hosts that a phage may infect would be highly 
similar and one might expect Type III TA system activation to be the same between 
similar hosts (for example between different common E. coli K12 strains such as DH5α 
and MG1655). This chapter examines the issue of host specificity in greater detail and 
discusses Type III TA activation of the same phage on hosts that are both similar or 
widely different. 
 
6.2 Coliphages can escape Type III TA mediated Abi on one strain of E. coli but 
are unable to escape in another 
 
The E. coli strain EPI300 has been previously used to test the effects of copy number 
on ToxINPa activation (Blower, 2009). The E. coli EPI300 strain was used as it contains 
a mutant trfA gene which codes for the TrfA protein required for the replication of 




plasmids containing the oriV origin of replication. Thus EPI300 strains carrying a 
plasmid with this origin of replication (e.g. pCC1BAC) only carries one to two copies of 
the plasmid per cell. However, the copy number of pCC1BAC can be increased to 10-
20 copies in the presence of TrfA that can be controlled by an inducible promoter. 
EPI300 was transformed with pTA46 (pBR322 containing ToxINPa) which has a copy 
number of 15-20. This plasmid, pTA46 is pBR322 based and uses a different origin of 
replication and thus should be unaffected by the trfA mutation.  When performing these 
experiments, it was noted that coliphage TB16 was aborted by DH5α carrying pTA46 
and unable to escape. However, when TB16 infected EPI300 carrying pTA46, the 
phage was aborted but plaques of escape mutants could be seen at a frequency of 10-
5 compared with the frame shift control plasmid, pTA47 (Blower, 2009). This led to the 
hypothesis that, although DH5α and EPI300 were similar K12 strains, there are small 
differences between the strains that could lead to a dissimilarity in ToxINPa activation. 
To examine whether these responses were limited to TB16, a selection of coliphages 
previously unable to evolve escapes on DH5α were plated on EPI300 carrying the 
same Type III TA containing plasmids (Table 6.1). These coliphages were additionally 
screened on DH5α to confirm that no escapes were observed. The data show that 
certain phages produced plaques on the EPI300 strain with a TA system which did not 
plaque on the same TA system on DH5α. This confirms that EPI300 must cause a 
differential TA activation compared to in DH5α, and for both the ToxINPa and TenpINPl 
systems. However, it should also be noted that not every phage that is aborted can 
evolve to escape in EPI300 (Table 6.1).  
  




Table 6.1 Certain coliphages produced plaques of escape mutants on EPI300 
strains containing Type III TA systems that are not detectable in DH5α 
 EOPs vs Type III TA plasmids 
Phage pTA46 (ToxINPa) pFR2 (TenpINPl) 
DH5α EPI300 DH5α EPI300 
ΦCHAI9 ~1 ~1 <1x10-8 1.7x10-4 
TRB18 <1x10-8 <1x10-8 <1x10-8 <1x10-8 
TRB19 <1x10-8 3.9x10-5 ~1 ~1 
F1 <1x10-8 <1x10-8 <1x10-8 <1x10-8 
F2 <1x10-8 6.2x10-5 ~1 ~1 
F4 <1x10-8 4.7x10-5 <1x10-8 4x10-9 
F5 <1x10-8 <1x10-8 <1x10-8 4.1x10-5 
F6 <1x10-8 <1x10-8 <1x10-8 <1x10-8 
F7 <1x10-8 8.6x10-5 ~1 ~1 
T4 ~1 ~1 <1x10-8 <1x10-8 
T6 ~1 ~1 <1x10-8 2.0x10-7 
 
All phage lysates tested were “bulked” on DH5α with titres of at least 1010 pfu.ml-1. 
EOPs were calculated by dividing the titre on the functioning Type III TA system with 
that on its frameshift control. Phages with EOPs of <1x10-8 showed no detectable 
plaques on the functioning TA system despite testing a titre of at least 1010 pfu.ml-1 on 
the frameshift control. Phages with EOPs of ~1 showed a similar number of plaques 
when compared to the frameshift control. N=1 
 
  




Furthermore, there are cases where a phage (e.g. F5) that is aborted by one TA system 
and able to escape it on EPI300 cannot escape a different TA system in EPI300, 
highlighting again that there may be different activation mechanisms for the different 
TA systems. To confirm that phages had evolved escapes in EPI300, spontaneous 
escapes from three different phages were isolated. These escapes were shown to 
breed true as they had an EOP close to 1 compared to their frame shift control (Table 
6.2). For phage F4 two escapes were picked representing escape from both the 
ToxINPa and TenpINPl system. F4E1 was selected on ToxINPa as it was insensitive to 
ToxINPa. However, it still remained sensitive to the TenpINPl, system although not 
aborted as strongly. F4E2 on the other hand was selected on the TenpINPl system as 
it was insensitive to that system but still highly sensitive to ToxINPa. This suggests that, 
although the activation of the Type III TA systems appeared to be unlinked, there may 
be factors that affect both of them, albeit to different degrees. 
 
  






Table 6.2 Escapes of coliphages isolated on EPI300 carrying Type III TA systems 
Phage TA system EOP 
ΦCHAI9 pFR2 1.7x10-4 
ΦCHAI9-E1 pFR2 0.88 
F4 pTA46 4.7x10-5 
 pFR2 4.0x10-9 
F4-E1 pTA46 0.53 
 pFR2 4.7x10-3 
F4-E2 pTA46 2.2x10-5 
 pFR2 1.2 
T6 pFR2 2.0x10-7 
T6-E1 pFR2 0.06 
 
ΦCHAI9-E1, escape of ΦCHAI9 selected on pFR2 
F4-E1, escape of F4 selected on pTA46 
F4-E2, escape of F4 selected on pFR2 
T6-E1, escape of T6 selected on pFR2 
 
  




6.3 Phage T6 can escape the TenpINPl system via mutations in a transcriptional 
inhibitor in EPI300 
 
As it was not possible to sequence all the phages and their escapes, one phage was 
picked for further characterisation. Phage T6 was chosen as, being one of the T-even 
phages, it was similar to the best characterised phage T4 and thus it was likely that 
any mutations found in escapes may be in a protein that had been studied before. 
There also had not been any coliphage escape of the TenpINPl system yet 
characterised. Thus two escapes selected on TenpINPl as well as the wild type T6 
genomic DNA was sequenced. Data from whole genome sequencing revealed that 
both escapes had mutations in the alc gene which codes for Alc, a transcriptional 
inhibitor (Table 6.3). Six more escapes were subsequently isolated and their alc genes 
sequenced. Two of these new escape mutants also had mutations in alc but the 
remaining four having no mutations in this gene implying that there is an additional 
escape locus in these T6 escapes. 
 
The function of the Alc protein was discovered originally through work using mutants 
of the T4 phage that incorporate cytosine into their DNA, during replication. The wild 
type T4 phage (and the other T-evens, T2 and T6) have glucosylated 
hydroxymethylcytosine in place of cytosine (Lehman and Pratt, 1960). These T4 
mutants that instead utilise cytosine are unable to produce progeny and this was 
thought to be because they could not produce any of their late RNA or proteins (Kutter 
et al., 1975). However, mutants were isolated that had mutations in a single gene that 
allowed late RNA and proteins to be produced, even with cytosine incorporated into 
the genome (Snyder et al., 1976). This gene was termed “allows transcription of late 
protein genes from T4 cytosine containing DNA” or alc for short. However, this name 
misrepresents its function as subsequent research showed that it blocks cytosine 
containing DNA of the host as well as other phages (Kutter et al., 1981; Pearson and 
Snyder, 1980). The predicted role of Alc is that it is used by T4 (and other T-even 
phages) to identify and differentiate its genomic DNA from host DNA to specifically halt 
host transcription while allowing transcription of viral genes with modified cytosine-
containing genomes. Alc is thought to interact with an actively transcribing RNA 
polymerase and is important in the switch from host to phage metabolism (Drivdahl 
and Kutter, 1990; Severinov et al., 1994). Furthermore, another gene designated unf 




which encoded a protein involved in unfolding the bacterial nucleoid, was shown to be 
the same gene as alc (Snyder and Jorissen, 1986).  
 
Both the Alc proteins in T4 and T6 are 167 amino acids long with only four different 
residues between them (Figure 6.1). Alignments of mutations that have been found 
previously in T4 mutant with an Alc- phenotype (Snyder and Jorissen, 1986) and T6 
Alc escapes of TenpINPl are shown in Figure 6.1. None of the T4 or T6 mutations are 
the same, with the T4 mutations located more N-proximal than the T6 mutations. T6 
alc mutations are very C-terminal, the T6E2 mutant only replaces eight amino acids 
with three different amino acids. This is vaguely reminiscent of the M1-23 protein 
escape of which versions have only minor alterations to the C-terminal domain. 
However, completely abolishing Alc activity may not be necessary to escape TenpINPl 
and perhaps only a slight disruption of protein activity is sufficient. 
  





Figure 6.1 Alc alignments of T4, T6 and mutants  
In green are residues that are different between T4 and T6 Alc proteins. Residues 
highlighted in purple and orange are differences in residues caused by mutations in 
the alc gene in T4 and T6 respectively. 
  





Table 6.3 ΦT6 escape mutants 
Isolation host Phage EOP on, 
EPI300 (pFR2) 
[TenpINPl] 
Mutation in alc Effect on 
protein 
EPI300* T6 2.0 x 10-7 None None 
     
EPI300, (pFR2) 
[TenpINPl] 
T6-E1 0.056 T398C V133A 
T6-E2 0.042 -478G Frameshift 
T6-E3 0.21 T386C M129T 
T6-E4 0.38 No mutation None 
T6-E5 0.050 -477AG Frameshift 
T6-E6 0.047 No mutation None 
T6-E7 0.039 No mutation None 
T6-E8 0.19 No mutation None 
 
  




6.4 Differences between DH5α and EPI300 
 
There is now clear evidence that host related factors can play a role in Type III TA 
activation. Nonetheless it is still curious that both DH5α and EPI300 carry the same 
plasmids and yet exhibit different phenotypes in relation to abortive infection. The 
disparity then must be the result of different mutations between the two K12 strains. 
Both DH5α and EPI300 are highly modified E. coli strains designed for specific roles. 
DH5α is one of the most used strains for gene cloning in molecular biology while 
EPI300 was designed to control the copy number of OriV-based plasmids. A closer 
analysis of the known genotype of DH5α and EPI300 shows that they share some of 
the same mutations which presumably play no role in the different Abi responses seen 
here (Table 6.4). However, there are multiple mutations not shared between the two 
strains (Table 6.5 and 6.6). Inspection of each of these mutations does not point to 
any obvious reasons for the difference in phenotype with regards to abortive infection. 
The only mutation that perhaps may have a role is trfA in EPI300, which prevents the 
replication of RK2 based plasmids. This mutation causes plasmids with the OriV origin 
of replication to be maintained at a single copy. However, there are no reports of trfA 
affecting the copy number of pBR322, so the cause of a differential response in the 
Abi system is not obvious. Nonetheless, copy number of plasmids has been shown to 
be important for ToxINPa activation (Blower, 2009) so further work will be required to 
assess the copy number of pBR322 in EPI300 and DH5α. It is also possible that there 
are other mutational differences between the strains that are unknown and play a role 









Table 6.4. Mutations shared between DH5α and EPI300 
Abbreviation Consequence 
F- Does not carry F plasmid 
endA1 Non-functional endonuclease I which prevents non-specific 
digestion 
recA1 Non-functional RecA DNA repair protein. Prevents unwanted 
DNA recombination in cloning 
nupG Nucleotide transporter deletion allows uptake of large 
plasmids 
Φ80dlacZΔM15 Carries defective Φ80 prophage with partial deletion of lacZ 
gene (used for blue and white screening on XGal) 
λ- Non lysogen (λ)  
 
Table 6.5 Mutations in DH5α not present in EPI300 
Abbreviation Consequence 
glnV44 Suppression of amber (UAG) stop codons which is required 
for certain phages to replicate 
thi-1 Thiamine auxotroph 
relA ppGpp synthesis during the stringent response. Required for 
RNA synthesis in the absence of protein synthesis 
gyrA96 Mutation in DNA gyrase leading to nalidixic acid resistance 
deoR Mutation in DeoR transcriptional repressor. Allows uptake of 
large plasmids (same result as nupG) 
purB20 Mutation in adenylosuccinate lyase leading to slow growth in 
M9 
(lacZYA-argF)U169 Deletion of lac operon and argF 
hsdR17(rK–mK+) Leads to loss of function of the restriction endonuclease from 
RM system EcoKI 
 




Complete deletion of RM system EcoKI 
ΔlacX74	 Deletion of entire lac operon 
araD139 Prevents arabinose metabolism by mutation in L-ribulose-
phosphate 4-epimerase 
Δ(ara,leu)7697 Deletion of an operon involved in the biosynthesis of leucine 
from valine. Auxotrophic for leucine. 
galU, galK Mutation prevents metabolism of galactose 
rpsL Mutation in ribosomal protein S12 that leads to streptomycin 
resistance 
trfA Gene encodes TrfA protein that is required for the replication 
of RK2 based plasmids (OriV origin of replications) 









6.5.1 ΦOT8s is a LamB dependent Tevenvirinae Serratia phage 
 
The E. coli DH5α and EPI300 experiments have shown that host related factors play 
a role in Type III TA activation. However, another phage had already been isolated that 
is capable of infecting two even more distantly related hosts that was sensitive to Type 
III TA systems (Blower, 2009). This phage, ΦOT8s, provided a further opportunity to 
investigate host related factors involved in Type III TA activation. ΦOT8s was isolated 
as a phage forming plaques on Serratia strain 39006 carrying a plasmid expressing 
the LamBE.coli protein (pMUT13) (Blower, 2009). It is unable to infect Serratia without 
the LamBE.coli protein but can infect strains of E. coli that naturally express the LamB 
protein (Blower, 2009). Sequencing results prior to this study revealed that ΦOT8s 
belongs to the Tevenvirinae subfamily (often referred to as T4-like phages) and it 
shared high sequence homology with other E. coli phages of the same subfamily 
(Figure 6.2). ΦOT8s is closely related to Rb69 (accession number AY303349) sharing 
89.8% nucleotide identity and thus belongs to the same genus i.e. Rb69virus. ΦOT8s 
shares only 61.7% nucleotide identity with phage T4. The sequence of ΦOT8s was 
annotated again during this study as previous annotation was several years ago. The 
new annotation of ΦOT8s predicts 271 ORFs with 2 tRNAs. A genomic map of ΦOT8s 
is also shown in Figure 6.3. 
 
  






Figure 6.2 Genome wide comparisons of ΦOT8s and related Tevenvirinae 
A. ΦOT8s shows higher homology to Rb69 than T4. B. ΦOT8s compared to T2 and 
T6. Comparison files were generated using a tblastx comparison with a 1x10-4 cut off 
value. 
  






Figure 6.3 Genomic map of ΦOT8s 
 The genome has been orientated to begin at RIIA as with other Tevenvirinae. Boxes 
in green, blue and red signify ORFs encoding proteins associated with metabolism, 
virion structure and lysis. Grey boxes signify ORFs that encode hypothetical proteins. 
The pink box in the inner most ring shows the location of the tRNA (~75,000 bp).  
  




The Tevenvirinae subfamily is named after the T-even phages and includes a wide 
range of phages that share several conserved proteins referred to as the core genome 
(Comeau et al., 2007). The receptors for Tevenvirinae phages tend to be outer 
membrane proteins with a few using LPS as a secondary receptor (Trojet et al., 2011). 
Several of the Tevenvirinae phages, including T2 and T6, use an adhesion protein 
called Gp38 to recognise their outer membrane protein receptors (Trojet et al., 2011). 
In these phages assembly of the tail is completed by cleavage of the C terminal end of 
Gp37 the distal tail fibre. The adhesion protein Gp38 then replaces the cleaved region 
of Gp37. Not every Tevenviriniae member constructs its tail fibres in this way and many 
of the host recognition adhesion proteins for these phages have not yet been identified. 
T4 is one of the phages that deviates from this tail fibre configuration. The C terminal 
region of the Gp37 of T4 is not cleaved and resembles the Stf protein of phage λ, a 
very different phage (George et al., 1983). Instead Gp37 by itself is able to recognise 
the T4 receptors, OmpC and LPS (Montag et al., 1990). Mutations of Gp37 can also 
lead to an expanded host range in T4 (Tétart et al., 1996). Furthermore, the Gp38 
protein in T4 does not share any homology with the Gp38 of phages that use it as an 
adhesion protein. Instead Gp38 and another protein in T4 (Gp57) act as chaperones 
that aid the folding of the Gp37 protein (Hashemolhosseini et al., 1996). Additionally 
the homolog of Gp38, (Tfa in λ) as well as the C-terminal region of Stf is able to 
complement defects in the Gp37 and Gp38 protein of T4 (Montag et al., 1989). 
Analysis of the Gp37 and Gp38 homologs of ΦOT8s revealed that they shared 
homology with those of T4 rather than Rb69 (Figure 6.4 A). Comparisons with the λ 
proteins, Stf and Tfa also show that the C-terminal region of Stf and Tfa have amino 
acid sequence homology with both the C-terminal of Gp37 and Gp38 of ΦOT8s. λ is 
well known to use LamB as a receptor which is recognised by the J protein, forming 
part of the tail spike (Wang et al., 1998). However, this protein has no homology with 
any protein of ΦOT8s (Figure 6.4 B). With regards to the Stf protein, the common wild 
type lab strain of λ has a frame shift mutation in this protein rendering it non-functional 
(Hendrix and Duda, 1992). The original λ isolate on the other hand has an intact Stf 
protein that binds to OmpC and thus has a broader host range (Hendrix and Duda, 
1992). The mutant λ that is commonly used today is thought to have been picked (by 
accident) from the original lysate as plaques produced by the original strain were 
smaller which was thought to be as a result of the tail fibres causing a slower diffusion 
in the agar (Casjens and Hendrix, 2015). The frame shift in the Stf protein has caused 




it to be split into two proteins originally annotated as orf401 and orf314 (Sanger et al., 
1982). A schematic showing the different tail fibre/tail spike configurations of 
Tevenvirinae and λ is shown in Figure 6.5. The receptor binding region that recognises 
OmpC or LPS within the C-terminal tail of T4 Gp37 has been shown to be at residues 
907 to 996 (Bartual et al., 2010; Montag et al., 1990). Comparisons with highly similar 
T4-like phage Gp37 proteins from phages TuIa, TuIb or the Stf protein from λ which 
recognise either OmpF or OmpC (Gp37 of T4 also recognises LPS) show that the 
receptor binding region is located in a variable area of the proteins (Montag et al., 
1990). Alignments with the Gp37 protein of ΦOT8s also shows variability where the 
receptor binding region is predicted to be (Figure 6.6). The Gp37 protein of ΦOT8s 
also shows higher similarity with the Gp37 proteins of λ, TuIa and TuIb than T4, 















Figure 6.4 Alignments of proteins involved in tail fibre construction 
A. ΦOT8s shows high amino acid sequence homology to the tail fibre proteins of T4. 
Rb69 additionally shows no homology in its Gp38 protein (orange) to the Gp38 protein 
(purple) of ΦOT8s and T4. There is also poor homology between the Gp37 protein 




(green) of Rb69 against ΦOT8s and T4. B. The C-terminal region of Gp37 of ΦOT8s 
and T4 show homology with the C-terminal end of Stf (green) and Gp38 (purple). The 
λ sequence used is the standard λ wild type strain which has a frame shift in the middle 
of the Stf protein causing it to be split into two proteins (J02459). Moreover, the J 
protein of λ (yellow) shows no homology to any ΦOT8s or T4 proteins. 
  





Figure 6.5 Tail fibre organisation of Tevenvirininae and λ 
Tail fibre organisation for A. ΦOT8s and T4, B. Majority of Tevenvirinae including T2 
and T6 and C. λ. In A and B tail fibre construction is similar apart from the tail end 
where Gp37 is not cleaved in A. In B Gp37 is proteolytically cleaved with the cleaved 
region replaced with another protein Gp38. C. The original λ isolate had side tail fibres 
made from the Stf protein which has homology with the C-terminal ends of the Gp37 
protein of ΦOT8s and T4. The LamB recognition protein in λ is protein J which forms 
part of the tail spike. 
 







Figure 6.6 Alignments of the C-terminal regions of Gp37 from T4, TuIa, TuIb, λ and 
ΦOT8s 
There is only a partial sequence of the Gp37 protein known for TuIa and TuIb thus the 
residue locations were not added. However, it is predicted to be of a similar size to the 
Gp37 protein of T4. The residues shaded in grey are predicted to be involved in the 
recognition of OmpC and LPS in T4. This is in a variable region with residues outside 
of this area being more conserved. In bold are the metal binding domains of which 
there are seven in T4 and eight in the other phages shown. Known receptors for the 
Gp37 proteins of the phages are T4 (OmpC and LPS), TuIa (OmpF), TuIb (OmpC 
only), λ (OmpC) and ΦOT8s (LamB).  
  




6.4.2 ΦOT8s escapes have mutations in motA and asiA 
 
ΦOT8s was previously found to be aborted by the ToxINPa system in both Serratia 
carrying pMUT13 and E. coli DH5α, and able to evolve escapes (Blower, 2009). Thus 
it provided a rare opportunity in which Type III TA activation from the same phage could 
be studied in different bacteria. Sixteen ToxINPa escapes were selected, eight from 
Serratia 39006 (pMUT13, pTA46) and the other eight from E. coli DH5α (pTA46) 
(Table 6.7). All escapes selected on Serratia (pMUT13, pTA46) were also shown to 
be insensitive to ToxINPa - carrying DH5α (pTA46). On the other hand, not all escapes 
isolated on DH5α were insensitive to Serratia (pMUT13) carrying ToxINPa. ΦOT8s-E14 
was still aborted by Serratia (pMUT13, pTA46) even though it had already been 
exposed to the ToxINPa system in DH5α (pTA46). This suggests that there may be 
multiple mutations involved where certain mutations can lead to insensitivity to two 
hosts while some only lead to insensitivity to one. 
 
Prior to this study several ΦOT8s escapes were isolated (Blower, 2009). Several of 
these escapes were sent for whole genome sequencing and results showed that they 
all had mutations in a single gene that encodes MotA. Sequencing of the motA gene 
in the newly isolated ΦOT8s escapes ΦOT8s-E1-16 revealed that six of the escapes 
had motA mutations (Table 6.8). One of the newly isolated escapes that did not have 
a motA mutation (ΦOT8s-E1) was sent for whole genome sequencing, alongside a 
wild type ΦOT8s as a control. The results from the sequencing revealed mutations in 
the asiA gene. Subsequent sequencing of genomes of escape mutants without motA 
mutations also revealed that some of the escapes also had asiA mutations as well 
(Table 6.8). However, there were several escapes in which there were no mutations 
in motA and asiA conferring that for some escapes, there are other mutations not yet 
identified. For the motA mutants three different mutations were observed. Two of the 
mutations were substitutions in base G404, which changed to T or A leading to Arg102 
being substituted by lysine or histidine respectively. The remaining motA mutation is a 
substitution of T110A leading to a valine to alanine conversion. All asiA mutations were 








Table 6.7 ToxINPa escapes of ΦOT8s 
Isolation host Phage EOPs 





ΦOT8s (wt) 2.2 x 10-5 2.0 x 10-3 




ΦOT8s-E1 0.18 0.78 
ΦOT8s-E2 0.25 0.92 
ΦOT8s-E3 0.26 0.84 
ΦOT8s-E4 0.71 0.92 
ΦOT8s-E5 0.70 1.2 
 ΦOT8s-E6 0.59 0.57 
 ΦOT8s-E7 0.47 1.1 
 ΦOT8s-E8 0.38 0.56 
    
E. coli DH5α 
(pTA46) 
ΦOT8s-E9 0.43 0.73 
ΦOT8s-E10 0.061 0.62 
ΦOT8s-E11 0.05 0.38 
 ΦOT8s-E12 0.74 0.86 
 ΦOT8s-E13 0.30 0.05 
 ΦOT8s-E14 1.9 x 10-5 0.12 
 ΦOT8s-E15 1.2 1.14 
 ΦOT8s-E16 0.03 0.41 
 
pMUT13 – plasmid expressing LamBE.coli 
pTA46 – pBR322 expressing the ToxINPa system 
EOPs are calculated by dividing the titre of phage on the strain carrying the function 
Type III TA system with the titre on the strain carrying the corresponding frameshift. 
  




Table 6.8 motA and asiA mutations in ΦOT8s escapes 
Phage motA mutation asiA mutation Effect on protein 
ΦOT8s (wt) None None None 
    
ΦOT8s-E1 None -127A Frameshift 
ΦOT8s-E2 G404T None R135L 
ΦOT8s-E3 None -127A Frameshift 
ΦOT8s-E4 None -127A Frameshift 
ΦOT8s-E5 G404A ND R135H 
ΦOT8s-E6 G404T None R135L 
ΦOT8s-E7 G404T None R135L 
ΦOT8s-E8 None -127A Frameshift 
    
ΦOT8s-E9 T110A ND V37D 
ΦOT8s-E10 None -127A Frameshift 
ΦOT8s-E11 None None None 
ΦOT8s-E12 None None None 
ΦOT8s-E13 None None None 
ΦOT8s-E14 None None None 
ΦOT8s-E15 G404A ND R135H 
ΦOT8s-E16 None None None 
 
ND – not determined i.e. not sequenced 
“-“ followed by a number and a letter represents an insertion at that position 
  




Genes for the Tevenvirinae are expressed at different stages of the phage lifecycle 
and are divided into three groups called early, middle and late, expressed sequentially 
(Miller et al., 2003). The promoters of early genes of Tevenvirinae closely resemble 
those of their hosts and have higher affinities thus redirects the host RNAP to 
preferentially cause the transcription of early phage genes. The switch from early to 
middle genes is controlled by two early proteins, MotA and AsiA through a process 
called σ appropriation (Ouhammouch et al., 1995). The promoter sequences of the 
middle genes differ from those of early genes as they contain a different -35 sequence 
which is a conserved 9 base pair sequence called the MotA box (Cicero et al., 1998). 
This sequence is recognised and bound by a single MotA protein (Cicero et al., 1998). 
The MotA protein is in two domains where the N-terminal domain binds sigma 70 while 
the C-terminal domain contains the DNA binding domain that recognises and binds to 
the MotA sequence (Li et al.; Pande et al., 2002). As MotA redirects the RNAP complex 
through its σ 70 subunit, AsiA prevents the transcription of both the host and early 
gene promoters. In the absence of phage infection, σ 70 binds to the -35 promoter 
regions though a conserved region called 4.2 (Campbell et al., 2002; Paget and 
Helmann, 2003). AsiA blocks the 4.2 interaction with the -35 promoter region by 
binding to 4.2 (Colland et al., 1998b). This then prevents the transcription of all early 
and host promoters that utilise this -35 sequence. However, as mentioned above, 
phage -35 middle gene promoters can still be recognised due to the interactions with 
MotA. Figure 6.7 shows a schematic of how the different proteins interact during sigma 
appropriation in T4. 
 
The amino acid sequence of T4 MotA and ΦOT8s and a representative of the different 
three mutations have been aligned (Figure 6.8). One of the MotA mutants has a 
mutation in the N-terminal domain although it is not located in any of the T4 MotA 
residues that are predicted to interact with the σ 70 unit (Bonocora et al.). However, 
previous experiments with the mutant MotA protein have also identified residues 
important in transcription that are not in the predicted interaction site (Finnin et al., 
1997). The C-terminal mutations in the MotA protein are far more common and are all 
substitution mutations of arginine 135. Structural analysis of the T4 C-terminal domain 
of MotA predicts that arginine 135 is one of the residues involved in DNA binding (Li et 
al.). 
 




The asiA mutations for ΦOT8s mutants escaping ToxINPa are all caused by an 
insertion of an adenine at position 127. These frameshift mutants generate a 
premature stop codon and effectively changes the last 46 amino acids of the wild type 
AsiA protein (Figure 6.9). The role of the C-terminal region in T4 AsiA is somewhat 
controversial. One study has shown that deletion of the last forty amino acids of T4 
AsiA had no effect on transcription (Pal et al., 2003). Another showed that single 
substitution mutations in residues within the last forty amino acids deleted in the 
aforementioned study does indeed have an effect on transcription, and additionally 
affects AsiA interactions with RNAP and MotA (Yuan and Hochschild, 2009; Yuan et 
al., 2009). Hence it is still unclear what effect the frameshift mutation in ΦOT8s will 










Figure 6.7 σ appropriation in phage T4 
A. In uninfected E. coli, the RNA polymerase holoenzyme recognises bacterial 
promoters through its interaction of the σ 70 subunit. B. During phage infection early 
proteins MotA and AsiA prevents this interaction. MotA interacts with a specific 
sequence called the MotA box present in the promoters of middle genes and activates 
the σ 70 subunit. AsiA binds to the 4.2 region and prevents it from recognising the -35 
region sequences of both the early genes of T4 and host genes. 
  





Figure 6.8 MotA protein alignments of T4, ΦOT8s and ToxINPa escape mutants 
Residues in blue represent the N-terminal domain of T4 MotA. Those that are in bold 
in this domain are predicted to interact with the sigma 70 subunit. Residues in grey are 
a linker region connecting the N and C terminal domains. Residues in green represent 
the C-terminal domain area with those in bold representing putative DNA binding 
regions. Residues highlighted in red for the ΦOT8s escapes signify residues that were 
mutated.  








Figure 6.9 AsiA alignments of T4, ΦOT8s and escape mutant 
Residues in red are differences from the wild type protein. 
  




6.4.3 ΦOT8s is aborted and able to escape TenpINPl in an EPI300 background 
 
ΦOT8s was tested for sensitivity to the TenpINPl system in both Serratia (pMUT13, 
pFR2) and DH5α (pFR2). The phage was aborted in both bacterial backgrounds but 
even at titres of over 1010 pfu.ml-1 was unable to evolve escapes. However, when 
tested on EPI300 (pFR2) not only was ΦOT8s aborted but escapes plaques were 
observed (Table 6.9). To confirm that they were true escapes a single plaque was 





Table 6.9 ΦOT8s can escape the TenpINPl system in EPI300 










ΦOT8s (wt) <1x10-8 <1x10-8 3.7x10-5 
E. coli EPI300 
(pFR2) 
ΦOT8s-Pl ND ND 0.55 
 











There is clear evidence that Type III TA system activation is at least partially dependent 
on the hosts in which they reside.  Results from the coliphage experiments with DH5α 
and EPI300 show that, even in similar strains of E. coli, there can be differences in 
whether phages can escape the Type III TA system or not. Analysis of the genotypes 
of both DH5α and EPI300 do not show obvious mutations that would lead to the 
difference in phenotype with regards to Type III TA systems. One possible hypothesis 
is that even though both strains harbouring the same TA plasmid have different 
phenotypes it may be possible that the copy number is not the same between the two 
strains. The copy number of pBR322 is reported to be 15-20 copies per cell, which 
would be the expected number maintained in both DH5α and EPI300 (Lee et al., 2006). 
Plasmid copy number could ultimately affect the total number of TA complexes in the 
cell and has already been noted as a potential factor in Type III TA activation (Blower, 
2009). 
 
Although the reasons why certain coliphages could escape Type III TA systems in 
EPI300 but not in DH5α couldn’t be defined in this work there are various conclusions 
that can be drawn from the results. One conclusion is that there are several mutations 
that can lead to phage escapes from Type III TA systems in one host that will not 
necessarily lead to escape in another. This may imply that the mutated phage products 
do not interact directly with the Type III TA systems but rather with a host factor that is 
linked to Type III TA activation. 
  
One phage capable of escaping a Type III TA system in EPI300 is T6. This phage was 
aborted by the TenpINPl system but was able to evolve mutations in the Alc 
transcriptional inhibitor that allow it to escape. In T4, Alc is involved in the takeover of 
the host transcriptional machinery by preventing transcription of non-modified cytosine 
bases. One obvious mechanism in which Alc might cause Type III TA activation is that, 
by generally repressing host transcription this will also prevent the transcription of the 
Type III antitoxin. The toxin of Type III TA systems is more stable than the cognate 
antitoxin counterpart, so generalised inhibition of transcription could eventually lead to 
a decrease in antitoxin levels thereby releasing the more stable toxin. It has also been 
shown that the Type III toxin-antitoxin full complex is not as common in vivo as 




originally presumed but rather the toxin is constantly cleaving newly synthesised 
antitoxin (Short et al., 2018). Follow up experiments that measure the TenpIPl levels 
during infection with T6 and an escape mutant should be performed to confirm whether 
this is true. If this were the case for TenpINPl activation in T6 in EPI300 it is curious 
that T6 doesn’t evolve the same mutations when selected on DH5α as one would 
expect the same result. Clearly T6 interacts with host related factors differently 
between the two strains and so it is feasible that inhibition of the host transcriptional 
machinery will be different. It may be that while certain mutations could slightly impair 
the phage’s ability to inhibit host transcription it may not be enough to escape in DH5α 
but is sufficient to allow the phage to escape in an EPI300 background. 
 
The LamB dependent Serratia phage ΦOT8s provided the opportunity to study Type 
III TA system activation between two very different bacteria. The experiments with 
ΦOT8s showed that there is a similar mechanism of escape that allows these phages 
to escape ToxINPa in both Serratia and E. coli backgrounds. These escape phages 
were found to have mutations affecting two proteins, MutA and AsiA, which function 
together in a process called sigma appropriation. Similar to the alc mutations found in 
T6 escapes from the TenpINPl system, MotA and AsiA may work in a similar process 
because by stopping transcription of host RNA, antitoxin levels would drop leading to 
an active toxin. Thus by disrupting MotA and AsiA function, host transcription, which 
would include the antitoxin is not as strongly affected thus Abi is avoided. An alternative 
mode of Type III TA system activation in this case is that, as MotA and AsiA promote 
the transcription of T4 middle gene products, that one of these middle gene products 
could be involved in activation of the system. The asiA mutation is also of interest as 
this is not the first time this protein has been investigated with regards to ToxINPa 
system escape. In fact, other Serratia Tevenvirinae phages, ΦCHI14, ΦXF20 and 
ΦCBH8 have been isolated previously in this laboratory that are able to escape 
ToxINPa through mutations in asiA (Chen et al., 2017). Other mutations identified in the 
latter phages that can allow escape of ToxINPa include a large deletion encompassing 
several tRNA and genes of unknown functions, as well as mutations in a single gene, 
orf84 encoding a protein of unknown function (Chen et al., 2017). ACT alignments of 
T4 and these Serratia phages showed no homology within the large deletion locus 
making it difficult to suggest its function. Furthermore, the proteins in that region in T4 
all have unknown functions although work on characterising these proteins in T4 has 




shown that several of these proteins are in fact toxic (Miller et al., 2003). This suggests 
that these phage products must interact with host factors in some important way. It is 
likely that overexpression of some of these Serratia phage products is toxic, indeed 
this is an emerging theme in several studies of Type III TA systems (Blower et al., 
2017). The M1-23 protein, Alc, MotA and AsiA are all highly toxic proteins when 
expressed in bacteria (Blower et al., 2017). ΦOT8s does not have a homolog of orf84, 
however it has homologs of four of the proteins deleted in the large deletion region of 
escapes. Whether these four proteins individually or collectively are able to activate 
ToxINPa has yet to be determined. 
 
One interesting point to note is that ΦCHI14, ΦX20 and ΦCBH8 are aborted by the 
TenpINPl system and unable to escape (Chen et al., 2017). ΦOT8s was also shown to 
be aborted by the TenpINPl system and unable to escape in a Serratia 39006 or DH5α 
background, however it was able to escape in an EPI300 background. It would be 
interesting to see if transfer of the Serratia phage receptor allows infection of these 
phages in an EPI300 background and whether these phages are then aborted and 
able to escape. Another Tevenvirinae phage that is able to escape the TenpINPl system 
in an EPI300 background is T6 which, as discussed previous, has mutations in the alc 
gene. There are several T6 escapes where the mutation is not in alc and are not 
identified. Further work is required to determine the nature of these mutations which 
could of course, be motA or asiA mutations. Furthermore, there are now a bank of 
coliphages that have been identified that are able to evolve escapes from Type III TA 
systems in an EPI300 background which will be an invaluable source for further study. 
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Chapter 7 Isolation of a broad host range superfamily of phages 
capable of infecting insect, animal, human and plant pathogens 
7.1 Introduction 
 
The Type III TA system, TenpINPl has been shown to be an effective abortive infection 
system based on previous work and in this study. This TA system originated from the 
Gram negative insect pathogen, Ph. luminescens TT01 where it is located 
chromosomally (Blower et al., 2012b). Expression of this TA system in plasmids 
showed it was capable of aborting phages isolated from P. atrosepticum, E. coli and 
Serratia (Blower et al., 2012b, 2017; Chen et al., 2017). However, there are no phages 
isolated on Ph. luminescens itself that are aborted by the TenpINPl system (Rao, 2014). 
Previous work from members of this lab has created a TenpINPl deletion strain of TT01, 
FRA2 (Rao, 2014). Phages isolated on this strain were tested on the wild type TT01 
strain (containing a single chromosomal copy of the TenpINPl system) as well as TT01 
transformed with pFR2. None of the phages isolated were aborted which was not 
expected as TenpINPl had been shown to abort a wide range of phages from different 
bacterial backgrounds. These results suggest that perhaps the normal physiological 
role of the TenpINPl system is not to function as an abortive infection system in Ph. 
luminescens but that it functions as an abortive infection system when in multiple 
copies in other bacteria.  
 
There has only been one phage published as infecting P. luminescens. However, there 
is limited data on this phage and no genomic sequence has been published (Poinar et 
al., 1989). Ph. luminescens is referred to in this publication as Xenorhabdus 
luminescens which was what it was previously called (Boemare et al., 1993). 
Sequencing of the TT01 genome has revealed numerous prophage elements, 
however, none have been reported to be produce an intact phage particle(Gaudriault 
et al., 2004). Thus there are no published genomes of TT01 phages to date. This 
chapter describes work on the isolation of novel TT01 phages and their 
characterisation with respect to Abi and other aspects. 
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7.2 All TT01 phages produce faint turbid plaques and are insensitive to both 
the ToxINPa and TenpINPl system 
From 2012 to 2016 several members of the lab had isolated phages from either the 
Milton sewage works or the river Cam using the Ph. luminescens strain FRA2. This 
formed a library of approximately 80 phages of which 31 were isolated during this 
study, ΦRAY0-30. All phages from this library produced extremely faint, turbid plaques 
on TT01, a phenotype seen previously (Rao, 2014). Furthermore, ΦRAY0-30 were not 
aborted by wild type TT01 or TT01 carrying pTA46 or pFR2. 
  
7.3 TT01 phages are motility dependent Chiviruses 
As there were no data published on TT01 phages and although none showed any 
sensitivity to the two Type III TA systems, eight phages from the TT01 library were 
chosen to be genomically sequenced. The phages were selected so that the dates on 
which they were isolated were as far apart as possible, in the hope of selecting the 
most diverse phages as possible. Sequencing results for the eight TT01 phages 
revealed that they all were similar phages that belonged to the phage genus Chivirus 
(Table 7.1). The TT01 phages had linear genomes that were a little under 60,000 base 
pairs long encoding 73 to 75 predicted ORFs and shared over 89.9% identity homology 
with each other (Table 7.1, 7.2). Their genomes also closely match that of the founding 
member phage Chi, a Siphoviridae member that was isolated on a strain of Salmonella 
(Sertic and Boulgakov, 1936). One of the sequenced phages, ΦRAY26 was viewed by 
TEM and was also shown to be a member of the Siphoviridae, characterised by a long 
non-contractile tail. (Figure 7.1). During the period of this study a member from the lab 
of Gordon Dougan at the Wellcome Trust Sanger Institute, Derick Pickard, isolated 
another Chivirus on S. Typhi (unpublished). The annotated genome sequence of this 
phage, YSD1 was provided by Derick as well as a phage lysate which has been used 
in this study for comparisons with the TT01 Chiviruses (Table 7.1, 7.2). 
 
Genomic analysis of the TT01 phages showed that their genomes could be spilt into 
six different regions based on the functions of the protein encoded within those regions 
(Figure 7.2). Alignments of the genomes of the TT01 phages showed that the regions 
that code for structural proteins were highly conserved with the greatest variability 
arising in the region associated with DNA modification and recombination (Figure 7.3). 
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The genomes of Chiviruses deposited into Genbank showed that these phages are 
commonly isolated worldwide with all phages isolated on various strains of Salmonella, 
bar one, which was isolated on E. coli (Table 7.3). Sequence alignments of these 
genomes with a representative member (ΦRAY26) also showed that these phages 
share similar genomic identities (Table 7.3). Alignments made with the TT01 phages 
and these Chiviruses also show a similar pattern where variability between phages is 
in the region associated with DNA modification and recombination (Figure 7.4). 
 
Phage Chi was previously shown to be dependent on motile flagella (Samuel et al., 
1999) thus the library of TT01 phages was tested on two motility mutants of TT01, 
ΔflgG and ΔmotAB (Easom and Clarke, 2008). As flgG encodes a structural 
component of the flagellar machinery deletion of this gene leads to the complete 
absence of flagella.  On the other hand, ΔmotAB encodes part of the motor component 
of the flagella so deletion of this gene still leads to the production of flagella but they 
are unable to rotate and thus the strain is non motile. Phages from the TT01 library 
were tested on these motility mutants but were found to be unable to infect either of 
the strains. An adsorption assay performed with ΦRAY26 showed that there was no 
adsorption to either mutants (Figure 7.5). This meant that, in the case of the ΔmotAB 
mutant, even though there were flagella present the phage could not adsorb onto it 
unless it was rotating. The reasons for the poor plaque formation of these phages on 
TT01 was investigated. One explanation is that the flagella are differentially expressed. 
To test this a 20 µl spot of neat TT01 phage, ΦRAY26 was spotted onto the centre of 
a lawn of TT01. The plates were incubated and a turbid spot appeared. The bacteria 
from this spot, which had been exposed to phage were streaked to single colonies and 
were tested for resistance to the phage. These bacteria were still sensitive to the phage 
suggesting that they might have gained temporary resistance to the phage by halting 
motility but, in the absence of phage, motility could be switched on again. 
 
As no TT01 phage could infect any of the motility mutants, these mutants were used 
in new enrichment assays to try to isolate novel TT01 phages that are not dependent 
on motility. Interestingly, with over 10 different water samples tested it was not possible 
to isolate any TT01 phage on either of the motility mutants despite facile isolation of 
flagellum-dependent phages on TT01. This implies that TT01 motility independent 
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phages are extremely rare. TT01 itself is an insect pathogen found in soil so it may be 
unlikely to find high populations of these bacteria in water sources. However, TT01 
Chiviruses are relatively easy to isolate,essentially every sample of water collected 
that had been enriched contains these viruses. Therefore, one hypothesis is that these 
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Table 7.2 Genomic data of TT01 phages and Salmonella phages Chi and YSD1 
Phage Isolation date Genome length (bp) Predicted ORFs 
Chi 1936 59,578 75 
ΦLT 2012 59,911 74 
ΦRAY0 5th Feb 2015 59,163 74 
ΦRAY1 13th Apr 2015 59,136 75 
ΦRAY19 13th May 2015 59.147 73 
ΦRAY26 30th Jul 2015 59,486 74 
ΦRAY27 11th Aug 2015 59,906 75 
ΦJB2 Apr 2016 58,922 74 
ΦJB15 Apr 2016 59.824 74 
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Figure 7.1 TEM image of ΦRAY26 
The long non contractile tail observed from the image confirms that ΦRAY26 is a 
Siphoviridae member concurring with the genomic data obtained. The black bar 
represents 100 nm. 
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Figure legend on next page 
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Figure 7.2 Genomic map of ΦRAY26 
The genome of ΦRAY26 and other Chiviruses can be split into six regions based on 
the functions of the proteins in the region. Arrows in green, blue and red represents 
ORFs involved in metabolism, virion structure and lysis respectively. Arrows in grey 
depict ORFs with unknown functions. F1-3 and R1-3, refer to the six different reading 
frames. 
  
Chapter 7 Isolation of a broad host range superfamily of phages capable of infecting 







Figure 7.3 Genome alignments of TT01 phages 
The variability between phages tend to be in the region encoding ORFs involved in 
DNA modification and recombination. The ACT comparison file was generated using 
tblastx with a cut off value of 1x10-4. Red bars show areas of high amino acid similarity.   
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Table 7.3 Complete Chivirus genomes deposited in Genbank 
 








Chi S. enterica 59,578 1936 Paris, France 94.7 
Φ37 S. gallinarum 60,216 2002 Pune, India 90.5 
Φ35 S. gallinarum 55,391 2002 Pune, India 86.4 
BP12C S. enterica Hadar 60,606 2003 
Montreal, 
Canada 90.8 
SPN19 Salmonella spp. 59,203 2011 Seoul, South Korea 90.3 






















enterica 59,518 2014 Portici, Italy 91.4 
Utah E. coli SKB178 59,024 2016 Texas, USA 92.7 
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Figure 7.4 Chiviruses are very well conserved apart from the regions involved in 
DNA modification and recombination 
A. ΦRAY26 compared with the oldest and founding member of the Chiviruses, Chi and 
YSD1. B. ΦRAY26 compared with iEPS5 and SPN19. C. ΦRAY26 compared with Sal1 
and the only Chivirus isolated on E. coli, phage Utah. D. ΦRAY26 compared with FSL 
SP-124 and BP12C. The ACT comparison file was generated using tblastx with a cut 
off value of 1x10-4. Red bars show areas of high amino acid similarity. 
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Figure 7.5 ΦRAY26 does not adsorb to TT01 motility mutants 
A. Adsorption assay of ΦRAY26 and the ΔflgG mutant. B. Adsorption assay of 
ΦRAY26 and the ΔmotAB mutant. Error bars represent the standard deviation with 
N=3. A MOI of 0.01 was used in both assays.  
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7.4 TT01 exhibit host range promiscuity but in a phage-dependent fashion 
The TT01 phages all shared high homology to the Chiviruses which have been mostly 
isolated on various Salmonella strains bar one which was isolated on an E. coli strain. 
The YSD1 phage that was isolated on a Salmonella strain was tested on TT01 and 
was able to infect it. Likewise, TT01 phages that were tested on S. Typhimurium strain 
5383 were found to be able to infect it (Table 7.4). Interestingly, not all of the TT01 
phages infected 5383 equally efficiently. While most phages infect Salmonella 5383 
just as efficiently as TT01, one phage ΦRAY0 infected 5383 poorly (Table 7.4). 
Plaques however, could still be picked and plating this phage mutant, ΦRAY0-5383, 
showed that it could then replicate just as efficiently on TT01 and 5383. To confirm that 
this result was not caused by restriction and modification (RM), a plaque of ΦRAY0-
5383 grown on TT01 was picked and plated on TT01 and 5383 again. The phage from 
this new plaque, ΦRAY0-5383-TT01, showed a three log drop in titre on 5383 
compared to TT01, the previous host on which it replicated, suggesting that it is likely 
not the result of RM (Table 7.5). Additionally, for all host range assays, a plaque of 
YSD1 grown on TT01 was used because the Salmonella strain that was host for YSD1 
was not available. 
 
Although isolated on Salmonella, phage Chi was also able to infect motile strains of E. 
coli and Serratia (Iino and Mitani, 1967; Schade and Adler, 1967). The TT01 phages 
were also shown to be able to infect motile strains of E. coli and Serratia (Table 7.4). 
Three E. coli strains were tested (DH5α, W3110 and MG1655) where only MG1655 is 
motile; the TT01 phages could only infect MG1655. Two motile strains of Serratia were 
also used, DB10 and ATCC 39006, however the TT01 phages could only infect DB10 
suggesting that there may still be specificity involved in adsorption to the different 
flagella. Furthermore, only one phage, (ΦRAY1), plated efficiently on DB10. All other 
TT01 phages, as well as YSD1, replicated poorly in this host. However, picking a 
plaque of ΦRAY26 grown on DB10 (ΦRAY26-DB10) and plating it back on DB10 and 
TT01, showed that it could then plate just as efficiently on both hosts (Table 7.5). 
Several other strains of bacteria available in the lab were also tested for their 
susceptibility to the TT01 phages. This included several Gram positive bacteria, S. 
aureus and three B. thuringiensis strains, and Gram negatives, Citrobacter rodentium, 
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Chromobacter violaceum, Pseudomonas aeruginosa and Vibrio harveyi but none of 
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Table 7.5 Putative host range mutants of selected TT01 phages 
Phage Host EOP 
ΦRAY0 TT01 1 
 5383 1.13x10-7 
   
ΦRAY-5383 TT01 0.79 
 5383 1 
   
ΦRAY-5383-TT01 TT01 1 
 5383 2.44x10-3 
   
ΦRAY26 TT01 1 
 DB10 2.76x10-6 
   
ΦRAY-DB10 TT01 0.49 
 DB10 1 
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TT01 is an insect pathogen, so to see if the TT01 phages could also infect other insect 
pathogens, they were tested on a small library of available insect pathogens (Table 
7.6). Results from these experiments confirmed that many of the insect pathogens 
tested were indeed vulnerable to TT01 phage infection. Again, a pattern emerged 
where particular TT01 phages could infect certain strains more efficiently than other 
TT01 phages. 
 
Several other libraries of bacteria were also tested for their susceptibility to TT01 phage 
infection. One of these libraries was a collection of phytopathogens which included 
various P. atrosepticum, P. carotovorum and Dickeya strains. A selection of these 
strains was tested but none were susceptible to TT01 phage infection (Table 7.7). The 
TT01 phages had previously been shown to infect S. marcescens strain Db10, so a 
library of other S. marcescens strains were tested (Table 7.8). Several of these strains 
were susceptible to TT01 phage infection and yet again there were differences in 
efficiency of infection between phages on certain strains. The host ranges of these 
phages also appears to be random with no obvious grouping. A final library was tested 
consisting of bacteria isolated from the rhizosphere that had been classified by FAME 
(Berg et al., 2002). Many of the bacteria were susceptible to TT01 phage infection 
suggesting that there are many bacterial habitats that harboured bacteria sensitive to 
the TT01 phages (Table 7.9). 
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Ph. luminescens has a particularly interesting lifecycle, forming a symbiotic 
relationship with nematodes but a pathogenic one with insects (Joyce et al., 2006). 
Briefly, the bacteria live in the gut of the nematode Heterorhabditis which provides a 
safe habitat for them. These nematodes then actively seek out and infect insect larvae. 
Once infected the nematodes release the Ph. luminescens bacteria into the 
bloodstream where the bacteria release numerous different toxins that kill the insect 
as well as an antibiotic that prevents growth of other bacteria (Ffrench-Constant et al., 
2007; Williams et al., 2005). The nematodes and bacteria are then able to use the 
insect cadaver as a nutrient source to replicate after which the progeny nematodes 
carrying the bacteria in their gut leave to seek out new insect hosts to begin the cycle 
anew. Ph. luminescens receives its name as during its replication in the insect larvae 
it produces a luciferase protein causing the corpse to glow blue (Poinar et al., 1980). 
This glowing ability is thought to be the cause of the phenomenon called Angel’s glow 
during the battle of Shiloh (Haynes, 2015). During this American Civil war battle, the 
wounds of certain soldiers began to emit a blue light, these soldiers’ wounds would 
heal faster than those that did not glow which was attributed to divine intervention at 
the time. It is now thought that this glow was caused by a Ph. luminescens infection 
which would also produce antibiotics preventing infection by pathogenic bacteria and 
lead to faster wound healing (Haynes, 2015). However, although beneficial to human 
health in this case, the Photorhabdus species is viewed as an emerging human 
pathogen with increasing reports of human infection (Gerrard et al., 2003). The 
insecticidal toxin complexes of Photorhadus additionally have homologues in Yersinia 
pestis the causative agent of plague which may be a cause of further concern as 
Photorhabdus is regarded as an emerging human pathogen (Rodou et al., 2010).  
 
The remarkable lifecycle of Ph. luminescens presents interesting challenges for 
phages that infect it as the phages too will have to adapt to the different environments 
that the bacteria cycle through during growth. One way in which phages have adapted 
is to take shelter within the bacterium itself by resorting to a temperate lifecycle. Indeed 
this may be the case for many of the phages that infected TT01 in the past as 4% of 
its genome is associated with prophage DNA (Gaudriault et al., 2004). The work in this 
chapter displays an alternative means of adaptation. The TT01 phages isolated in this 
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chapter are capable of infecting a wide range of bacteria originating from very different 
environments. This strategy to act as a generalist phage with a wide host range allows 
such phages to have many opportunities to interact with a suitable permissive host and 
to replicate and maintain viral population. However, the results of the TT01 host range 
tests also suggest that there are several disadvantages in targeting so many different 
bacteria. Many of the TT01 phages, after replicating in TT01 then replicate very poorly 
in some hosts, and for others are unable to infect at all. Some TT01 phages have 
evolved to no longer be able to infect certain hosts which suggest that they may have 
gained certain mutations that now allow it to infect other hosts more efficiently. None 
of the TT01 phages show the same host range patterns implying that these phages 
may be constantly evolving, depending on the hosts that they may have encountered 
in the past. Several host range mutants isolated agree with this view as they were 
shown to replicate just as efficiently in their new host as well as TT01 compared to 
their wild type counterparts.  Although not tested in this chapter due to time constraints 
it is very likely that the host range profile of these mutants will have changed from their 
original wild type. One of the remarkable observations was that these TT01 were highly 
similar in to each other and yet have wide host ranges. This is particularly interesting 
as the high genomic similarities would make these phages highly susceptible to 
CRISPR-Cas systems. It remains unknown whether many spacers of different bacteria 
include the genomes of TT01 phages. 
 
All the TT01 phages isolated were shown to be Chiviruses named after phage Chi 
isolated in 1936 (Sertic and Boulgakov, 1936). The receptor for phage Chi is the 
flagellum and the phage was shown to infect a wide range of motile bacterial strains 
including Salmonella (Meynell, 1961), E. coli (Schade and Adler, 1967) and Serratia 
(Iino and Mitani, 1967). The TT01 phages were only able to infect motile bacteria and 
so, by targeting a common bacterial component are able to infect many strains of 
bacteria. It seems likely that phage Chi and other Chiviruses will have much larger host 
ranges than previously thought and could be able to infect many of the strains that the 
TT01 phage are able to infect. This is supported by the YSD1 phage data. This phage 
was isolated on a strain of Salmonella but was subsequently shown here to be able to 
infect strains that were also susceptible to TT01 phage infection. Phylogeny trees 
constructed with the TT01 phages compared to the other Chiviruses show that the 
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TT01 phages do not belong in a specific clade and are just as related to the other 
Chiviruses are to each other (Figure 7.6). This result and the fact that the TT01 phages 
all have different host range profiles suggests they are all replicating on different hosts 
in the environment. Thus although phages are usually referred to from the hosts they 
are isolated from e.g. Salmonella phages or coliphages, it is perhaps not completely 
accurate to refer to the TT01 phages as Photorhabdus (TT01) phages (Adriaenssens 
and Brister, 2017). It seems very unlikely that there will be a significant abundance of 
Ph. luminescens growing in the river Cam, hence it is more likely that these “TT01” 
phages are naturally growing on alternative environmental hosts. The nature of these 
hosts remains a mystery but it may be far wider than implied by the host range tests. 
One feature is that none of the TT01 phages are capable of infecting P. aeruginosa 
PA01, although it is motile. Only one strain of P. aeruginosa was tested as there were 
not many strains of P. aeruginosa available while this work was in progress but it is 
likely that if several more strains were tested perhaps one would be susceptible to 
infection with these phages.  Nonetheless, these phages are of particular interest in 
terms of phage therapy due to their extensive host range in important pathogens. 
Flagella are important virulence factors in Salmonella (Carsiotis et al., 1984) and in 
Photorhabdus play a role in competitive fitness during infection of the insect larvae 
(Easom and Clarke, 2008).  
 
The mechanism by which phage Chi infects is still poorly understood. One of the 
models proposed is that Chi infects via a nut and bolt approach (Samuel et al., 1999; 
Schade et al., 1967). In this model the tail fibre of phage Chi fits into grooves on the 
surface of the flagella and spins down to the base of the flagellum that is attached to 
the bacterial surface. The rotating flagellum is thought to provide the force necessary 
to allow the phage to travel down the flagella in this way. Once at the base, phage Chi 
is then thought to inject its genomic material. The direction in which the flagella turns 
is also crucial for successful adsorption as Chi and another Chivirus (iEPS5) can only 
adsorb to bacteria whose flagella are turning in a counter-clockwise direction (Choi et 
al., 2013). In bacteria with peritrichous flagella, such as Salmonella and E. coli, the 
overall direction in which these bacteria move is by a process called run and tumble 
(Armitage, 2016; Larsen et al., 1974). In this process, when bacteria need to move 
towards a more favourable location they tend to “run” i.e. travel in a straight line more 
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often when orientated in that direction and “tumble” more until they are correctly 
orientated. The change from run and tumble is caused by the direction in which the 
flagella are rotating. When the flagella are turning counter-clockwise the bacteria are 
motile, and run, but when the flagella are turning clockwise the flagella are not ordered 
and so the bacteria tumble instead. At least two Chiviruses have been shown to be 
dependent on flagella that are turning counter-clockwise (Choi et al., 2013). Adsorption 
may occur when certain flagellar residues are exposed when the flagella are rotating 
in this way or it could follow the nut and bolt theory in which the rotating flagella force 
the phage to the flagellar base. The nut and bolt theory is likely not the only mechanism 
through which Chiviruses inject their DNA however, as there is evidence the Chivirus 
iESP5 injects its DNA directly into the flagellum and the authors propose that the DNA 
travels inside the flagellum to reach the bacterial body (Choi et al., 2013). Although the 
size of DNA may allow it to fit into the narrow central cavity of the flagellum, it is not 
yet understood how the DNA would bypass the motor components of the flagellum at 
the base. The phylogenetic trees show that a few of the TT01 Chiviruses are more 
closely related to iESP5 which could suggest they follow a similar mode of infection 
(Figure 7.6). While the adsorption mechanism(s) by which Chiviruses bind to flagella 
and infect their genetic material is unclear, the TT01 phages have been shown to be 
able to evolve host range mutants when infecting other susceptible hosts. By 
characterising the mutations that these host range mutant phages evolve it may be 
possible to identify residues important in adsorption. Furthermore, Chiviruses are easy 
to isolate when using TT01 and so this provides the opportunity to isolate and study 
even more variants of this genera of phage. 
 
The TT01 phages were originally isolated to see if the TenpINPl system located 
chromosomally in Ph. luminescens could abort any TT01 phages. None of the TT01 
phages isolated however were aborted, even when the system was introduced in 
multiple copies via a plasmid. Thus the role of TenpINPl within TT01 is still unclear, 
although with the many different environments TT01 encounters during the replication 
of its nematode symbiont, it is likely that during certain conditions, the ability to halt 
bacterial growth or kill a small proportion of the population is advantageous. The 
ToxINBt system has no reported anti-phage activity but functions as a plasmid 
maintenance system during development of spores (Short et al., 2015) so there may 
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yet be a function still to be revealed for the TenpINPl system. The TenpINPl system was 
of particular interest as a chromosomal TA system with unknown roles. Many 
experiments using chromosomal TA systems often highly expresses these TA systems 
and thus may not define a physiologically relevant functions (Ning et al., 2013; 
Pedersen et al.). This is also the case with the TenpINPl system that is shown to have 
abortive infection properties, but this is only when on a plasmid where it is expressed 
in much higher amounts than in its natural host TT01 (Blower et al., 2012b). The 
functions of chromosomal TA systems are still not known however, one possible role 
in which chromosomal TA systems may be involved is as anti-addiction modules (Bast 
et al., 2008). `Clearly, further work is required to determine the exact role of the 
TenpINPl system in TT01. 
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Figure 7.6 TT01 phages do not fit into a specific clade 
Phylogenetic trees were constructed using the neighbour-joining method with a 
bootstrap test of 1000 replicates. Two different phage proteins were used A. Major 
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capsid protein or B. Large terminase. Proteins were aligned using the MUSCLE 
algorithm.  





Chapter 8 Final discussion 
The Type III TA systems have been shown to be potent anti-phage systems aborting 
a wide range of phages. One of the methodologies used to determine the factors 
involved in Type III TA activation is to identify the nature of the mutations that phages 
evolve to escape these systems. Several of these phages, and their mutations, have 
been identified. However, apart from four phages, all mutations were either found in 
genes of unknown functions or, in the case of ΦTE, the evolution of an antitoxin mimic. 
One of the phages with a mutation in a known product is phage 2, which escapes the 
AbiQ system in E. coli, MG1655, through mutations in a putative DNA polymerase. The 
other three phages are highly similar with three different types of mutations. Only one 
of the mutations is in a known gene coding for the σ appropriation protein, AsiA. The 
results described in this dissertation reveal novel phage escape loci and candidate 
factors related to Type III TA activation. The study begins to build a wider picture of 
how and why these TA systems are activated during phage infection.  
 
8.1 Summary of findings 
The first Type III TA system identified was ToxINPa, which was located on a cryptic 
plasmid carried by P. atrosepticum SCRI1039 and was found to be a potent anti-phage 
system (Fineran et al., 2009). In this project, to understand ToxINPa activation in 
physiologically natural settings, newly and previously isolated P. atrosepticum phages 
were tested for their susceptibilities to ToxINPa using plasmid pTA46. Genomic 
sequencing of 36 of these P. atrosepticum phages revealed six different groups, with 
four of the groups never seen before among P. atrosepticum phages. Highlights of the 
analysis of the genomic data included several phages showing very high genomic 
identities to ΦTE, which escapes the ToxINPa system by producing an RNA antitoxin 
mimic (Blower et al., 2012a). These new ΦTE-like phages, however, were unable to 
escape and were found to either have only a partial antitoxin repeat sequence or none 
at all, hence they are unable to evolve to produce an antitoxin mimic. These findings 
also imply that, without the antitoxin mimic sequence, ΦTE itself would be unable to 
escape the ToxINPa system. It is particularly interesting that ΦTE contains a homologue 
of the DNA polymerase that is mutated in AbiQ escapes of phage 2 yet corresponding 
mutations were not seen in ΦTE or any of the new phages. None of the newly 




sequenced ΦTE-like phages could code for an antitoxin mimic, and this discovery 
served to highlight the apparent uniqueness of ΦTE and its serendipitous discovery. 
The only other Abi-sensitive P. atrosepticum phage to be characterised in detail is ΦM1 
and extensive characterisation of new escapes confirmed that a single protein is 
responsible for the escape of ToxINPa, and TenpINPl. ΦM1 was found to be more 
sensitive to ToxINPa than TenpINPl. However, the reverse was found in another newly 
sequenced ΦM1-like phage, ΦRC10. ToxINPa and TenpINPl escapes of ΦRC10 were 
also found to have mutations in the homologue of the corresponding protein mutated 
in ΦM1 escapes. In addition, a new group of P. atrosepticum phages, ΦRC6-like, were 
also found to be aborted by the ToxINPa system but were unable to produce escapes. 
Interestingly, the ΦRC6-like phages carried a putative CRISPR repeat that has not 
been seen before in any P. atrosepticum phages.  
 
The other three groups of phages were not aborted by either of the Type III TA systems 
used and included the ΦR1-like phages. This group of phages shared high homology 
to a P. carotovorum phage suggesting that ΦR1-like phages may also be able to infect 
P. carotovorum. Indeed, subsequent host range tests of these phages confirmed that 
certain strains of P. carotovorum were indeed susceptible to these phages. This 
observation led to the idea that at least for the ΦR1-like group, some phages named 
after the host on which they were isolated, may not necessarily reflect the host on 
which they replicate in the environment. The final two groups of phages had particularly 
interesting genomes, as they belonged to a rare class of phages called jumbophages 
(Chapter 3). Many of the proteins from these two phages do not show homology to 
any previously sequenced gene products and presumably present exciting and 
completely novel phage biology, yet to be discovered. 
 
ToxINPa and TenpINPl were previously found to abort many phages infecting E. coli 
DH5α. However, the evolution of escape mutants was not seen before. Coliphage 
ΦCHAI8 represents the first ToxINPa-sensitive coliphage that is able to evolve escapes. 
ToxINPa escapes of ΦCHAI8 had deletions in a putative RNA repair locus. Additionally, 
ΦCHAI8 shared high genomic similarity to phage 2, which is sensitive to the Type III 
TA system, AbiQ. Escapes of AbiQ have mutations in a putative DNA polymerase. It 
was a curious result as other than ΦCHAI8, phage 2 was also the only other coliphage 
that could escape the AbiQ system.  





The majority of work performed with ToxINPa and AbiQ using coliphages has used 
either DH5α or MG1655 (Blower et al., 2012b; Samson et al., 2013). However, there 
is now evidence that, for an unknown reason, certain coliphages that are aborted but 
can’t escape ToxINPa or TenpINPl, are able to do so in the E. coli strain EPI300 
(Chapter 6). This implies that the activation of these Type III TA systems can be also 
dependent on one or more host factors. One of the phages, T6, that could escape the 
TenpINPl system in EPI300 was characterised further. Several TenpINPl escapes of T6 
that were sequenced had mutations in the alc gene, encoding a transcriptional 
inhibitor.  
 
The final phage to be characterised with regards to abortive infection was the LamB-
dependent Serratia phage, ΦOT8s. This phage is aborted by the ToxINPa system in 
both Serratia 39006 and E. coli DH5α. ToxINPa escapes selected from the two hosts 
have mutations in motA and asiA genes. This is the second time that a mutant asiA 
gene has been defined as the escape locus in response to ToxINPa as prior work in 
this laboratory showed that three Serratia phages, ΦCHI14, ΦX20 and ΦCBH8 also 
had mutations in asiA (Chen et al., 2017). 
 
Finally, the nature of Photorhabdus TT01 phages were examined in the last results 
chapter. All TT01 phages isolated thus far belong to the “new” Chivirus genus and 
have extraordinarily large host ranges. The differences seen in the host range tests 
suggested that there is constant evolution occurring between these phages depending 
on their past host histories. None of the TT01 phages were aborted, which could mean 
that TenpINPl has a different natural role in TT01.  
 
In total, forty-five novel phage genomes were sequenced from phages isolated on P. 
atrosepticum (Chapter 3), E. coli (Chapter 4) and Ph. luminescens (Chapter 7). A 
taxonomy tree of these phages is shown in Figure 8.1. Many of these phages were 
tested for their susceptibility to the ToxINPa or TenpINPl systems by transferring the 
plasmids pTA46 or pFR2, respectively, into the relevant hosts. It is clear that 
“activation” of both these systems can occur in many different types of phages and in 
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8.2 Proposed model for Type III TA activation 
Several new escape loci have been identified in this study. All known escape loci are 
shown in Table 8.1. Many of the identified escape loci carry mutations in single genes 
of unknown functions. However, it appears that these genes are all within areas 
associated with nucleotide metabolism. Furthermore, the escape loci that do have 
known functions are also associated with nucleotide metabolism i.e. processes that 
affect the transcription of genes in both the phage and their bacterial hosts. Only three 
different Type III TA systems has been studied in detail but it is clear that all of the 
three TA systems can be transferred to different bacterial host backgrounds and are 
still able to abort phages in those hosts (Blower et al., 2012b; Chen et al., 2017; 
Samson et al., 2013). Perhaps the most extreme transfer would be the AbiQ system 
originating from a Gram positive i.e. L. lactis to a Gram negative i.e. E. coli where the 
phages that infect each host would be widely different.  
 
The escape loci of phage escape mutants of Type III TA systems are associated with 
nucleotide metabolism (Table 8.1). This implies that the factor(s) activating the Type 
III TA systems is a fundamental process that involves a bacterial-phage interaction 
linked to the identified escape loci. It is evident that the bacterial host itself plays a key 
role in activating the Type III TA systems. As different bacterial hosts that carry 
identical plasmids with the same Type III TA system can behave differently to the same 
phage. For example, ΦOT8s is aborted by the TenpINPl system but can only escape 
in an EPI300 background and not on DH5α or S 39006. Moreover, the factor(s) 
activating Type III TA systems are linked to an essential component of the phage life 
cycle. Numerous phages aborted by Type III TA systems are unable to escape even 
when challenged at high titres. However, there are phages that can evolve escapes 
but this doesn’t necessarily mean that this component of the phage cycle is not 
essential. An explanation for this is that for phages that can escape, this essential can 
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One process that fits all these criteria (i.e. essential to the phage but mutable to a 
certain degree, affected by phage/host combination as well as the Type III TA system) 
is transcription. Every phage is an obligate bacterial parasite as they do not carry all 
the genes required to replicate independently of their hosts. Consequently, phages 
have to use the bacterial transcriptional machinery to replicate their genetic material, 
thus making it an essential process. However, every phage has evolved different 
means of taking over the host cell machinery and the way that this occurs for the same 
phage will also be different depending on the host it infects. For example, the process 
in which the ΦOT8s phage hijacks the bacterial cell machinery will be slightly different 
when infecting E. coli compared to Serratia. While the phages have to use the bacterial 
transcriptional machinery to replicate, certain phage genes involved in this process can 
be altered, thus changing the way in which the phage hijacks the cell. These phage 
products may not necessarily be essential, e.g. the M1-23 and RC10-26 proteins of 
the ΦM1 and ΦRC10 phages can be effectively deleted without any obvious fitness 
effects to the phage at least under lab conditions (Chapter 4).  
 
However, as transcription of phage genes by hijacking the bacterial transcriptional 
machinery is essential for phage replication, many of the viral genes that are involved 
in this process will also be essential. This may explain why certain phages are unable 
to evolve escapes as the mutations that may prevent Type III TA activation, are also 
be required for taking over the bacterial transcriptional machinery. The mutations of 
different proteins may affect the rates of transcription differently which explains why 
selection of a Type III TA system escape mutant on one host will not necessary lead 
to escape in another host. An example of this is the ΦOT8s phage. A ToxINPa escape 
can be selected on DH5α that is still aborted by the ToxINPa system in Serratia 
(Chapter 7). The explanation behind this is that as the same phage is exploiting 
different bacterial transcriptional machinery when infecting the two different hosts, the 
rate of transcription will be different as well. This may mean that the mutation that 
allows it to escape ToxINPa in DH5α may not have the same impact in Serratia. 
Nonetheless, there are ΦOT8s phage mutations that will have a significant impact in 
both E. coli and Serratia such as the motA and asiA mutations which can then lead to 
ToxINPa escape in both hosts (Chapter 6). 
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The control of transcription is pertinent to the regulation of the Type III TA systems and 
this is highlighted by the genetic organisation of Type III TA loci. The genetic locus of 
Type III TA systems is composed of multiple repeats of the antitoxin subunit followed 
by a Rho-independent terminator that separates it from the toxin sequence. The locus 
is under the control of a single promoter and with the presence of the terminator this 
leads to an antitoxin to toxin transcript ratio of ~10:1 for the ToxINPa system. Moreover, 
the ToxIPa subunit is repeated 5.5 times resulting in 50 antitoxin “units” to a single toxin. 
The control of antitoxin to toxin stoichiometry is highly important because a decreased 
level of antitoxin can lead to the activation of the Type III TA system (Fineran et al., 
2009). The ratio of antitoxin to toxin is a feature that is also important in other TA 
systems including Type I and II. The ToxINPa system has been shown to form a 
heterohexameric complex consisting of three antitoxins and three toxins (Blower et al., 
2011). However, it has recently been shown that this complex is not the prevalent state 
of toxin and antitoxin in vivo. Instead, a much more dynamic process of neutralisation 
by the antitoxin and toxin was observed where the ToxNPa is constantly cleaving newly 
transcribed antitoxin (Short et al., 2018). Thus it seems entirely plausible that, during 
phage infection, a generalised inhibition of host translation and/or the promotion of 
phage replication will lead to a decrease in the level of antitoxin, leading eventually to 
the release of the toxin. The ΦM1 phage infection results supports this as, during 
infection, the ToxIPa levels have been shown to drop faster in the wild type phage 
compared to an escape mutant (Blower et al., 2017). The ToxNPa levels do not increase 
during infection implying that the activation is caused by either the decrease of the 
antitoxin levels or disruption of the complex. As mentioned above, the disruption of the 
complex is unlikely since this doesn’t seem to be the predominant form in vivo. 
Furthermore, the ΦM1 phage is aborted by both the ToxINPa and TenpINPl system and 
escapes are through mutations of the same protein. A single protein is not likely to be 
able to directly activate these two very different TA systems, thus it is more likely that 
the protein is in fact affecting a common process determining the activation of the 
systems. Further evidence that a single phage protein is not likely to directly activate 
a Type III TA system is evident in phage escapes of the AbiQ system. Both P008 and 
bIL170 are lactococcal phages that are able to escape the AbiQ system through 
defects in a single protein. However, while they share homologues of the same escape 
proteins, the gene that is mutated is different in the two phages (Samson et al., 2013).  
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ToxINPa, TenpINPl and AbiQ all have different abortive infection profiles although, for 
ΦM1 and ΦRC10, it seems that a single protein can effect two Type III TA systems. 
How then does a decrease in transcription efficiency cause certain phages to be 
aborted by one system but not the other? As mentioned above the levels of antitoxin 
play a key role in the activation of these systems and in fact there is high variability in 
the antitoxin sequence (Goeders et al., 2016). During the initial screen for Type III TA 
systems it became apparent that copy number differed widely between TA systems. 
Experiments determining the effects of the antitoxin copy number has also shown that 
there are variabilities in the number of antitoxin repeats necessary to neutralise the 
toxin. For ToxINPa, 1.5x ToxIPa repeats using the native promoter could never be 
cloned, suggesting that it was insufficient for neutralisation. The smallest repeat that 
could be cloned was 2.5x, which is in contrast to the results of the AbiQ system where 
a repeat of only 1.8x was necessary (Bélanger and Moineau, 2015). Additionally, 
phage mutants of P008 isolated on the AbiQ system with 1.8x repeats did not have 
any mutations in orf38, suggesting that the gene product does not directly activate 
AbiQ (Bélanger and Moineau, 2015). This agrees with the proposed model that the 
mutation in these P008 phage escapes must have a more significant impact on the 
transcriptional rates. Furthermore, a ToxNPa mutant, ToxN-Y115A, which encodes a 
toxin that forms a less stable complex with ToxIPa, was still able to abort phages that 
were previously selected on, and insensitive to, the wild type ToxINPa system (Blower 
et al., 2011; Short et al., 2018). This highlights the importance of the ToxI-ToxN 
interaction and any disturbance of this (i.e. by decreasing the antitoxin levels), leads 
to the activation of the Type III TA system. 
 
The ideal antiphage system would target an essential process that is widespread 
among phages, thereby having as much coverage as possible with limited capacity for 
resistance to develop. As every phage has to use the transcriptional machinery of their 
hosts having an antiphage system that is sensitive to transcription, fulfils these criteria 
(i.e. essential and widespread). Some phages could get around this by evolving a 
replication cycle that has minimal effect on the bacterial transcriptional machinery, so 
that these systems aren’t activated. Alternatively, other phages may have a fast 
replication cycle that may be too quick for these systems to detect and respond to. If 
Type III TA systems activation are reliant on transcription of their antitoxins, it would 
explain why TA systems from other bacteria could abort phages that infect completely 
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different bacteria. It is also the likely explanation as to why copy number of these TA 
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8.3 Future directions 
The results obtained during this study have shown just how little of the relevant phage 
biology is understood and there are many avenues which warrant further investigation. 
In Chapter 3, 36 novel P. atrosepticum phages were sequenced, and many shared 
very little homology to the other published phages. As P. atrosepticum phages are 
already being used to treat potatoes in “phage therapy” (Branston, 2012), it is crucial 
that much more is understood about these phages. While some basic characterisation 
has already been performed on these phages, there are many more interesting 
characterisation that could be followed up with. For example, transduction assays 
could be conducted. Given that a large proportion of the sequenced phages are similar 
to ΦTE and ΦM1. It is likely that many of these phages will be transducers, which could 
be potentially undesirable in phage therapy cocktails. More host range tests could also 
be performed and the receptor binding proteins for these phages should also be 
determined. With regards to abortive infection, the nature(s) of the M1-23 and RC10-
26 proteins are still unknown. It would be interesting to define the function of these 
proteins but, given the toxicity of these proteins, it may be easier to first characterise 
other escape loci identified in this study. 
 
The escape locus of the ΦCHAI8 phage is one of the novel escape loci that may be 
easier to characterise. Initial follow up experiments should include complementation 
assays to determine which components are necessary for ToxINPa activation. It would 
also be necessary to determine the natures of the putative RNA repair pathway 
encoded in the escape loci. Although there is an interest in this RNA repair pathway 
with regards to ToxINPa activation, there are also other reasons to investigate this 
further. This RNA repair pathway is also involved in another abortive infection system 
and furthermore, there are homologues of these proteins in eukaryotes which have 
been shown to be essential proteins (Chapter 5). Complementation assays for the 
escape loci of all other escapes phages such as T6 and ΦOT8s, should also be 
performed. The escape proteins of these phages, Alc, AsiA and MotA are well 
characterised in phage T4 but their activities should also be determined. 
Complementation assays with these proteins could also be performed with T4 
homologues. For all phages that were capable of escaping the two Type III TA 
systems, the amount of antitoxin and toxin during infection of both the wild type and 
different escapes should be determined. This will help to test whether or not the current 
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proposed model that depicts decreased antitoxin levels after phage infection leads to 
abortive infection. 
 
While there is plenty of further work to be done on the products of the escape loci of 
these phages, the EPI300 experiments have also shown that there are many more 
escape phages that could be characterised and their escape loci determined (Chapter 
6). Many of these new phages show abortive infection profiles that are different from 
any of the currently characterised phages, so are worth of further study. 
 
The final chapter of this dissertation focussed on the phage Chi, a very old phage 
whose adsorption mechanism has yet to be solved (Chapter 7). The phages examined 
and discussed within the chapter had the potential to create many host range mutants, 
creating the opportunity to identify residues important in adsorption. This could help to 
narrow down important components of Chiviruses’ tail fibres and the definition of the 
flagellum proteins of the hosts critical for adsorption. 
 
Type III Toxin antitoxin research has come a long way from the original discovery of 
ToxINPa on a cryptic plasmid. Since then, there has been extensive research 
performed to determine its activation mechanisms. While these are still unknown, the 
work performed during this research has helped extend our understanding of how Type 
III TA systems function as abortive infection systems. 
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Abstract: Toxin-antitoxin (TA) systems are small genetic modules that encode a toxin (that targets
an essential cellular process) and an antitoxin that neutralises or suppresses the deleterious effect
of the toxin. Based on the molecular nature of the toxin and antitoxin components, TA systems are
categorised into different types. Type III TA systems, the focus of this review, are composed of a
toxic endoribonuclease neutralised by a non-coding RNA antitoxin in a pseudoknotted configuration.
Bioinformatic analysis shows that the Type III systems can be classified into subtypes. These TA
systems were originally discovered through a phage resistance phenotype arising due to a process
akin to an altruistic suicide; the phenomenon of abortive infection. Some Type III TA systems are
bifunctional and can stabilise plasmids during vegetative growth and sporulation. Features particular
to Type III systems are explored here, emphasising some of the characteristics of the RNA antitoxin
and how these may affect the co-evolutionary relationship between toxins and cognate antitoxins in
their quaternary structures. Finally, an updated analysis of the distribution and diversity of these
systems are presented and discussed.
Keywords: abortive infection; altruistic suicide; type III toxin-antitoxin; bacteriophages; quaternary
structures; co-evolution; pseudoknotted RNA; endoribonuclease
1. Introduction
Toxin-antitoxin (TA) systems are composed of a bacteriostatic or bactericidal toxin and a cognate
antidote which is referred to as the antitoxin. In most cases, the antitoxin directly interacts with
either the proteinaceous toxin or its mRNA and thus antagonises the deleterious effect of the toxin.
In addition to their physical interdependence, they are linked at the genetic level and are often
encoded in bicistronic operons with a promoter-proximal antitoxin gene. Save for a few Type I systems,
all TA systems are encoded in operons wherein the antitoxin gene is usually found upstream of the
toxin-encoding ORF. Nonetheless a few Type II systems such as HigBA and HicAB are exceptions and
have a reverse genetic organisation [1]. This transcriptional organisation favours an excess of antitoxin
in homeostatic conditions where the toxin is inhibited. The harmful activities of the toxins are due to
their interference with essential cellular processes including DNA replication, translation, cell wall
synthesis, and maintenance of membrane integrity [2–6].
The active toxin always interacts with its targets as a protein while the nature of the potent
antitoxin is either RNA or protein. In addition, antitoxins neutralise their cognate toxins at several
levels and act via distinct mechanisms. The nature of the antitoxin and its mode of action underpin
the classification of TA systems into five Types (I–V) [7–9]. RNA antitoxins of Type I and III interact
with the toxin transcripts (RNA-RNA interactions) or with the toxic protein (RNA-protein interactions)
respectively. Most Type I antitoxin RNAs bind the toxin transcript in its 5'UTR region. Formation of
this RNA-RNA duplex has two main effects [10]. Firstly, translation of the mRNA into the toxic protein
Toxins 2016, 8, 282; doi:10.3390/toxins8100282 www.mdpi.com/journal/toxins
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is hindered as the antitoxin RNA is usually complementary to the region containing the ribosome
binding site (RBS) of the toxin transcript or directly competes with ribosomes. In addition to blocking
translation initiation, the antitoxin/toxin RNA duplexes are the targets of cellular RNases and thus
antitoxin binding ultimately leads to degradation of the toxin transcripts [6]. Aside from Type I TA
systems, inhibition of toxin translation is also used by the only Type V system identified so far [7].
In this case, toxin production is turned off directly by the antitoxin which is an RNase that degrades
toxin mRNAs and thus directly regulates toxin transcript levels [7]. In Type II, III, and IV systems,
translation of the toxin is not directly affected. Type II systems use direct protein-protein interactions
where antitoxins either mask the toxin active site or sterically hinder the toxins from reaching their
target [1–3]. Type IV antitoxins also prevent toxin-target interactions but achieve this by competing
with the toxins for their target, without direct contacts with their cognate toxins [8,9]. Finally, Type III
TA systems fall into the category of RNA-protein interactions in which the toxin active site is occluded
by the antitoxin RNA [11–14].
TA systems were originally discovered in the late 80s [15,16] and, for a long period, were defined in
only two types (Type I and II) which have been extensively studied. In contrast, the archetypal Type III
TA system and, subsequently, the Type IV and V systems, were discovered only recently. While data
are still comparatively limited for the newer Type IV and V systems, a more holistic image is beginning
to emerge regarding Type III systems, with accumulating biochemical, structural, and functional
data. This review covers these systems, describing their diversity and toxin-antitoxin/abortive
infection bifunctionality and discusses their impact on bacteria-phage co-evolution, given their
anti-phage activity.
2. Type III TA Systems Are Split into Three Families Which Share the Same Genetic Organisation
The novelty of Type III TA systems involves the nature of RNA-protein interactions between
their components [11,12]. These interactions are unusual as the toxin is involved in processing the
antitoxin into its active form. More precisely, the antitoxin, a small non-coding RNA (sRNA) composed
of several repeats of short nucleotide sequences, is processed into monomers of these repeats by the
toxin. The heteromeric complexes adopted by Type III systems during homeostatic conditions are
composed of alternating interactions between antitoxin and toxin monomers [12–14]. As for other
Types of TA systems, the antitoxin has a shorter half-life than the toxin [11] but the specific details of
antitoxin degradation are not yet completely clear.
At the genetic level, Type III TA systems are organised in characteristic bicistronic operons
transcribed from a single promoter. The downstream toxin gene is preceded by a Rho-independent
terminator that separates it from the upstream short repetitive nucleotide sequences that encode the
antitoxin sRNA (Figure 1) [11,17]. Presumably, organisation in operons ensures a higher synthesis of
the antitoxin compared to the toxin and thus avoids physiologically precocious, and potentially lethal,
toxin activity. Unique to Type III systems toxin expression is further modulated by the presence of
the inter-gene Rho-independent terminator. A final regulatory fail-safe may reside in the fact that one
antitoxin sRNA will be processed into several monomers that could neutralise two or three toxins,
thus further ensuring an appropriately regulated antitoxin:toxin stoichiometry.
Although all Type III TA systems share the same genetic arrangement, they can be further
differentiated into three families which are classified according to the amino acid sequence similarities
that they share [18]. The subfamilies are called ToxIN, CptIN, and TenpIN where the “I” and
“N” represent the antitoxin and toxin components respectively. Thus, for the ToxIN system of
Pectobacterium atrosepticum the antitoxin is referred to as ToxIPa, the toxin as ToxNPa and both
components as ToxINPa [18]. CptIN was named after the Coprococcus catus GD/7 system (CoPrococcus
Type III Inhibitor/toxiN) and the third family, TenpIN for Type III ENdogenous to Photorhabdus
Inhibitor/toxIN [18]. While the toxin sequence directly influences the subgroup to which a particular
system belongs, it is also interesting to note how their cognate antitoxins differ between and within
the subgroups.
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3. Antitoxin Length Is Important for Type III System Functions
ntitoxin repeats are a key feature of Type III syste s. The nu ber of repeats varies bet een
syste s and they have been sho n to be crucial for antitoxin activity. For instance, the antitoxins of
the ToxI a, ToxI Bt, and AbiQ systems that belong to the ToxIN family, all diverge at the pri ary
sequence level and nu ber of repeats, hile the length of the ono ers is quite conserved. ToxI a,
ToxI , and antiQ sRNAs are composed of, respectively, 36 nucleotides repeated 5.5 times, 34 nucleotides
repeated 2.9 times, and 35 nucleotides repeated 2.8 times (Figure 1). In vitro, the antitoxin activity
can be retained despite increasing or decreasing repeat numbers. However, the range of repeats in
which each antitoxin remains functional varies. For instance, 2.5 repeats from 5.5 were necessary and
sufficient for ToxIPa antitoxin to inhibit its toxin [19] while at least 1.8 repeats from 2.8 were essential for
the antitoxin activity of antiQ [17]. antiQ mutants containing 1.8 and 3.8 repeats were readily obtained
hile clones with only 0.8 of a basic repeat were inviable, suggesting that an incomplete repeat
sequence is insufficient to avoid toxicity of AbiQ [17]. In addition to its TA function, the AbiQ system
also acts as an abortive infection system against some phages (See below, Section 6.1). This activity is
also affected by the number of antiQ repeats however the anti-phage activity of the system is altered
independently of its toxin neutralising activity. For instance, deletion or addition of one repeat to
antiQ decreased the phage resistance provided by the AbiQ system, indicating that the length of the
wild-type antiQ is critical for optimal anti-phage activity. Similarly, mutations in key residues for
antitoxin processing led to significant loss of anti-phage activity while a point mutation that affects
pseudoknot structure increased anti-phage activity, but did not affect bacterial fitness [17].
4. Assembly of the Toxin-Antitoxin Complexes
When the paradigmatic ToxINPa system was first discovered, the activity of the toxin component
was unknown and mining structural databases with the predicted structure of ToxNPa gave no
meaningful results [11]. Insight into its activity was gained later with the resolution of its crystal
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structure and the discovery of the triangular architecture adopted by the three toxin-antitoxin
monomers [12]. Resolution of the quaternary structures of further Type III systems showed that
this interesting feature of Type III TAs exhibits some variations on a theme where toxin and antitoxin
monomers alternate (in hexameric or tetrameric complexes) in which only RNA-protein interactions
occur. A hallmark shared by all the structures is that it is the antitoxin processing that leads to the
inactive, stable TA complex [12–14]. So far, the core architecture of Type III systems seems to be
subfamily specific and likely depends on the length and fold of the antitoxin monomers.
4.1. The ToxIN Systems Form Triangular Heterohexamers
Most of the structural data currently available concerns the ToxIN subfamily. The quaternary
structure of the ToxINPa and ToxINBt systems has been resolved (Figure 2A,B) and bioinformatic
analyses predict that the AbiQ system shares the same quaternary architecture [12,13,20]. These crystal
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Figure 2. Crystal structures of Type III TA systems. (A) ToxINPa (PDB ID: 2XDD) and (B) ToxINBt
(PDB ID: 4ATO) form heterohexameric complexes [12,13]; (C) CptINEr (PDB ID: 4RMO) assembles into
a heterotetrameric complex [14].
Both the ToxINPa and ToxINBt systems assemble into heterohexameric complexes (Figure 2A,B)
that adopt a triangular architecture where toxins occupy the apices and are held together by processed
antitoxin monomers [12,13]. In the complexes, each pseudoknotted ToxI RNA is bound head to
tail to two separate ToxN monomers and occludes their active sites. Since ToxNPa and ToxNBt are
both endoribonucleases, cleavage of cognate tandem RNAs into single repeats and assembly into the
ToxIN complexes is likely associated with the inhibition of toxicity. Experimental data show that,
while ToxNPa is neutralized by both the processed and precursor forms of ToxIPa, the precursor ToxIPa
is the preferred substrate, indicating the involvement of the antitoxin processing in toxin inhibition [13].
Additionally, the pseudocontinuous arrangement of ToxI units in these structures and the 20-30 cyclic
phosphates at the 30 end of the processed antitoxins support this mechanism [12,13]. Finally, ToxINPa
complexes can self-assemble in vitro from ToxNPa combined either with processed or precursor ToxIPa
RNAs indicating that the self-assembly of these structures is largely mediated by the antitoxin RNAs
and does not require any cellular factors or exogenous energy [13].
Both ToxIPa and ToxIBt antitoxin monomers fold into a classic H-type pseudoknot structure
flanked by two single-stranded tails. These ends and the adjacent areas of the pseudoknot interact
with their respective toxins to stabilise the trimeric structure (Figure 2A,B) [12,13]. Analysis of the
crystal structure of ToxINPa showed that each ToxIPa tail interacts with a different ToxNPa monomer
via electropositive grooves where hydrogen bonds occur between the protein and the RNA bases.
The antitoxin 30 end tail containing the 20-30 cyclic phosphate is held in place in this groove by five
side chains, Tyr29, Lys33, Thr52, Ser53, and Lys55, that form the ToxNPa active site [12]. Similarly,
key areas of ToxIBt that interact with ToxNBt are the single stranded tails, where C19 and G20 interact
with Lys148 of the toxin, and the 50 tail of ToxIBt and U10 interact with a hydrophobic pocket of the
ToxNBt interacting with the 30 end [13].
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4.2. CptINEr Assembles into Heterotetramers
In contrast to the ToxIN systems, CptINEr—currently the only other Type III TA system with
a solved crystal structure—assembles into tetramers (Figure 2C). Its quaternary structure is composed
of two toxin monomers joined by two antitoxin RNAs [14]. The CptI monomers are longer than the
corresponding examples in the ToxI repeats and the fold they adopt probably accounts for the difference
in quaternary structures—with the nature of the pseudoknotted RNA perhaps driving the evolution of
the toxin-antitoxin complexes.
4.3. Type III Antitoxins Form Pseudoknots
All the antitoxins crystallised so far adopt a pseudoknotted fold in their TA complexes.
Pseudoknots are a recurrent RNA structural motif in which a loop forms interactions with distal bases
outside the loop to form triple stranded structures. Usually the third nucleotide is an adenine enabling
A-minor interactions [21]. In the quaternary structures of the TA systems, the antitoxin pseudoknots
exhibit three distinct regions that interact with each other through duplex and triplex hydrogen bonds
(Figure 3) [12,13]. An important feature is the core of the pseudoknot which contains three internal
base triplexes. One of these internal base triplexes (triplex 3, GUU) separates the two based-paired
stems of the pseudoknot with interdigitation of a guanine (Figure 3A,B). While key components are
conserved in both ToxI pseudoknots, this curious structural aspect was not predicted due to the
low sequence homology between the antitoxins. Despite overall similar structures, the RNA-protein
interfaces show substantial differences as highlighted by the selective inhibition displayed by both
antitoxins and the absence of functional cross-talk between antitoxins and toxins of the Pectobacterium
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extremely short and only consists of a single base that does not interact with S2 and is instead held 
in place by interactions with the 3′ end of L2 (Figure 3C) [14]. L2 of CptIEr is adenine rich and longer 
than  in  the other  antitoxins  and  forms  a novel  counter‐clockwise A‐minor  twist motif  [14]. This 
conformation  appears  to  be  necessary  for  its  antitoxin  activity,  as  suggested  by  experiments  on 
Figure 3. Pseudoknot arrange ts of Type III antitoxins. (A) ToxIPa; (B) ToxIBt; and (C) CptIEr.
Base-base hydrogen bonds are shown by black lines. Nucleotides involved in loops are indicated in
brown. Corresponding areas for each antitoxin are highlighted by similar colors.
In contrast, CptIEr monomers fold into an H-type pseudoknot distinctly different from the fold of
the antitoxins of the ToxIN family. Firstly, CptIEr has two coaxial stems assembled entirely from duplex
base pairing (Figure 3C) as opposed to the triplex base pairing seen in the other two antitoxins [14].
Even among RNA pseudoknots, the loops of the CptIEr pseudoknots are unusual. Indeed, loop 1
(L1) interacts with stem 2 (S2) while loop 2 (L2) interacts with stem 1 (S1), a configuration that leads
often to triplex base pairing [21]. These canonical pseudoknot interactions are found in the ToxI RNAs
where two triplex b se pairs occur from the interaction of L2 with S1, alth ugh there is no triplex
pairing with L1 and S2 (Figure 3A,B) [12,13]. The CptIEr ps ud knot is more atypical as L1 is extremely
short and only consists of a single base that does not interact with S2 and is instead eld in place by
interactions with the 30 end of L2 (Figure 3C) [14]. L2 of CptIEr is adenine rich and longer than in the
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other antitoxins and forms a novel counter-clockwise A-minor twist motif [14]. This conformation
appears to be necessary for its antitoxin activity, as suggested by experiments on substitution and
deletion mutations that disrupted key features of this twist [14]. As with the ToxI-type antitoxins,
functional cross inhibition experiments have confirmed that CptI antitoxins also show high toxin
specificity [14].
5. Type III Toxins Share a Common Fold and Activity
To date, the structures of four Type III toxins have been solved; three of which belong to members
of the ToxIN family (ToxINPa, ToxINBt and AbiQ) and, more recently, a member of the CptIN family.
All toxins share a globular   core surrounded by ↵-helices and loops. While the core structure is
conserved, most variations are found on the surface. These variations are thought to account for
cleavage and antitoxin specificity of the toxins. All Type III toxins tested so far for their mechanistic
action have been shown to be endoRNases that cleave mRNAs in adenine-rich regions but with
slightly different substrate specificities: ToxNPa AA/AU, ToxNBt A/AAAA, and AbiQ A/AAA [13,20].
As for other toxins that inhibit translation, Type III toxins initially have a bacteriostatic effect on
growth [3,11,20] that ultimately leads to lethality.
5.1. The ToxN Family
ToxNPa and ToxNBt have the same highly twisted core of six anti-parallel  -sheets and five main
variable loop regions (Figure 4A,B) [12,13]. Four of these loops, especially the long kinked helix H3,
act as the major sites of interaction between the toxins and their respective antitoxins while the fifth
encompasses the active site. In line with the structural data, bioinformatics analysis of the sequences
of the other members of the ToxN family showed that the core fold is conserved while most sequence
variability clusters in regions corresponding to these five loops [12]. The structure of AbiQ also
encompasses a core of six-stranded anti-parallel  -sheets surrounded by 6 ↵-helices (Figure 4C) [20].
Surprisingly, the RNase activity of AbiQ was only eliminated by one site-directed mutation in Ser51Leu
which is thought to make the nucleophilic attack during the cleavage [20]. The RNase activity of AbiQ
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5.2. The CptN Family
CptNEr shares the same core fold found in the other toxins despite its lower primary sequence
identity with members of the ToxN family (Figure 4E). In CptNEr, the highly twisted anti-parallel
 -sheets that form the core are surrounded by four ↵-helices that make extensive interactions with
the cognate antitoxin sRNA [14]. Compared to the ToxN family, in which ToxNPa, ToxNBt, and AbiQ
have a kink in helix three [12,13,20] the equivalent helix in CptNEr, helix H4, is much shorter [14].
However many of the hydrogen bonding networks in the RNase active site are also conserved
suggesting that this toxin is also an endoRNase.
5.3. Type III Toxins Share Homology with Type II Toxins
Unexpectedly, the structure of Type III toxins shows significant homology with toxins from the
Type II MazF/Kid/CcdB family (Figure 4). Members of this Type II family share a similar fold despite
low sequence similarity and different mechanisms of action. For instance, Kid and MazF toxins inhibit
translation by acting as endoRNases while CcdB toxins interact with DNA gyrase and affect DNA
replication [23–25]. Type II and Type III toxins share very low sequence similarity, e.g., only 11%
identity between ToxNPa and Kid, but their respective structures encompass a similar   core fold
region surrounded by helices and loops. Interestingly, despite sharing the same overall structure and
the same molecular activity i.e., endoRNases, the active sites of ToxN and Kid do not match well [11,25].
Less surprisingly, differences are also found in the regions that interact with their respective antitoxins.
For instance, the helix 3 region of ToxNPa overlays with the Kid structure but is greatly extended in the
N-terminal section of the ToxNPa, the main site of ToxI recognition. The equivalent helix in CptNEr,
helix H4, is much shorter and, as such, resembles more closely to the Kid toxin (Figure 4A,D,E).
6. Functions of Type III TA System
Two functions have been ascribed to Type III TA systems so far. Historically, the first function was
their abortive infection (Abi) activity that protects bacterial populations from invading bacteriophages.
Their second known function involves their role in stabilisation of plasmids.
6.1. Abortive Infection
Some Type III systems are active protagonists in the “molecular arms race” that occurs between
bacteria and phages. As these outnumber bacteria 10-fold in some environments, the prokaryotic hosts
are potentially subject to constant viral predation [26]. In response to this acute selective pressure on
microbial communities, bacteria have evolved a large array of defense mechanisms to circumvent the
lethal impact of viral infections [27,28].
At least some of these Type III systems are bifunctional and can act as abortive infection (Abi)
systems in addition to their TA functionality. This bifunctionality is possible as both activities require
the involvement of a self-poisoning protein. Abi mechanisms rely on a toxic protein that can be
viewed, from an evolutionary perspective, as inducing the altruistic suicide of infected cells to
prevent phage propagation in bacterial populations. Even though 23 different Abi systems have
been reported, mostly carried on lactococcal plasmids, there is still a paucity of information on the
molecular mechanisms involved in their function, with the exception of TA/Abi systems for which
some insight has been acquired recently [29]. Abi systems have been shown to act at different steps of
the phage replication cycle i.e., from DNA replication to the lysis step—but ultimately they all lead to
the death of the infected bacteria [29]. TA/Abi bifunctionality is not restricted to Type III systems as
TA systems from Type I to IV have been shown to protect bacteria from bacteriophages [8,11,30–32].
While molecular details are still elusive in most cases, a working model is that—following toxin
activation by the infecting phage—dissemination of phage progeny in the bacterial population is
restricted. Toxin activation could rely on the differential stability of the antitoxin and toxin products.
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Post-infection, this characteristic of TA systems could favour a state of free toxins upon the depletion
of the shorter lived antitoxins.
The ToxINPa system of P. atrosepticum was identified originally through its phage resistance
capacity encoded by a cryptic plasmid. Subcloning of different plasmid fragments eventually
narrowed the anti-phage activity down to the ToxIN system genetic module [11]. ToxINPa can
inhibit a spectrum of phages infecting multiple Gram-negative enterobacteria such as P. atrosepticum,
Escherichia coli, and Serratia spp. ([10] and unpublished data). This dual Abi and TA functionality
was shown later to be shared by some other Type III TA systems. The chromosomal tenpIN locus
from Photorhabdus luminescens, effectively aborts environmental coliphages when expressed from
a plasmid in E. coli [11,18,33] and, likewise, AbiQ is effective, in Gram-positive Lactococcus lactis,
against members of the common 936 and c2 phage groups as well as rarer lactococcal phages. When
expressed in E. coli, AbiQ also protects this Gram-negative host from some coliphages [33]. Therefore,
the protective effect against phages appears to be independent of the organism in which the systems
are present [11,18,33]. Phage resistance may be also independent of the original genetic location as
both plasmid and chromosomal systems can effectively inhibit phage replication [11,18]. Similarly,
no correlation between the Type III TA systems families and Abi activity can be drawn currently.
For instance, despite proficient anti-phage activity of the ToxINPa and AbiQ systems, no anti-phage
activity could be shown for the closely related ToxINBt system in its native host [13] and while both
phenotypes have been observed for members of the ToxIN family, no anti-phage activity has yet been
observed for the two tested CptIN systems from Eubacterium rectale and Ruminococcus torque [14,18].
A further aspect of anti-phage activity of Type III systems is the specificity these systems show
against subgroups of sensitive phages [11,18]. No correlation has been found between phage families
(Myoviridae, Siphoviridae, and Podoviridae) and abortive infection [33,34]. It is not known whether
phages that are not aborted by the TA/Abi systems have naturally and actively evolved resistance
mechanisms against these systems in the perpetual arms race that occurs between them and their
bacterial hosts, or whether they “simply” do not activate the toxin of these systems. Some examples
of mechanisms selected by phages to avoid Abi systems in general (as well as TA/Abi systems)
are known in the literature [34]. For instance, point mutations in key phage products have been
identified as the basis of escape mechanisms. More recently it was shown that phage T4 has an ADP
ribosyltransferase that chemically modifies the Type II MazF toxin to downregulate its activity and
thus avoid this TA/Abi system [32]. Another phage escape mechanism includes two examples where
the phages evolved mimics of the toxin’s substrates. In the case of the Type II RnlAB/LsoAB systems
of E. coli and phage T4, the phage uses the Dmd protein which acts like a Type II antitoxin and directly
interacts with the toxins. In contrast to the canonical antitoxins of RnlA and LsoA, Dmd is able to
cross-neutralise several toxins. Recent crystallographic studies showed that Dmd is thought to have a
different inhibition mechanism and directly interacts with the toxin active site by mimicking the toxin
substrates [35].
In the Type III systems, the ToxIN-sensitive phage TE was shown to produce low frequency
spontaneous mutants that escaped the ToxINPa system [36]. Analysis of the escape mutants revealed
that the majority of the mutants had extended a short viral sequence similar to the repeats of the ToxI
sRNA into a ‘pseudo-ToxI’ which functionally suppressed the toxin. In one case, recombination had
allowed the phage escape mutant to obtain natural ToxI repeats from the original plasmid antitoxin
sequences. Both scenarios allowed phage replication unaffected by the Abi/TA system [36].
The precise molecular mechanisms of these bifunctional TA/Abi systems are still under
investigation. In agreement with the current model, the toxin endoRNase activity and the Abi
phenotype have been shown to be linked [19]. However, this may not be a universal situation
because mutagenesis of key toxin residues can lead to the loss of the Abi phenotype despite retained
RNase activity [20] indicating that the details of the toxin activation are more subtle. This leads to
the question as to how Type III TA/Abi systems are actually activated and the molecular basis of the
differential sensitivity of different phages. Phage products that are involved in the activation of Type III
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TA/Abi systems might directly interact with the toxin, the antitoxin, or both, to prevent assembly of the
TA heterocomplexes, or to disrupt them. Alternatively, a phage product might interrupt transcription
of the TA operon or affect antitoxin RNA stability, thus causing imbalance in the TA components.
Both scenarios would lead to an excess of free toxin, which could inhibit mRNA translation, leading to
cell growth arrest and thereby ultimately prevent the release of phage progeny. The nature of the phage
products involved and the way they interact (directly or indirectly) with the TA system is unknown.
Experimental data for the ToxINPa and the AbiQ systems showed that toxin levels are not affected
during phage infections nor is transcription of the TA systems increased [19,20]. However transcripts
of the AbiQ system, expressed constitutively before infection, decrease during the infection, possibly as
part of a general infection phenomenon [20]. Based on experimental data, it is thought that the TA
systems are activated at late steps of phage replication, at least in the AbiQ system. It has been shown
that phage DNA is replicated in infected cells in the presence of the AbiQ system, as indicated by the
accumulation of concatemeric viral DNA [37].
6.2. Plasmid Inheritance through Addiction
Another function known for Type III systems is plasmid addiction. In contrast to the Abi
phenomenon where TA systems protect bacteria from invading DNA, when acting as “addiction”
modules they ensure the stable inheritance of plasmids in bacterial populations.
This feature of TA systems also relies on the antagonism of the self-poisoning essence of the
toxin and the labile nature of the antitoxin [11]. It supposes a continuous synthesis of the antitoxin
in order to keep the toxin in an inhibited state and thus renders the cell ‘addicted’ to the TA
system. Consequently, when present on mobile genetic elements such as plasmids, these “addiction”
modules promote the maintenance of the DNA molecule encoding the TA system and ensure the
continued presence of plasmids in bacterial populations via killing of plasmid-free segregant cells
by the toxins [15,38]. Historically, this mechanism has also been named post-segregational killing
(PSK) as lethality arises when plasmids are not segregated into both daughter cells during cell
division [38]. Alternatively, given the initially bacteriostatic—rather than bactericidal—nature of
Type III toxins [11,20], mis-segregation could lead to a transitory growth inhibition. Bacteria that
retained the plasmid would then be able to outgrow those that “lost” it, thus ensuring plasmid
maintenance at the population level.
Plasmid addiction is a function found in many TA systems of Type I and II and has also been
shown for some Type III TA systems. For example, ToxINPa and CptINEr increased plasmid retention
in E. coli W3110 to 100%, compared to 50% loss of the control vector [13,14]. Notably, the fact that
CptINEr is located on the chromosome of the original host, yet could promote plasmid maintenance
when cloned, suggests that CptINEr can promote its own retention and might be disseminated through
horizontal gene transfer [14].
In addition to the post-segregational killing during the exponential growth phase, one Type III
system has been show to ensure plasmid maintenance in stress conditions leading to sporulation
of Bacillus subtilis. During sporulation, bacteria differentiate into spores, a metabolically dormant
cell-type that can survive adverse environments and switch back to vegetative growth in favorable
conditions. The frequency of plasmid loss during sporulation is higher than in vegetative growth [39]
and the rate of plasmid loss can vary from 5% to 95% in Bacillus [40]. The B. subtilis ToxINBt system
favours plasmid retention in this specific context by decreasing plasmid loss around 10-fold (from 58%
for the control plasmid to 6% when the TA system was present) [39]. This was achieved by reducing
the proportion of cells that form mature spores—probably by the action of the toxin in plasmid-free
forespores. Only forespores that inherited a plasmid copy were able to mature and so this mechanism
ensures plasmid maintenance throughout the environmental stress that precipitated sporulation. It is
formally possible that other types of TA systems might affect plasmid retention by similar routes
during sporulation [39].
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7. New Bioinformatic Analysis Reveals a Significant Increase in Potential Novel Systems
Mining databases for ORFs and subsequent analysis of the proteins encoded by them can be
a powerful tool to gain evolutionary insight into genes encoding TA systems [41,42]. Investigating
the occurrence of Type III systems was initially complicated as bioinformatic analysis of non-coding
RNAs is still problematic. Solving the structure of ToxN made it possible to identify new members
of the Type III TA family by performing de novo structure-based homology searches [18]. A set of
criteria was used to determine which ToxN structural homologues found by FUGUE [43], a program
for sequence-structure comparison, are truly from Type III TA systems. The logic of the definition
was as follows: the ToxN homologues should be preceded by a palindromic repeat acting as
a Rho-independent terminator, which in turn should be preceded by sequences with a similar
organization to toxI—composed of a tandem array of nucleotide repeats. Subsequently, samples from
each family were taken and exhaustive BLASTp searches were performed, yielding a final list of
125 putative type III TA systems. The majority of hits were found on bacterial chromosomes and
plasmids of Firmicutes, Fusobacteria, and Proteobacteria as well as Archaea. One toxIN locus was
also encoded on a prophage [18]. Using these criteria, 37 putative Type III loci were identified
and were divided into three independent families according to their protein sequences as described
previously [18].
Given the near exponential increase of sequenced genomes available in databases during the
last few years, we did a new BLASTp search. Using the amino acid sequences of the characterized
ToxNPa, ToxNBt, AbiQ, TenpNPl, and CptNEr toxins as input, we did an initial BLASTp search against
the Bacteria and Viruses databases of Uniprot. We identified 603 potential Type III toxins with an
E-value <0.001. A selection of these predicted toxins were further analysed following the previously
established criteria. After validation as members of putative Type III TA systems, these toxins were
used for a further round of BLASTp. The new round of BLASTp searches with the selected toxin
homologues gave a few new putative toxins indicating that the search is exhaustive. The different
toxin groups seem to cluster to particular phylogenetic groups. For instance, the ToxN family is
primarily found in Firmicutes, Fusobacteria and occasionally other species. Systems from this group
also seem associated with the mobilome as they can be found on plasmid and chromosomal locations,
sometimes in the close vicinity of transposase elements. Despite the increased number of predicted
systems, Type III TA systems appear largely restricted to a limited group of phyla as only 8 out of
the currently estimated 74–76 bacterial phyla have at least one potential system [44]. Whether Type
III TA systems are indeed only confined to a restricted number of bacteria, or whether the current
distribution pattern is biased by the limited phylogenetic breadth of genome sequencing, is unknown.
It is intriguing that Type III TA systems seem to be confined to a few phylogenetic groups. As the
toxin mode of action, i.e., cleaving RNAs, is a general one that does not require any known external
factors, and given that they are found on plasmids, one might expect them to be spread through more
phylogenetic groups, in a similar way to the Type II systems where the majority of toxins are also
RNases [41,42,45].
Advances in technologies such as single-cell genomics and metagenomics will enable the
sequencing of uncultivated organisms from diverse habitats [44,46] and might affect the picture
of TA system distribution as the current “tree of life” expands and culturing-associated biases are
overcome [43,47]. When placing the consensus antitoxin repeats next to a phylogenetic tree based on
the protein toxin sequences, it becomes clear that the antitoxins of closely related toxins are conserved
as well (Figure 5). This consistency provided evidence for the notion of co-evolution of toxin and
antitoxin components. The length and the primary sequence of the consensus repeats are usually quite
conserved within the different toxin groups. On the other hand, the number of repeats is prone to
slight variations.
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Figure 5. Phylogenetic tree based on representative toxins of putative Type III TA systems associated
with the consensus repeats of the antitoxins: adenine (grey), guanine (white), cytosine (yellow),
and uracil (orange). Toxin protein sequences were aligned using MUSCLE [48]. The tree has been
constructed using PhyML and nearest neighbour interchange [49,50] and the figure has been made
using Ete3 [51].
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8. Conclusions
Work in recent years has increased our understanding of bacterial Type III TA systems. However,
it is abundantly clear that our understanding of the molecular mechanisms involved in Type III systems
and their activation is still rudimentary. These TA systems provide valuable reagents for fundamental
biochemical studies on protein:RNA interactions and the study of quaternary nucleoprotein complex
assemblies. The ecological and fitness implications of bacterial carriage of Type III TA systems
have yet to be investigated. Furthermore, the role of Type III systems in the evolution, replication,
and physiology of both bacteria and their viral parasites warrants deeper consideration.
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Evolution of Pectobacterium
Bacteriophage !M1 To Escape Two
Bifunctional Type III Toxin-Antitoxin and
Abortive Infection Systems through
Mutations in a Single Viral Gene
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ABSTRACT Some bacteria, when infected by their viral parasites (bacteriophages),
undergo a suicidal response that also terminates productive viral replication (abor-
tive infection [Abi]). This response can be viewed as an altruistic act protecting the
uninfected bacterial clonal population. Abortive infection can occur through the ac-
tion of type III protein-RNA toxin-antitoxin (TA) systems, such as ToxINPa from the
phytopathogen Pectobacterium atrosepticum. Rare spontaneous mutants evolved in
the generalized transducing phage !M1, which escaped ToxINPa-mediated abortive
infection in P. atrosepticum. !M1 is a member of the Podoviridae and a member of
the “KMV-like” viruses, a subset of the T7 supergroup. Genomic sequencing of !M1
escape mutants revealed single-base changes which clustered in a single open read-
ing frame. The “escape” gene product, M1-23, was highly toxic to the host bacte-
rium when overexpressed, but mutations in M1-23 that enabled an escape pheno-
type caused M1-23 to be less toxic. M1-23 is encoded within the DNA metabolism
modular section of the phage genome, and when it was overexpressed, it copurified
with the host nucleotide excision repair protein UvrA. While the M1-23 protein inter-
acted with UvrA in coimmunoprecipitation assays, a UvrA mutant strain still aborted
!M1, suggesting that the interaction is not critical for the type III TA Abi activity.
Additionally, !M1 escaped a heterologous type III TA system (TenpINPl) from Photo-
rhabdus luminescens (reconstituted in P. atrosepticum) through mutations in the
same protein, M1-23. The mechanistic action of M1-23 is currently unknown, but fur-
ther analysis of this protein may provide insights into the mode of activation of
both systems.
IMPORTANCE Bacteriophages, the viral predators of bacteria, are the most abun-
dant biological entities and are important factors in driving bacterial evolution. In
order to survive infection by these viruses, bacteria have evolved numerous an-
tiphage mechanisms. Many of the studies involved in understanding these interac-
tions have led to the discovery of biotechnological and gene-editing tools, most no-
tably restriction enzymes and more recently the clustered regularly interspaced short
palindromic repeats (CRISPR)-Cas systems. Abortive infection is another such an-
tiphage mechanism that warrants further investigation. It is unique in that activation
of the system leads to the premature death of the infected cells. As bacteria in-
fected with the virus are destined to die, undergoing precocious suicide prevents
the release of progeny phage and protects the rest of the bacterial population. This
altruistic suicide can be caused by type III toxin-antitoxin systems, and understand-
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ing the activation mechanisms involved will provide deeper insight into the abortive
infection process.
KEYWORDS type III toxin-antitoxin, !M1, Pectobacterium atrosepticum, abortive
infection, bacteriophage-bacterium interaction
It is estimated that there are more than 1030 bacteriophages (phages) on Earth,outnumbering their bacterial hosts 10-fold (1, 2). These large viral numbers generate
an estimated 1025 infections per second, imposing a large evolutionary selection
pressure on bacteria (2). In response, bacteria have evolved a plethora of defensive
mechanisms to counter these overwhelming phage insults (3). Consequently, phages
are continually evolving counterdefenses, and thus both the host and parasite are
locked together in a perpetual molecular arms race (4). Bacterial antiphage mechanisms
that have been observed include adsorption prevention, restriction-modification sys-
tems, superinfection systems, abortive infection (Abi) systems, and the clustered reg-
ularly interspaced short palindromic repeats (CRISPR)-Cas systems (3). Studies of these
phage-host interactions have been translated into significant molecular technologies
and reagents, most notably the use of restriction enzymes in cloning (5) and, more
recently, the CRISPR-Cas systems, the use of which is currently revolutionizing eukary-
otic molecular biology (6).
One of the more curious antiphage mechanisms is Abi, in which, postinfection, the
host bacterium is driven toward precocious cell death. This simultaneously terminates
viral replication and prevents a productive phage burst. Thus, the Abi response in
infected cells protects the bacterial population from progeny phage infection in a
process akin to an altruistic suicide (3). The majority of Abi systems have been studied
in Lactococcus lactis (7), an important bacterium in the dairy industry (8). Phage
contamination in fermentation cultures can cause substantial economic losses. Conse-
quently, considerable research has been conducted to identify and define many
antiphage systems useful for control of bacteriophages in lactococcal fermentations (7).
However, there are also well-studied Abi systems in other bacteria, such as Escherichia
coli, namely, the Rex, Lit, and PrrC systems (9–11). A commonly recurring theme of Abi
systems is that they involve the activation of a toxic protein that is suppressed under
normal growth conditions. However, environmental insults, phages, or other physio-
logical stresses can activate the toxin. Once activated, the toxin interferes with an
essential cellular process and induces bacteriostasis, ultimately leading to cell death.
This is a common feature shared by toxin-antitoxin (TA) systems (12).
TA systems were originally discovered on plasmids, where they function as plasmid
maintenance systems through postsegregational killing mechanisms (13). They have
been found in the majority of bacteria, both on plasmids (13) and chromosomally (14),
as well as in archaea (15) and phages (16). TA systems are typically bicistronic,
comprising a bacteriostatic or bactericidal toxic protein that is neutralized either
directly or indirectly by an antitoxin counterpart. To date, there are six TA system types
which are characterized by the nature and mode of action of their antitoxins (17). In the
case of type III TA systems, an RNA antitoxin directly interacts with the toxic protein to
form a nontoxic complex (18).
At least four types of TA systems confer phage resistance. These are the hok/sok
systems of type I (19), mazEF, rnlAB, and lsoAB of type II (20, 21), ToxINPa, TenpINPl, and
AbiQ of type III (22–24), AbiE of type IV (25), and sanaTA (which is currently not
characterized but likely to be a type II, having a proteinaceous antitoxin) (26). ToxINPa
was the first type III system to be identified and originated from Pectobacterium
atrosepticum plasmid pECA1039. The toxin ToxNPa is encoded by toxN, and the anti-
toxin ToxIPa is encoded by toxI, a 36-nucleotide sequence repeated five and a half times
(22). The ToxINPa system provides protection against multiple phages infecting not only
its cognate host, P. atrosepticum, but also other enteric bacteria, including E. coli DH5!
and Serratia marcescens Db11 (22). One such aborted pectobacterial phage is the
Myoviridae phage !TE. !TE phages that were no longer sensitive to ToxINPa had
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evolved to encode an RNA antitoxic mimic of ToxIPa, which was able to neutralize
ToxNPa (27). However, it did not shed light on how ToxINPa was activated during phage
infection. In fact, very little is known about the activation of any type III toxin-antitoxin
systems. The other type III system that has been studied for Abi is AbiQ from Lacto-
coccus lactis, which shows structural homology with ToxNPa (24). Three lactococcal
siphophages that were aborted by AbiQ have been examined in detail. However, all
had mutations in genes of unknown functions; orf38, m1, and e19 of phages P008,
bIL170, and c2, respectively (28). The AbiQ system was also reconstructed in a heter-
ologous host, E. coli MG1655, and was shown to confer resistance to a range of
coliphages, including T4 and T5. However, escape mutants could be obtained only for
a single phage (phage 2). Escape mutants of this phage showed mutations in orf210, a
predicted DNA polymerase (28). Studies of the AbiQ system suggests that there may be
multiple potential routes of escape involving several genes from different phages in the
activation of a single Abi system.
Previously it was shown that the pectobacterial phage !M1 was aborted by the
ToxINPa system and was able to escape by evolving rare mutants (29). !M1 was isolated
in 1995 during a search for new transducing phages effective as genetic tools in P.
atrosepticum (30). Here we characterize !M1 and its escape mutants in depth. All !M1
escape phages evolved through mutations in a gene encoding a small, highly toxic
protein, M1-23. When the related TenpINPl system of Photorhabdus luminescens was
transferred to P. atrosepticum, the system was able to abort !M1 in the heterologous
host. Furthermore, it was possible to select spontaneous viral mutants that escaped
both ToxINPa and TenpINPl through mutations in M1-23.
RESULTS
!M1 is a “KMV-like” virus. !M1 is a generalized transducing phage of Pectobac-
terium atrosepticum (previously Erwinia carotovora subsp. atroseptica) (30). This podo-
virus is aborted by the type III TA system, ToxIN, from P. atrosepticum, namely, ToxINPa
(22). !M1 generates spontaneous escape mutants that are resistant to Abi by ToxINPa
at a rate of "10#5 (29). In order to improve our understanding of ToxINPa-phage
interactions, we sequenced !M1 wild type (wt) and three previously isolated escape
phages, !M1-A, -B, and -D (29).
Using BLAST searches (31), !M1 was classified as a member of the “KMV-like”
subgroup of the T7 supergroup of phages (32). T7-like phage linear genomes are
typically flanked by direct terminal repeats (DTRs) (33). However, the DTRs could not be
defined by a primer walking strategy along the !M1 genome, consistent with results
from another KMV-like phage, LIMEzero (34). The presence and approximate size of the
DTRs, 293 bp, were therefore confirmed through restriction digest analysis of the !M1
genome (see Fig. S2 in the supplemental material). The final !M1 wild-type genome
was 43,827 bp long with a GC content of 49.30%. In comparison, the host P. atrosep-
ticum genome has a GC content of 50.97% (35). The two genomes therefore closely
match each other in GC content.
Global nucleotide alignments were performed to assess the relationship between
the KMV-like phages and !M1. Compared with !M1, phage VP93 (43,931 bp) (36),
phage LKA1 (41,593 bp) (32), phage LKD16 (43,200 bp) (32), and !KMV itself (42,519 bp)
(33) shared between 48.2% and 49.2% sequence identity. These values match well
those of other KMV-like phages (34).
!M1 contains 52 putative genes, named phiM1-1 to phiM1-52. The gene products
were named M1-1 to M1-52, and they are encoded by 92.6% of the genome. Subse-
quent BLASTp searches identified homologues for 32 of the open reading frames (ORFs)
from other KMV-like phages (Table S1). In most cases, it was therefore possible to assign
putative functions and categorize ORFs as containing either metabolism, structural, or
host lysis genes (Fig. 1A). !M1 also encodes a single tRNAIle, between phiM1-38 and
phiM1-39.
!M1 escape mutations had specific base substitutions. The genome sequences
of the three escape phages, M1-A, -B, and -D, were compared with that of the wt. All
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three escape phages had single point mutations localized to a 124-bp stretch (Fig. 1B),
across phiM1-22 and phiM1-23, which we refer to as the “escape locus.” To ascertain
whether these point substitutions were individual changes, further escape phages were
isolated using independent lysates to avoid the possibility of sibling mutants. The new
escape phage mutants were isolated following selection on P. atrosepticum pTA46
(ToxINPa) (22, 29). The escape locus of each phage was sequenced following amplifi-
cation of the region from the purified genomic DNA. We observed that all 10 escape
phages had unique mutations distributed across 246 bp of the escape locus (Fig. 1B).
Nine of these mutations were base substitutions, while one was a single base deletion
(Table 1).
Infection with !M1 affects the ToxIPa/ToxNPa ratio. Though it has been shown
that ToxNPa levels do not alter during a !M1 phage infection (29), it was not known
how the ToxIPa levels were affected. The identification of the escape phages provided
an opportunity to address this question. To investigate alterations to the ToxIPa/ToxNPa
ratio, we monitored the levels of ToxIPa and ToxNPa-FLAG during the infections by !M1
and the escape phage !M1-O within P. atrosepticum carrying a ToxINPa-FLAG plasmid
(pMJ4). Total protein and RNA samples were taken at different times after infection and
subjected to Western blotting and an S1 nuclease assay, respectively. While ToxNPa
levels stayed constant throughout infection (Fig. 2A, lower panel), ToxIPa levels dropped
dramatically after 30 min compared to those of an uninfected control (Fig. 2A).
Interestingly, ToxIPa levels increased back to original levels at 60 min. In comparison to
the infection with !M1 wt, ToxIPa levels did not change significantly at 30 min during
FIG 1 Genomic map of !M1 wild type and its escape locus. (A) All 52 annotated ORFs are coded on the forward reading strand, in a linear
progression from metabolic genes to structural genes and, finally, to host cell lysis genes. Each forward reading frame is labeled F1, F2, or F3. ORFs
are shown to scale as shaded boxes numbered with the gene number, colored according to the predicted role. The single tRNAIle gene is
positioned on the scale, shown in purple. Where it was possible to identify a protein by homology searches, that ORF is labeled. The scale is in
base pairs. The figure was drawn to scale using Adobe Illustrator. (B) Schematic of the escape locus of !M1. All escape phage mutations are within
phiM1-23. Each forward reading frame is labeled F1, F2, or F3. Each ORF is shown to scale as a box, numbered with the gene number. Each stop
codon is represented as a green vertical line. The positions of the !M1 escape phage mutations are shown by red vertical lines, labeled with the
parent phage. The scale is in base pairs.
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infection with the escape phage !M1-O (Fig. 2B). The ToxIPa level did decrease with the
!M1-O infection but only at 40 min (Fig. 2B). The ToxIPa levels were not then restored,
as in the case of !M1 wt (Fig. 2B). !M1 appears to activate ToxNPa, and thereby initiate
Abi, by causing a decrease in the cellular ToxIPa levels, either through direct or indirect
means. In the case of !M1-O, this activation is prevented due to the mutation in M1-23.
This would allow the phage to propagate, which may then account for the delayed
decrease and lack of restoration in ToxIPa levels.
Identification and characterization of the !M1 escape product. The majority of
escape mutations occurred within phiM1-23. On first analysis, two mutations, those
from !M1-B and !M1-X, occurred at the 3= end of phiM1-22. Another mutation, from
!M1-C, mapped further upstream, again within phiM1-22. This gene, phiM1-22, en-
codes a homologue of a putative DNA exonuclease from phage LKA1 (Table S1) (32).
Unfortunately, there were no database hits for phiM1-23 and phiM1-24, using either the
nucleotide or encoded protein sequences.
Specific regions of this escape locus were amplified from !M1 phages and then
cloned into pBAD30 (37) to make inducible constructs (Fig. 3A and B). The cloning
began with constructs 1 to 6, using DNA from !M1 wt and !M1-B (Fig. 3B).
Constructs 1 and 2 could not be obtained with !M1 wt DNA, presumably through
toxicity of the resulting wt constructs in E. coli DH5!, but could be made using





relative to !M1 wta
Effect on forward reading frameb:
F1 F2 F3
!M1-A March 2007 15416, A to C Y to S T to P No change
!M1-B March 2007 15292, C to T R to stop No change P to L
!M1-C March 2007 15170, T to C M to T Stop to S No change
!M1-D March 2007 15410, T to C M to T W to R No change
!M1-O June 2009 15407, A to C Q to P No change No change
!M1-V May 2009 15415, T to G Y to D No change V to G
!M1-W May 2009 15398, A to T D to V M to L Stop to C
!M1-X May 2009 15288, AA to A FS to stop after 9 aa
(wild-type F1 continues
phiM1-23)
FS causing Q to H and stop after
3 aa (wild-type F2 stops after
9 aa)
FS causing N to T and shift of
ORF1 into ORF2 (wild-type
F3 stops after 3 aa)
!M1-Y May 2009 15397, G to A
!M1-Z May 2009 15416, A to G (cf. !M1-A)
aMutations are indicated as, e.g., Y to S.
bFS, frameshift; aa, amino acid.
FIG 2 ToxIPa levels are affected during phage infection. (A) S1 nuclease assay targeting the full 5.5-repeat ToxIPa
sequence was used to monitor ToxIPa levels during !M1 infection. Assays were performed on 10 "g total RNA
prepared from P. atrosepticum ToxINPa (pMJ4) at different times following !M1 infection. Numbers indicate the
time (minutes) after infection with phage ("!M1) and the negative control without phage (#!M1). Hybridization
to total RNA from P. atrosepticum expressing ToxINPa (pTA46) and DH5! served as positive and negative controls,
respectively. The expression of ToxNPa at the respective time points of infection is shown in the lower panel using
Western blotting; “C” indicates the 11-kDa SdhE-FLAG protein used as a loading and size control (54). (B) S1
nuclease assay targeting ToxIPa for the infection with the escape phage !M1-O. The assay was done as described
for panel A.
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!M1-B escape phage DNA. Constructs 3, 4, 5, and 6 could be made using both
sources of DNA. Due to the regions covered by these constructs, we could deter-
mine that within this locus, the genes of interest were phiM1-22 and phiM1-23 and
that phiM1-24 did not contribute to toxicity. As pBAD30 is tightly repressed by
FIG 3 Toxicity of the !M1 escape locus products. (A) The escape locus of !M1 as described in the legend
to Fig. 1B. The positions of the !M1 escape phage mutations are shown by red vertical lines, labeled with
the parent phage. The scale is in base pairs. (B) Specific regions of the phage genomes, designated by
the length of the line that corresponds to the genomic locus shown in panel A, were cloned into pBAD30
to make nine different constructs. Blue dashed lines in panel A reflect the construct boundaries in panel
B. The figure is drawn to scale. (C) Expression of !M1 wt and !M1-B escape loci in P. atrosepticum. Strains
of P. atrosepticum containing either a ToxINPa or ToxINPa-FS plasmid (pTRB125 or pTRB126), together with
a phage construct (or pBAD30 vector control), were tested for toxicity. (D) A range of construct 7
plasmids was tested for toxicity in P. atrosepticum. The escape phage constructs were all reduced for
toxicity. Error bars show the standard deviations for triplicate data.
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glucose in E. coli DH5!, this also implied that toxicity from this region of DNA might
be occurring via an internal promoter.
Upon first analysis, the putative ATG start of phiM1-23 was at bp 15304. Taking into
account the stop codons of each frame (Fig. 1B, green vertical lines), the putative ATG
start codon of phiM1-23 could theoretically have been upstream of this initial annota-
tion. There were three possible ATG sites upstream of the putative start codon for
phiM1-23. The mutation of !M1-C specifically altered the middle of these start codons
from M to T (Table 1). This start codon also had a ribosome binding site closer to
consensus than those of the other potential start codons, making it the most obvious
candidate. If this were the case, the escape mutations would span phiM1-23 specifically.
Constructs 7 to 9 were designed and made in order to test whether phiM1-23 alone
could generate a toxic phenotype.
We performed experiments to assess the toxicity of the escape locus constructs and
to determine whether toxicity was related to the presence of ToxINPa. P. atrosepticum
was transformed with inducible derivatives of the escape locus in combination with
either pBluescript-based (Fermentas) ToxINPa or negative-control ToxINPa-frameshift
(FS) vectors (pTRB125 and pTRB126, respectively). Serial dilutions of these dual-vector
strains of P. atrosepticum were then incubated with and without induction, overnight,
to determine the viable count (Fig. 3C). This clearly showed that the product of
construct 7, covering phiM1-23 specifically, was toxic. There was no toxicity in the case
of !M1-B, the mutation in which causes a premature stop codon in phiM1-23. Toxicity
was also independent of the presence of ToxINPa. These results strongly suggested that
phiM1-23 produces a small, toxic protein, responsible either directly or indirectly for
activation of Abi against !M1.
New versions of construct 7 (Fig. 3D) were then generated, with the addition of a
C-terminal FLAG tag to the M1-23 product, using both !M1 wt and escape sequences.
Various constructs were then tested for toxicity in the cognate host, P. atrosepticum
(Fig. 3D). All the escape constructs tested showed reduced toxicity (Fig. 3D). It was
therefore possible to attempt overexpression and purification of M1-23, using an E. coli
expression strain, ER2566. After expression trials using constructs made from !M1 wt
and !M1-O, -W, and -Y phage DNA, the M1-O-23FLAG product was chosen for further
study. Sufficient M1-O-23FLAG protein was purified to allow mass spectrometry to
confirm both the identity of the protein and, specifically, the presence of the expected
Q-to-P mutation. Furthermore, the protein sample was subjected to N-terminal se-
quencing, generating a sequence of TKM. This implied that phiM1-23 started at the ATG
specifically mutated by !M1-C, as described earlier, and that the initial methionine is
cleaved posttranslationally. The annotation of the !M1 wt genome was then altered to
accommodate phiM1-23 beginning at this confirmed start codon. In summary, this
result shows that all the escape mutations map to a single gene, phiM1-23, which
generates a 9.8-kDa protein. These mutations reduce the toxicity of the protein product
and allow viral escape from ToxINPa-induced Abi.
It had not been possible to clone constructs 1 and 2 (Fig. 3B) using the !M1 wt
sequence, despite the pBAD30 vector system being repressed in the presence of
glucose. This suggested that a promoter internal to those cloned regions might be
inducing the transcription of phiM1-23. A range of pRW50-based (38) lacZ transcrip-
tional fusion constructs was generated to investigate the possible presence of a
promoter (Fig. S3A). In this case, it was possible to clone the equivalent of construct 2
using !M1 wt DNA (Fig. 3B), perhaps due to pRW50 having a low copy number, so the
level of toxicity was sufficiently low. Plasmid pTA104 (22), containing the promoter for
ToxINPa, was used as a positive control. All the test constructs except pTRB162, which
was an extremely truncated clone, generated LacZ activity (Fig. S3B). This confirmed the
presence of a weak phiM1-23 promoter within phiM1-22.
Extensive analysis of !M1 escape mutants map all mutations to phiM1-23. The
initial 10 escape mutants of !M1 all had unique mutations in M1-23, so it was likely that
there were other possible mutations not yet observed. Identifying these other mutations
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could reveal important residues involved in the functionality of M1-23. Consequently, a
larger library of escape mutants was isolated and characterized in the same way as the
initial escape mutants. A total of 51 new, independent escape phages were isolated, and
their phiM1-23 sequences were characterized. All escape phages were shown to have
a mutation in this region, and several new unique escape phages were isolated (Table
S2). With the addition of these new escape phages, the number of different mutations
increased to 20. Interestingly, mutations in all three of the bases of the putative start
codon were isolated, consistent with this being the correctly annotated start site. Other
interesting mutations were those causing N-terminally located truncations of M1-23. In
particular, !M1-E11 produced only a hypothetical dipeptide or indeed just a single
amino acid if the initial starting methionine was removed. Although most mutations in
M1-23 were missense alleles generating single amino acid residue changes, the ability
to isolate derivatives with major truncations showed that the M1-23 protein must be
nonessential for a productive !M1 lytic cycle. Other notable mutations were !M1-E48
and !M1-E49 (both generating the same outcome), which modify the stop codon and
lead to a 10-amino-acid C-terminal extension. It is puzzling why the 10-mer extension
might impact function, because the addition of the octameric FLAG tag to the C
terminus of M1-23 did not disrupt protein toxicity. Perhaps the extension might harbor
a sequence that could act as an autoinhibitor or disrupt protein structure.
M1-23 interacts with UvrA, but abortive infection can still take place in UvrA-
deficient P. atrosepticum. To assess whether there is a direct interaction of M1-23 with
the ToxINPa complex, His-tagged forms of both M1-23 and M1-O-23 were cloned,
allowing overexpression and purification of these proteins. Coimmunoprecipitation
reactions were carried out, but the results showed no evidence for interactions be-
tween M1-23 and the ToxINPa complex and no impact of M1-23 on the ToxI RNA (data
not shown).
During the process of purifying M1-23-6His, it was noted that an additional high-
molecular-weight band that was not present in control samples appeared in the eluted
sample, and it was then copurified with M1-23 following ion-exchange fast perfor-
mance liquid chromatography (FPLC; data not shown). Mass spectrometric analysis
identified the host nucleotide excision repair protein, UvrA. Reciprocal coimmunopre-
cipitation assays were performed using purified protein samples to confirm this inter-
action (Fig. 4). M1-23 protein retained UvrA, while M1-O-23 did not, and similarly, only
M1-23 was retained by immobilized UvrA (Fig. 4). This strongly suggests that M1-23 is
a viral product that is able to bind host UvrA.
To assess potential effects of UvrA on abortive infection, a uvrA mutant was
constructed in P. atrosepticum and confirmed by sequencing and then by hypersensi-
FIG 4 Coimmunoprecipitation of M1-23, M1-O-23, and UvrA. (A and B) Coimmunoprecipitation experi-
ments with wild-type M1-23 and UvrA. (A) M1-23-6His was used as the bait and attached to a Ni" column
with UvrA-FLAG passed through. (B) The reciprocal experiment was performed with UvrA-6His used as
the bait with M1-23-FLAG passed through. (C and D) The same coimmunoprecipitation experiments as
described for panels A and B but using M1-O-23 instead of M1-23. (C) M1-O-23 was used as bait; (D)
UvrA-6His was used as bait.
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tivity to UV light (Fig. S1). This strain was tested for its ability to abort !M1 via the
ToxINPa system. Surprisingly, !M1 was still aborted in the uvrA mutant and to the same
extent as in the wild-type P. atrosepticum strain (efficiency of plating [EOP] of !M1 on
the uvrA mutant with ToxINPa, 1.1 " 10#5). Escape phages of !M1 were isolated from
the uvrA mutant, and their DNA was sequenced. Interestingly, all escape phages
isolated on the uvrA mutant, !M1-U1, -U2, and !M1-U4 to !M1-U10 (which were
independently isolated), carried mutations in the M1-23 sequence (Table S2). The
results suggest that although M1-23 clearly has a specific interaction with UvrA, it
appears that the escape route is either subtle or occurs indirectly.
The !M1 escape mechanism works in another type III TA and Abi system. Two
further families of type III TA systems were recently identified, CptIN and TenpIN (23).
TenpINPl, from the chromosome of Photorhabdus luminescens TT01, was able to act as
an Abi system against coliphages when cloned on a multicopy plasmid and tested in
an E. coli background (23). By transforming P. atrosepticum SCRI1043 with the TenpINPl
expression plasmid, pFR2 (23), we were able to test three Pectobacterium phages
against the Abi activity of TenpINPl (Table 2). While !S61 (29) and !TE (27) were
dramatically affected by ToxINPa, neither were inhibited by TenpINPl (Table 2). This
indicates a degree of selectivity between the two Abi systems. !M1, however, was
aborted by both systems, though to different degrees, which also underlines the
selectivity under which ToxINPa and TenpINPl appear to operate. As with ToxINPa, it was
possible to select for phages of !M1 that escaped Abi by TenpINPl. One of these escape
phages, !M1-PL2, was isolated and sequenced. This escape phage had a single base
substitution, T15410C, the same mutation as in !M1-D. To test this in reverse, escape
phage !M1-O, selected with ToxINPa, was tested against TenpINPl (Table 2). !M1-O was
also resistant to TenpINPl. These results imply that in the case of !M1, the two systems
operate in a similar fashion with a single protein, M1-23, being a key mediator.
DISCUSSION
The pectobacterial phage !M1 was shown previously to be sensitive to the ToxINPa
system and capable of producing spontaneous escape mutants (29). Here we found
that the !M1 phage is also sensitive to TenpINPl when reconstructed in P. atrosepticum
and is correspondingly able to evolve escape mutants. This is the first time we have
been able to identify a phage that is able to escape the TenpINPl system, and so further
study may provide information about its activation. Interestingly, the !M1 phage is
insensitive to two other type III systems tested, ToxINBt from Bacillus thuringiensis and
the CptINEr system from Eubacterium rectale (data not shown), and no Abi activity
has so far been observed in these two systems (23, 39). In contrast, the P.
atrosepticum phage !TE is aborted by ToxINPa and able to escape the system by
RNA-based molecular mimicry of the antitoxin (27) but is not aborted by the
TenpINPl system (Table 2).
Characterization of the !M1 phage in this study has shown that all escape mutants
selected on ToxINPa or TenpINPl have mutations in a gene encoding M1-23. Alteration
of single amino acids, extreme truncations due to very 5= stop codons, or even stop
codon mutations leading to short C-terminal extensions of M1-23 cause insensitivity to
both ToxINPa and TenpINPl. Escape mutants selected on one system are also insensitive
to the other system, suggesting that there is a common pathway for the !M1 phage
in the activation of these two systems. The role of M1-23 is unknown, but it was shown
TABLE 2 EOPs against ToxINPa and TenpINPl type III TA systems
Phage EOP vs ToxINPa EOP vs TenpINPl
System on which escape
was selected
!M1 wt 1.3 " 10#5 1.1 " 10#2
!S61 $3.2 " 10#9 0.9
!TE 1.0 " 10#8 0.7
!M1-O 1.0 1.0 ToxINPa
!M1-PL2 0.9 0.9 TenpINPl
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to be nonessential, and as it is located between a predicted exonuclease gene,
phiM1-22, and a predicted endonuclease gene, phiM1-25, it might have a role in the
regulation of nucleases or indeed may be able to act as a nuclease itself. In a previous
study, it was shown that ToxNPa levels do not change during infection of the !M1
phage (29). In this study, we found that the ToxIPa levels decrease 30 min postinfection.
In contrast, during the infection by the !M1 escape phage !M1-O, ToxIPa levels
decreased only slightly after 40 min and were not restored. It appears that wild-type
!M1 activates ToxNPa by decreasing the levels of ToxIPa and therefore initiating Abi. For
!M1-O, the mutation in M1-23 prevents this early activation and thereby provides a
window of opportunity for the phage to replicate.
To investigate the mechanism of M1-23 action, a large number of !M1 escape
phages were isolated and their phiM1-23 regions were sequenced. The results showed
a number of escape mutations near the 5= end of the gene, resulting in extremely
truncated versions of the protein. This confirms that M1-23 is a nonessential viral
protein. However, the majority of mutations found were toward the 3= region of the
gene and were mostly missense mutations resulting in single amino acid changes,
implying that the C-terminal domain of the protein is important for Abi functionality.
To further characterize M1-23, it was overexpressed and purified, but due to high
toxicity, only a small amount of protein could be produced. Using the limited amount
of protein available, interaction studies were performed to see if M1-23 interacted with
ToxINPa. During purification of M1-23, a high-molecular-weight protein always copuri-
fied. Mass spectrometry of this protein confirmed that it was the DNA repair protein
UvrA. It was shown through coimmunoprecipitation experiments that while M1-23
could interact with UvrA, the escape version of the protein M1-O-23 could not.
UvrA forms part of the SOS response in bacteria, a DNA damage response pathway
(40) that has previously been shown to be involved in TA activation. The type I TA
system TisB-IstR is under direct SOS response control, as tisAB, which encodes the TisB
toxin, contains a LexA operator region that is inhibited by LexA (41). In addition to the
SOS response, the stringent response has also been shown to play a role in the
activation of TA systems. Both type I and type II TA systems have been shown to be
regulated by (p)ppGpp, the central regulator of the stringent response (42, 43). How-
ever, !M1 and !TE were tested in a (p)ppGpp-negative double mutant (relA spoT) and
were still aborted in that background (data not shown).
During the course of this study, the genomes of two new pectobacterial phages
were sequenced. These were P. atrosepticum phage Peat1 (44) (GenBank accession
number KR604693) and P. carotovorum phage PPWS1 (45) (DDBJ accession number
LC063634). Both of these were podoviruses that shared high sequence identity to !M1.
Peat1 (45,633 bp) shared 77.7% sequence identity, and PPWS1 (44,539 bp) shared
59.7% sequence identity. Furthermore, analysis of the two genomes revealed that both
phages encoded M1-23 homologs, with the Peat1 homolog differing by only a single
amino acid. Therefore, it is highly likely that both phages would be aborted by both the
ToxINPa and TenpINPl systems and evolve escapes in the same way. If this was the case,
it would show a common route through which phages of different bacteria are able to
escape the same system.
Both ToxINPa and TenpINPl are very powerful antiphage abortive infection systems
that belong to two different families of type III TA systems and are effective against a
wide variety of phages. While many phages show differing sensitivities to the two
systems, this study has shown that in !M1, there is a common pathway through which
these two families of type III TA systems can be activated. This pathway involves a small
toxic protein, M1-23, of unknown metabolic function that does not directly interact
with the ToxINPa complex but that interacts directly with UvrA. !M1 infection causes
a diminution in ToxIPa levels, presumably leading to the destabilization of the ToxINPa
complex and consequent liberation of ToxNPa to induce cell death and concomitant
abortive infection of the viral parasite.
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Bacterial strains, bacteriophages, and growth conditions. Bacterial strains and bacteriophages are
listed in Table 3. E. coli strains were grown at 37°C, and Pectobacterium atrosepticum SCRI1043 (35) was
grown either at 25°C on agar plates or at 25, 28, or 30°C as required for liquid culture in Luria broth (LB)
at 250 rpm or on LB agar (LBA). LBA contained 1.5% (wt/vol) or 0.35% (wt/vol) agar, to make LBA plates
or top-LBA, respectively. Bacterial growth was measured using a spectrophotometer set to 600 nm. When
required, media were supplemented with ampicillin (Ap) at 100 !g ml!1, chloramphenicol (Cm) at 50 !g
ml!1, kanamycin (Km) at 50 !g ml!1, tetracycline (Tc) at 10 !g ml!1, isopropyl "-D-thiogalactopyranoside
(IPTG) at 0.5 mM, or 2, 6-diaminopimelic acid (DAPA) at 300 !M. Spontaneous escape phage mutants
were isolated as described previously (27). Phage lysates were made as described previously (46). Phages
were stored at 4°C in phage buffer, i.e., 10 mM Tris-HCl (pH 7.4), 10 mM MgSO4, and 0.01% (wt/vol)
gelatin. A few drops of chloroform saturated with sodium bicarbonate was also added to the phage
lysates to maintain sterility. EOP was calculated after overnight incubation of serial dilutions of phage
lysates in a top-LBA lawn of each bacterial host and recorded as the number of PFU on the test strain
relative to the number of PFU on the control strain. EOPs were calculated using P. atrosepticum wt or a
frame-shifted toxN plasmid strain as the negative control (22).
!M1 genomic sequencing. Bacteriophage DNA was extracted with phenol-chloroform, using Phase
Lock Gel tubes (Eppendorf) and in accordance with the manufacturer’s instructions, as for bacteriophage
#. The extracted DNA was subjected to pyrosequencing on a Roche 454 Genome Sequencer FLX at the
DNA sequencing facility, Department of Biochemistry, University of Cambridge. Contiguous read seg-
ments (contigs) were assembled using Newbler (Roche). The "M1 wild-type sequence was determined
in one lane of the sequencing run. The three escape phage genomes were individually tagged with
independent identifying sequences and then combined and sequenced as a mixture within a second
lane. For each of the four phages, the final assembled sequence consisted of a single contig of
approximately 43,500 bp. The average read length was 250 bp. The wild-type sequence was assembled
from 13,628 reads, leading to approximately 78# coverage of the full sequence. Escape phage "M1-A,
-B, and -D sequences were assembled from 4,925, 5,188, and 5,886 reads, respectively, resulting in
approximately 29# coverage of each sequence.
When the sequence data are viewed, beginning at bp 43572 (in the final "M1 wt sequence), there
are 15 tandem repeats of the 2-bp sequence TG. The number of TG repeats varied between the raw
TABLE 3 Bacterial strains and bacteriophages used in this study




Escherichia coli "2163 F! RP4-2-Tc::Mu dapA::(erm-pir) Kmr 57
E. coli DH5$ F! endA1 glnV44 thi-1 recA1 relA1 gyrA96 deoR nupG purB20 %80dlacZ∆M15
∆(lacZYA-argF)U169 hsdR17(rK! mK$) #!
Gibco/BRL
E. coli ER2566 F! #! fhuA2 [lon] ompT lacZ::T7 gene 1 gal sulA11 ∆(mcrC-mrr)114::IS10
R(mcr-73::miniTn10-TetS)2 R(zgb-210::Tn10) (TetS) endA1 [dcm]
NEB





"M1 Podoviridae, propagated on wt SCRI1043 30
"M1-A ToxINPa escape mutant of "M1 29
"M1-B ToxINPa escape mutant of "M1 29
"M1-C ToxINPa escape mutant of "M1 29
"M1-D ToxINPa escape mutant of "M1 29
"M1-O ToxINPa escape mutant of "M1 This study
"M1-V ToxINPa escape mutant of "M1 This study
"M1-W ToxINPa escape mutant of "M1 This study
"M1-X ToxINPa escape mutant of "M1 This study
"M1-Y ToxINPa escape mutant of "M1 This study
"M1-Z ToxINPa escape mutant of "M1 This study
"M1-Q ToxINPa escape mutant of "M1 This study
"M1-E1 to -E49 ToxINPa escape mutant of "M1 This study
"M1-U1 ToxINPa escape mutant of "M1 on UvrA mutant This study
"M1-U2 ToxINPa escape mutant of "M1 on UvrA mutant This study
"M1-U4 ToxINPa escape mutant of "M1 on UvrA mutant This study
"M1-U5 ToxINPa escape mutant of "M1 on UvrA mutant This study
"M1-U6 ToxINPa escape mutant of "M1 on UvrA mutant This study
"M1-U7 ToxINPa escape mutant of "M1 on UvrA mutant This study
"M1-U8 ToxINPa escape mutant of "M1 on UvrA mutant This study
"M1-U9 ToxINPa escape mutant of "M1 on UvrA mutant This study
"M1-U10 ToxINPa escape mutant of "M1 on UvrA mutant This study
"M1-PL2 TenpINPl escape mutant of "M1 This study
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sequences of each phage, from 17 in !M1-A to 1 in !M1-B and 7 in !M1-D. The exact number of TG
repeats in each phage genome could not be accurately confirmed by sequencing a specific amplicon.
Therefore, in order to sequence this region, it was specifically amplified (primers TRB107/TRB108 and
TRB115/TRB116) and cloned into pBR322 (NEB). From the resulting plasmid DNA, the region was
successfully sequenced on both forward and reverse strands.
Potential ORFs were identified using gene prediction tools such as ORFfinder (https://www.ncbi.nlm
.nih.gov/orffinder/), GeneMark.hmm (47), and Glimmer (48), along with BLAST (31) homology searches
and manual annotation. RBSfinder (49) was used to predict ribosome-binding sites (see Table S1 in the
supplemental material). !M1 tRNAs were identified using tRNAScan-SE (50). The BDGP Neural Network
Promoter Prediction (51) program did not identify any consensus promoters. The program Stretcher,
from the EMBOSS suite (http://www.ebi.ac.uk/Tools/psa/emboss_stretcher/nucleotide.html), was used
for global nucleotide alignments. The !M1 genome was viewed and annotated using Artemis (52).
Plasmid construction. Molecular biology techniques were performed as described previously (53).
All primers were obtained from Sigma-Genosys and Invitrogen and are listed in Table 4. All plasmids
constructed and/or used in this study are listed in Table 5, along with the primers used for their
construction. All recombinant plasmid sequences were verified by DNA sequencing.
Measuring ToxIPa and ToxNPa levels during phage infection. Two cultures of 180 ml of LB
containing Ap were inoculated with 2-ml overnight cultures of P. atrosepticum(pBR322) or P. atrosepti-
cum(pMJ4), respectively. Cultures were grown at 25°C and shaken at 180 rpm to an optical density at 600
nm (OD600) of 1, and each was split into two 80-ml volumes, one of which was infected with phage at
a multiplicity of infection (MOI) of 1, while the other served as a negative control without infection.
Cultures were left for 10 min without shaking for phage adsorption and then shaken at 25°C and 180
rpm. Samples for OD600 measurement, RNA preparation, and protein analysis were taken regularly during
infection. Total RNA was isolated using the TRIzol method and subsequently DNase treated. Cell pellets
for Western blot analysis were resuspended in 1" phosphate-buffered saline (PBS) according to the
OD600 measurement.
Western blot analysis of ToxNPa during infection. One-milliliter samples of the cell cultures were
taken, pelleted, and resuspended in 1" PBS according to the OD600. For samples taken during !M1
phage infection, the protein was quantified using a NanoDrop spectrophotometer (ThermoScientific),
and equal amounts of protein (150 !g) were resolved by 12% PAGE. Proteins were transferred to a
polyvinylidene difluoride (PVDF) membrane and blocked for 1 h in 1" PBS containing 5% milk powder.
Immunodetection of FLAG-tagged ToxN was performed overnight at 4°C in 1" PBS using anti-FLAG M2
antibody (Sigma). Goat anti-mouse IgG-horseradish peroxidase (HRP) (Santa Cruz) was used as a
secondary antibody. Bands were visualized on X-ray film using the SuperSignal West Pico chemilumi-
TABLE 4 Primers used in this study
Primer Sequence (5=–3=) Description
Restriction
site
KDOI TTTTGGATCCGTTTTATCGACATTGTGAACC toxIN locus BamHI
PF147 GTATCTAGAGTAGTCGCCTCTTTTACTTTATTAC toxI XbaI
PF217 TTGTATACTTAAGTTATTGACTCTATAGCTCAG ToxI amplification for S1 nuclease
protection assay
HindIII
PF218 TTGACTATGTAGTCGCCTCTTTTACTTTATTTCGAACCTCGGACCTGCG ToxI amplification for S1 nuclease
protection assay
DrdI
TRB37 CCGGCATATGAAATTCTACACTATATCAAGC Used for ToxIN CBD NdeI
TRB38 GTGGTTGCTCTTCCGCACTCGCCTTCTTCCGTAT Used for ToxIN CBD SapI
TRB107 TTGAATTCTGCGCAAGCAACTGGTGCACC !M1 sequencing primer EcoRI
TRB108 TTAAGCTTCTTGAATCTGTACTCACCG !M1 sequencing primer HindIII
TRB111 TTGAATTCCTGTAGGAGCGTGGAATGC !M1 escape locus EcoRI
TRB115 TTGAATTCCAGGGGTGTTACCTACTCC !M1 sequencing primer EcoRI
TRB116 TTAAGCTTGTAACTGTGCAGTGATACC !M1 sequencing primer HindIII
TRB117 TTGAATTCCCTACAATGCCCCAGATGC !M1 escape locus EcoRI
TRB118 TTAAGCTTACGGTCGTACTTGGCTTCG !M1 escape locus HindIII
TRB125 TTAAGCTTCTAATCCTACGCCTTGTGC !M1 escape locus HindIII
TRB126 TTGAATTCAAGGTGGATGCAACTCGGG !M1 escape locus EcoRI
TRB127 TTAAGCTTCTCTACATCATCCAACATC !M1 escape locus HindIII
TRB128 TTGAATTCGAGCTGCGTGATGAGTTCC !M1 escape locus EcoRI
TRB129 TTGAATTCGCTTACCCGATTATATCC !M1 escape locus EcoRI
TRB130 TTGAATTCCCAATTTAAAATTAATGA !M1 escape locus EcoRI
TRB134 TTAAGCTTATTACTTGTCATCGTCGTCCTTGTAGTCTCCTAGGTACCCCATCTGG !M1 construct 7/ORF23 FLAG HindIII
TRB135 TTAAGCTTAGTGATGGTGATGGTGATGTCCTCCTAGGTACCCCATCTGG !M1 construct 7/ORF23-6His HindIII
TRB332 TTAAGCTTATTACTTGTCATCGTCGTCCTTGTAGTCTCCCAGCATCGGCTTAAGGAAGCG uvrA-FLAG HindIII
TRB337 ATTAGGATCCGATAAGATCGAAGTTCG uvrA primer BamHI
TRB338 ATTAAAGCTTTTACAGCATCGGCTTAAG uvrA primer HindIII
UvrA dnF TTTATTCCGGGAAGTGTGTGAATTTAAATTAGCGAGAGGCCAAATCATG Fwd, 500 bp downstream of uvrA SwaI
UvrA dnR TTATCAGAATTCCTGCCGTGCAGGCAGTTCAG Rev, 500 bp downstream of uvrA EcoRI
UvrA upF TTATCATCTAGATTGCAGTGCGCCTTCGATG Fwd, 500 bp upstream of uvrA XbaI
UvrA upR CATGATTTGGCCTCTCGCTAATTTAAATTCACACACTTCCCGGAATAAA Rev, 500 bp upstream of uvrA SwaI
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nescent substrate kit (Pierce). SdhE-FLAG expressed from pMAT7 (54) was used as a control in the blot
tracking !M1 infection.
S1 nuclease protection assays. An antisense probe covering the complete ToxIPa sequence was
made by amplification of the ToxIPa locus from plasmid pTA110, using primers PF217 and PF218, and
subsequent in vitro transcription and gel extraction of the probe as described previously (55), generating
a uniformly [32P]UTP-labeled antisense transcript. Ten micrograms of DNase-treated total RNA was
hybridized to the antisense probe overnight at 68°C in a total volume of 30 !l containing 22% or 6%
formamide for the !M1 or !M1-O total RNA, respectively, 40 mM PIPES [piperazine-N,N=-bis(2-
ethanesulfonic acid)]-KOH (pH 6.4), 1 mM EDTA, and 400 mM NaCl. Reaction mixtures were treated with
S1 nuclease (Invitrogen) (1 U !l"1) for 1.5 h at 37°C in a total volume of 300 !l 1# S1 nuclease buffer
to degrade any single-stranded nucleic acids. Double-stranded hybridization products were precipitated,
resuspended, and resolved by 10% PAGE. Bands were visualized by phosphorimaging (Bio-Rad Personal
FX phosphorimager).
Toxicity assays. When required, media were supplemented with Ap, D-glucose (glu) at 0.2% (wt/vol),
and L-arabinose (L-ara) at 0.1% (wt/vol). P. atrosepticum strains containing two plasmids were grown as
10-ml overnight cultures, used to inoculate 25 ml LB, Ap, Cm, and glu in 250-ml conical flasks, and grown
at 25°C and 250 rpm, from a starting OD600 of $0.04, until exponential phase ($1 # 108 CFU ml"1).




pACYC184 Cloning vector 59 Cm
pBR322 E. coli cloning vector NEB Ap, Tc
pFR2 Photorhabdus luminescens TT01 full TenpINPl locus 23 pBR322 Ap
pKNG-uvrA UvrA marker exchange construct UvrA upF, UvrA upR, UvrA dnF,
UvrA dnR
pKNG101 Tc, Kan
pKNG101-Tcr Marker exchange suicide vector 60 Tc
pMAT7 SdhE-FLAG expression vector 54 pBAD30 Ap
pMJ4 ToxIPa, ToxNPa-FLAG with native promoter in pBR322 29 pBR322 Ap
pQE80L Protein expression vector Qiagen Ap
pRW50 Promoterless LacZ 38 Tc
pTA46 ToxINPa with native promoter 29 pBR322 Ap
pTA104 ToxINPa promoter 22 pRW50 Tc
pTA110 In vitro transcription vector for antisense ToxIPa RNA PF217, PF218 pBSII SK" Ap
pTRB18-KP14 ToxIPa containing KDO1, PF147 pACYC184 Cm, Tc
pTRB14 ToxNPa CBD TRB37, TRB38 pTA46 Ap
pTRB113 !M1 wt construct 3 TRB126, TRB118 pBAD30 Ap, glu
pTRB114 !M1 wt construct 4 TRB117, TRB127 pBAD30 Ap, glu
pTRB115 !M1 wt construct 5 TRB126, TRB125 pBAD30 Ap, glu
pTRB116 !M1 wt construct 6 TRB128, TRB118 pBAD30 Ap, glu
pTRB121 !M1-B construct 2 TRB117, TRB125 pBAD30 Ap, glu
pTRB123 !M1-B construct 4 TRB117, TRB127 pBAD30 Ap, glu
pTRB124 !M1-B construct 5 TRB126, TRB125 pBAD30 Ap, glù
pTRB133 !M1 wt construct 7 TRB111, TRB125 pBAD30 Ap, glu
pTRB134 !M1 wt construct 8 TRB129, TRB125 pBAD30 Ap, glu
pTRB135 !M1 wt construct 9 TRB130, TRB125 pBAD30 Ap, glu
pTRB136 !M1-A construct 7 TRB111, TRB125 pBAD30 Ap, glu
pTRB139 !M1-B construct 7 TRB111, TRB125 pBAD30 Ap, glu
pTRB140 !M1-B construct 8 TRB129, TRB125 pBAD30 Ap, glu
pTRB141 !M1-B construct 9 TRB130, TRB125 pBAD30 Ap, glu
pTRB148 !M1 wt construct 7-FLAG TRB111, TRB134 pBAD30 Ap, glu
pTRB151 !M1-O construct 7-FLAG TRB111, TRB134 pBAD30 Ap, glu
pTRB153 !M1-W construct 7-FLAG TRB111, TRB134 pBAD30 Ap, glu
pTRB154 !M1-Y construct 7-FLAG TRB111, TRB134 pBAD30 Ap, glu
pTRB155 !M1-D construct 7 TRB111, TRB125 pBAD30 Ap, glu
pTRB156 !M1-O construct 7 TRB111, TRB125 pBAD30 Ap, glu
pTRB157 !M1-V construct 7 TRB111, TRB125 pBAD30 Ap, glu
pTRB158 !M1-W construct 7 TRB111, TRB125 pBAD30 Ap, glu
pTRB159 !M1-Y construct 7 TRB111, TRB125 pBAD30 Ap, glu
pTRB160 !M1 wt LacZ fusion construct TRB117, TRB127 pRW50 Tc
pTRB161 !M1 wt LacZ fusion construct TRB111, TRB127 pRW50 Tc
pTRB162 !M1 wt LacZ fusion construct TRB126, TRB127 pRW50 Tc
pTRB163 !M1-O LacZ fusion construct TRB117, TRB125 pRW50 Tc
pTRB164 !M1 wt LacZ fusion construct TRB117, TRB125 pRW50 Tc
pTRB189 !M1-23-6His TRB111, TRB135 pQE-80L Ap
pTRB190 !M1-O-23-6His TRB111, TRB135 pQE-80L Ap
pTRB300 UvrA-FLAG TRB330, TRB332 pBAD33 Cm, glu
pTRB301 UvrA-6His TRB337, TRB338 pQE-80L Ap
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Samples were removed, washed with PBS, serially diluted, and plated for viable counts at 25°C on
LBA-Ap-Cm plates containing either (i) glu, to repress expression, or (ii) L-ara, to induce expression.
Single-plasmid strains were treated in the same way, except that Cm was omitted from the growth
conditions.
!-Galactosidase assays. Liquid assays for LacZ activity were performed using the substrate 4=-
methylumbelliferyl-!-D-glucuronide (MUG) as described before (56). Briefly, samples of culture (150 "l)
were taken at each time point and frozen at !80°C until required. Ten-microliter aliquots of each sample
culture were frozen at !80°C for 10 min and then thawed at room temperature. Next, 100 "l reaction
buffer (PBS, 400 "g ml!1 lysozyme, 250 "g ml!1 MUG) was added, and samples were immediately
monitored in a Gemini XPS plate reader with the following parameters: excitation, 360 nm; emission, 450
nm; cutoff, 435 nm; eight reads per well; measurements taken every 30 s for 30 min. Relative fluorescence
units min!1 was calculated from a period of linear increase in fluorescence, normalized to the OD600 of
the sample.
Pulldown of ToxINPa and M1-23 from cell lysates. Using "M1 and "M1-O genomic DNA, "M1-23
and M1-O-23 were amplified via PCR using TRB111 and TRB135 as primers. The products were then
digested using the relevant restriction enzymes, ligated into pQE-80L, and then used to transform
ER2566. For the ToxINPa strains, pMJ4 (which contains ToxINPa-FLAG) was used, and a new plasmid was
constructed to make a ToxNPa-chitin binding domain (CBD) fusion. This was produced using pTA46 and
primers TRB37 and TRB38. The plasmid pTRB14 was then used to transform ER2566, which had previously
been transformed with pTRB18-KP14, which contains a ToxIPa sequence.
Expression strains were grown in 2# YT medium (per liter, 16 g tryptone, 10 g yeast extract, 5 g NaCl)
at 37°C until an OD600 of approximately 1. The cultures were then induced with the appropriate
supplement (0.5 mM IPTG for M1-23-6His and M1-O-23-6His) and then left to grow overnight at 18°C. No
inducers were added to the tagged ToxINPa-containing strains, as ToxINPa is constitutively expressed on
pBR322.
Cells were harvested by centrifugation at 8,000 # g, and the pellets were resuspended in 10 ml lysis
buffer (50 mM NaH2PO4·2H2O, 500 mM NaCl, 10 mM imidazole, 10% glycerol, pH 8.0) per 500 ml of
original culture volume. Cells were then lysed by four passes through a high-pressure homogenizer
(EmulsiFlex; at up to 15,000 lb/in2). Lysed cells were centrifuged at 8,000 # g, and the supernatants were
kept for further coimmunoprecipitation experiments.
In the experiments using M1-23-6His and M1-O-23-6His as bait, 1.5 ml Ni2$ resin columns were used
with ToxINPa-FLAG. The columns were equilibrated using 3 column volumes (CV) of lysis buffer before the
His-tagged protein lysates were loaded onto the resin. Loaded resins were washed with 5 CV of wash
buffer 1 (20 mM imidazole), followed by 10 CV of wash buffer 2 (40 mM imidazole). The FLAG-tagged
ToxINPa was then loaded onto the appropriate columns via continuous flow for at least 3 h (often
overnight) before washing with 5 CV wash buffer 1 and 10 CV wash buffer 2.
Samples were eluted from the resin using elution buffer (250 mM imidazole) via three 1-ml fractions
and analyzed by Western blot analysis using antibodies against His (Novagen) and FLAG (Sigma) tags.
Briefly, samples were run on 12.5% Tris-Tricine gels and transferred onto Immobilon-P PVDF membranes
(pore size, 0.45 "m; Millipore) at 250 mA for 90 min. Membranes were then blocked with a 5% milk plus
PBST (PBS with Tween 20) solution for 1 h before incubation with anti-His and anti-FLAG antibodies at
1:10,000 for 2 h. After incubation, the membranes were washed three times for 5 min each in PBST and
then incubated with the secondary anti-mouse antibody (Sigma) at 1:10,000 for 1 h before they were
washed again three times for 5 min each in PBST. The blots were then probed with Immobilon-Western
chemiluminescent HRP-substrate (Millipore) and developed.
For experiments in which ToxINPa was used as the bait, the strain expressing ToxINPa-CBD was used
with 1 ml chitin resin. The protocol and buffers used were as described by the manufacturer (NEB). Briefly,
the ToxINPa-CBD lysate was loaded onto the column and washed with 40 ml of column buffer. The M1-23
or control pQE-80L lysates were then added to their respective columns. The columns were washed twice
with 10 ml and then 27 ml of column buffer, followed by a dithiothreitol (DTT) flush, 5 to 7 ml for 10 min.
Columns were then left to incubate overnight at room temperature. After incubation, elution was carried
out using 15 ml of column buffer. Western blot analyses were then performed on the samples as
previously described.
Measuring ToxIPa levels after ToxINPa pulldown with M1-23. ToxIPa levels were measured in the
eluted fractions of the ToxINPa-CBD chitin resin column experiments. Samples from cultures either
expressing M1-23 or containing the pQE-80L vector control were separated by electrophoresis at 80 V,
using a 1% (wt/vol) agarose gel made with 0.5# TAE (Tris-acetate-EDTA). Additionally, samples were also
measured with a NanoDrop spectrophotometer (Labtech; ND-1000).
Coimmunoprecipitation of UvrA and M1-23. UvrA-6His was constructed by amplification from the
E. coli W3110 genome using primers TRB337 and TRB338. PCR products were then digested with the
appropriate restriction enzymes, and the digested product was purified and then ligated into pQE-80L
to generate UvrA with an N-terminal His tag, pTRB301. This plasmid was then used to transform the E.
coli expression strain ER2566. Likewise, UvrA-FLAG was constructed in a similar way but using primers
TRB330 and TRB332 and ligated into pBAD33.
Expression and subsequent experiments were performed as described earlier using His-tagged
proteins as bait on Ni2$ resin. Expression of UvrA-FLAG was induced by the addition of 0.02% arabinose.
Construction of the P. atrosepticum uvrA mutant. The uvrA mutant of P. atrosepticum was
constructed via allelic exchange. This was performed using the plasmid pKNG-uvrA, which was derived
from pKNG101. The plasmid was constructed by first amplifying 500-bp regions up- and downstream of
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the uvrA gene in P. atrosepticum SCRI1043. These two sequences were then ligated together with a
kanamycin cassette inserted in between.
The suicide vector derivative pKNG-uvrA was used to transform E. coli !2163 and grown overnight
in the appropriate selective medium. This served as the donor strain and, along with an overnight culture
of the recipient strain, P. atrosepticum SCRI1043, was pelleted and resuspended in LB. Both cultures were
then mixed at the ratios of 2:1, 1:1, and 1:2 up to a final volume of 100 "l. The resulting mixtures
were then spotted on DAPA-containing plates and incubated at 25°C for 24 h. After mating, the patches
were resuspended in 100 "l LB, serially diluted, and spread onto LBA plates containing tetracycline.
These plates were incubated for 2 days at 25°C, and colonies that appeared were picked and grown in
LB overnight. The subsequent overnight cultures were serially diluted, and 50-"l samples were plated
onto LBA plates containing 10% (wt/vol) sucrose. Colonies were also patched onto LBA plates containing
kanamycin, and the gene deletion was confirmed using colony PCR and DNA sequencing. The strain was
confirmed phenotypically as UvrA negative by demonstrating a hypersensitivity to UV light (see Fig. S1
in the supplemental material).
Accession number(s). The genome of !M1 has been submitted to GenBank under the accession
number JX290549.
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